PSMD14 Data Analysis

HGNC Gene Name
proteasome 26S subunit, non-ATPase 14
HGNC Gene Symbol
PSMD14
Identifiers
hgnc:16889 NCBIGene:10213 uniprot:O00487
Orthologs
mgi:1913284 rgd:1594532
INDRA Statements
deubiquitinations all statements
Pathway Commons
Search for PSMD14
Number of Papers
102 retrieved on 2023-02-19

DepMap Analysis

The Dependency Map (DepMap) is a genome-wide pooled CRISPR-Cas9 knockout proliferation screen conducted in more than 700 cancer cell lines spanning many different tumor lineages. Each cell line in the DepMap contains a unique barcode, and each gene knockout is assigned a “dependency score” on a per cell-line basis which quantifies the rate of CRISPR-Cas9 guide drop. It has been found that proteins with similar DepMap scores across cell lines, a phenomenon known as co-dependent genes, have closely related biological functions. This can include activity in the same or parallel pathways or membership in the same protein complex or the same pathway.

We identified the strongest seven co-dependent genes (“Symbol”) for DUBs and ran GO enrichment analysis. We used Biogrid, IntAct, and Pathway Commons PPIDs, and the NURSA protein-protein interaction databases (PPIDs) to determine whether co-dependent genes interact with one another. The “Evidence” column contains the PPIDs in which the interaction appears as well as whether there is support for the association by an INDRA statement. As another approach to identify potential interactors, we looked at proteomics data from the Broad Institute's Cancer Cell Line Encyclopedia (CCLE) for proteins whose expression across ~375 cell lines strongly correlated with the abundance of each DUB; it has previously been observed that proteins in the same complex are frequently significantly co-expressed. The correlations and associated p-values in the CCLE proteomics dataset are provided. And, we determined whether co-dependent genes yield similar transcriptomic signatures in the Broad Institute's Connectivity Map (CMap). A CMap score greater than 90 is considered significantly similar.

DepMap Correlations

Symbol Name DepMap Correlation Evidence CCLE Correlation CCLE Z-score CCLE p-value (adj) CCLE Significant CMAP Score CMAP Type
CHEK1 checkpoint kinase 1 0.525 Reactome (11) 0.08 0.36 2.08e-01
SMU1 SMU1 DNA replication regulator and spliceosomal factor 0.508 Reactome (1) 0.10 0.46 1.12e-01
PSMA6 proteasome 20S subunit alpha 6 0.49 BioGRID INDRA (1) Reactome (150) 0.62 3.32 2.76e-38
PSMD7 proteasome 26S subunit, non-ATPase 7 0.487 BioGRID IntAct NURSA Pathway Commons INDRA (2) Reactome (151) 0.53 2.85 6.91e-27
HNRNPK heterogeneous nuclear ribonucleoprotein K 0.484 Reactome (5) -0.13 -0.80 1.69e-01
PSMA1 proteasome 20S subunit alpha 1 0.46 BioGRID IntAct INDRA (1) Reactome (150) 0.54 2.87 2.68e-27 99.82 kd
SNRPF small nuclear ribonucleoprotein polypeptide F 0.459 Reactome (5) 0.26 1.37 1.66e-06

Dependency GO Term Enrichment

Gene set enrichment analysis was done on the genes correlated with PSMD14using the terms from Gene Ontology and gene sets derived from the Gene Ontology Annotations database via MSigDB.

Using the biological processes and other Gene Ontology terms from well characterized DUBs as a positive control, several gene set enrichment analyses were considered. Threshold-less methods like GSEA had relatively poor results. Over-representation analysis with a threshold of of the top 7 highest absolute value Dependency Map correlations yielded the best results and is reported below.

GO Identifier GO Name GO Type p-value p-value (adj.) q-value
GO:1902750 negative regulation of cell cycle G2/M phase transition Biological Process 3.06e-08 7.22e-06 2.03e-06
GO:0043620 regulation of DNA-templated transcription in response to stress Biological Process 6.19e-08 1.46e-05 2.05e-06
GO:1902749 regulation of cell cycle G2/M phase transition Biological Process 5.46e-07 1.29e-04 1.21e-05
GO:0006521 regulation of cellular amino acid metabolic process Biological Process 1.10e-06 2.59e-04 1.27e-05
GO:1901988 negative regulation of cell cycle phase transition Biological Process 1.26e-06 2.97e-04 1.27e-05
GO:1905369 endopeptidase complex Cellular Component 1.33e-06 3.14e-04 1.27e-05
GO:0044839 cell cycle G2/M phase transition Biological Process 1.34e-06 3.16e-04 1.27e-05
GO:0061418 regulation of transcription from RNA polymerase II promoter in response to hypoxia Biological Process 2.14e-06 5.04e-04 1.37e-05
GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I Biological Process 2.40e-06 5.67e-04 1.37e-05
GO:0060218 hematopoietic stem cell differentiation Biological Process 2.40e-06 5.67e-04 1.37e-05
GO:0033238 regulation of cellular amine metabolic process Biological Process 2.50e-06 5.89e-04 1.37e-05
GO:0031145 anaphase-promoting complex-dependent catabolic process Biological Process 2.59e-06 6.12e-04 1.37e-05
GO:1901532 regulation of hematopoietic progenitor cell differentiation Biological Process 2.69e-06 6.35e-04 1.37e-05
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process Biological Process 3.56e-06 8.41e-04 1.39e-05
GO:1905368 peptidase complex Cellular Component 3.56e-06 8.41e-04 1.39e-05
GO:0019773 proteasome core complex, alpha-subunit complex Cellular Component 3.26e-06 7.70e-04 1.39e-05
GO:0045930 negative regulation of mitotic cell cycle Biological Process 3.20e-06 7.56e-04 1.39e-05
GO:0010948 negative regulation of cell cycle process Biological Process 4.17e-06 9.84e-04 1.46e-05
GO:0002474 antigen processing and presentation of peptide antigen via MHC class I Biological Process 4.19e-06 9.90e-04 1.46e-05
GO:0070498 interleukin-1-mediated signaling pathway Biological Process 5.05e-06 1.19e-03 1.67e-05
GO:2000736 regulation of stem cell differentiation Biological Process 6.89e-06 1.63e-03 2.08e-05
GO:0009308 amine metabolic process Biological Process 1.18e-05 2.79e-03 3.13e-05
GO:0010565 regulation of cellular ketone metabolic process Biological Process 1.18e-05 2.79e-03 3.13e-05
GO:1901987 regulation of cell cycle phase transition Biological Process 1.31e-05 3.09e-03 3.24e-05
GO:0001738 morphogenesis of a polarized epithelium Biological Process 1.32e-05 3.11e-03 3.24e-05
GO:0090263 positive regulation of canonical Wnt signaling pathway Biological Process 1.44e-05 3.39e-03 3.40e-05
GO:0035567 non-canonical Wnt signaling pathway Biological Process 1.62e-05 3.83e-03 3.71e-05
GO:0002244 hematopoietic progenitor cell differentiation Biological Process 2.09e-05 4.92e-03 4.61e-05
GO:0038095 Fc-epsilon receptor signaling pathway Biological Process 2.33e-05 5.49e-03 4.67e-05
GO:0005839 proteasome core complex Cellular Component 2.21e-05 5.21e-03 4.67e-05
GO:0033209 tumor necrosis factor-mediated signaling pathway Biological Process 2.28e-05 5.39e-03 4.67e-05
GO:0070003 threonine-type peptidase activity Molecular Function 2.44e-05 5.76e-03 4.76e-05
GO:0030177 positive regulation of Wnt signaling pathway Biological Process 2.58e-05 6.09e-03 4.89e-05
GO:0038061 NIK/NF-kappaB signaling Biological Process 2.72e-05 6.41e-03 4.90e-05
GO:0005681 spliceosomal complex Cellular Component 2.76e-05 6.52e-03 4.90e-05
GO:1905330 regulation of morphogenesis of an epithelium Biological Process 2.81e-05 6.63e-03 4.90e-05
GO:0010499 proteasomal ubiquitin-independent protein catabolic process Biological Process 2.94e-05 6.94e-03 5.00e-05
GO:0048002 antigen processing and presentation of peptide antigen Biological Process 3.25e-05 7.68e-03 5.39e-05
GO:0042180 cellular ketone metabolic process Biological Process 3.47e-05 8.18e-03 5.60e-05
GO:0061013 regulation of mRNA catabolic process Biological Process 3.80e-05 8.96e-03 5.86e-05
GO:0070555 response to interleukin-1 Biological Process 3.80e-05 8.96e-03 5.86e-05
GO:0050852 T cell receptor signaling pathway Biological Process 3.97e-05 9.38e-03 5.99e-05
GO:0030178 negative regulation of Wnt signaling pathway Biological Process 4.34e-05 1.02e-02 6.39e-05
GO:0019882 antigen processing and presentation Biological Process 5.41e-05 1.28e-02 7.81e-05
GO:0071453 cellular response to oxygen levels Biological Process 6.25e-05 1.47e-02 8.82e-05
GO:0038093 Fc receptor signaling pathway Biological Process 6.74e-05 1.59e-02 9.31e-05
GO:0048863 stem cell differentiation Biological Process 7.43e-05 1.75e-02 1.01e-04
GO:2000027 regulation of animal organ morphogenesis Biological Process 7.79e-05 1.84e-02 1.03e-04
GO:0071011 precatalytic spliceosome Cellular Component 1.10e-04 2.59e-02 1.42e-04
GO:0006520 cellular amino acid metabolic process Biological Process 1.19e-04 2.82e-02 1.52e-04
GO:0070646 protein modification by small protein removal Biological Process 1.29e-04 3.05e-02 1.62e-04
GO:0050851 antigen receptor-mediated signaling pathway Biological Process 1.40e-04 3.30e-02 1.71e-04
GO:0000209 protein polyubiquitination Biological Process 1.43e-04 3.37e-02 1.71e-04
GO:0034612 response to tumor necrosis factor Biological Process 1.44e-04 3.40e-02 1.71e-04
GO:0002218 activation of innate immune response Biological Process 1.51e-04 3.56e-02 1.76e-04
GO:0060070 canonical Wnt signaling pathway Biological Process 1.72e-04 4.05e-02 1.96e-04
GO:0062012 regulation of small molecule metabolic process Biological Process 1.94e-04 4.58e-02 2.18e-04

Transcriptomics

The following table shows the significantly differentially expressed genes after knocking out PSMD14 using CRISPR-Cas9.

Knockout Differential Expression

Symbol Name log2-fold-change p-value p-value (adj.)
UBC ubiquitin C 2.17e+00 2.48e-278 2.61e-274
FTL ferritin light chain 1.90e+00 9.89e-142 5.20e-138
SQSTM1 sequestosome 1 2.61e+00 7.02e-133 2.46e-129
ANXA1 annexin A1 1.43e+00 5.82e-82 1.53e-78
HSPA8 heat shock protein family A (Hsp70) member 8 1.53e+00 1.51e-73 3.17e-70
MMP1 matrix metallopeptidase 1 1.34e+00 5.13e-65 8.99e-62
LRRC69 leucine rich repeat containing 69 9.60e-01 5.53e-61 8.31e-58
PSMC4 proteasome 26S subunit, ATPase 4 1.55e+00 4.67e-52 6.14e-49
MRNIP MRN complex interacting protein 2.22e+00 2.89e-50 3.37e-47
MT1X metallothionein 1X 1.22e+00 8.06e-49 8.48e-46
MLLT11 MLLT11 transcription factor 7 cofactor 2.43e+00 4.69e-46 4.49e-43
CXCL2 C-X-C motif chemokine ligand 2 2.56e+00 3.56e-42 3.12e-39
SOD1 superoxide dismutase 1 1.33e+00 5.25e-42 4.25e-39
BLVRB biliverdin reductase B 1.58e+00 1.19e-40 8.92e-38
TALDO1 transaldolase 1 1.10e+00 3.52e-40 2.47e-37
GLA galactosidase alpha 1.87e+00 1.14e-35 7.51e-33
FTH1 ferritin heavy chain 1 1.42e+00 3.14e-35 1.91e-32
HSP90AA1 heat shock protein 90 alpha family class A member 1 1.18e+00 3.27e-35 1.91e-32
CXCL3 C-X-C motif chemokine ligand 3 2.64e+00 1.82e-34 1.01e-31
TTC1 tetratricopeptide repeat domain 1 1.19e+00 8.40e-34 4.42e-31
KLF6 Kruppel like factor 6 1.24e+00 4.96e-32 2.49e-29
ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif 1 2.12e+00 5.96e-32 2.85e-29
ATP6V0E1 ATPase H+ transporting V0 subunit e1 9.74e-01 5.18e-30 2.37e-27
RND3 Rho family GTPase 3 1.62e+00 6.43e-30 2.82e-27
MAP1LC3B microtubule associated protein 1 light chain 3 beta 1.62e+00 8.25e-30 3.47e-27
PSMC5 proteasome 26S subunit, ATPase 5 9.80e-01 1.64e-29 6.61e-27
UBB ubiquitin B 6.29e-01 3.05e-26 1.19e-23
PSMB7 proteasome 20S subunit beta 7 9.10e-01 2.47e-25 9.28e-23
DUSP1 dual specificity phosphatase 1 2.21e+00 2.65e-25 9.62e-23
CCL26 C-C motif chemokine ligand 26 2.35e+00 3.62e-25 1.27e-22
TFPI2 tissue factor pathway inhibitor 2 1.32e+00 4.47e-25 1.52e-22
PTMA prothymosin alpha -6.95e-01 4.72e-25 1.55e-22
ANKRD1 ankyrin repeat domain 1 8.56e-01 5.13e-25 1.59e-22
SAT1 spermidine/spermine N1-acetyltransferase 1 1.14e+00 5.03e-25 1.59e-22
HMOX1 heme oxygenase 1 2.21e+00 7.60e-25 2.28e-22
CYB5R1 cytochrome b5 reductase 1 1.60e+00 2.32e-24 6.78e-22
GPX3 glutathione peroxidase 3 1.57e+00 4.64e-24 1.28e-21
ACOT13 acyl-CoA thioesterase 13 1.08e+00 1.40e-23 3.76e-21
HMGN2 high mobility group nucleosomal binding domain 2 -9.32e-01 1.77e-23 4.65e-21
H4C3 H4 clustered histone 3 -1.41e+00 2.52e-23 6.46e-21
POMP proteasome maturation protein 7.03e-01 4.93e-23 1.23e-20
IGFBP4 insulin like growth factor binding protein 4 -1.21e+00 2.75e-22 6.72e-20
GLRX glutaredoxin 1.17e+00 4.47e-22 1.07e-19
ZFAND2A zinc finger AN1-type containing 2A 1.64e+00 5.85e-22 1.37e-19
PSMB2 proteasome 20S subunit beta 2 8.28e-01 1.23e-21 2.81e-19
HSPA5 heat shock protein family A (Hsp70) member 5 8.09e-01 2.20e-21 4.93e-19
DNAJB1 DnaJ heat shock protein family (Hsp40) member B1 1.45e+00 2.84e-21 6.23e-19
ALDH2 aldehyde dehydrogenase 2 family member 1.40e+00 4.68e-21 1.00e-18
CXCL8 C-X-C motif chemokine ligand 8 1.68e+00 4.75e-20 9.99e-18
RNF181 ring finger protein 181 8.08e-01 7.96e-20 1.64e-17
FTLP3 ferritin light chain pseudogene 3 1.40e+00 1.57e-19 3.17e-17
PSMA7 proteasome 20S subunit alpha 7 5.41e-01 1.60e-19 3.18e-17
PSMB4 proteasome 20S subunit beta 4 8.33e-01 2.74e-19 5.34e-17
RPL41 ribosomal protein L41 -5.71e-01 7.96e-18 1.52e-15
PSMA2 proteasome 20S subunit alpha 2 7.30e-01 8.27e-18 1.55e-15
HMGB2 high mobility group box 2 -1.04e+00 9.17e-18 1.69e-15
SPANXB1 SPANX family member B1 5.39e-01 1.61e-17 2.91e-15
DNAJA1 DnaJ heat shock protein family (Hsp40) member A1 7.14e-01 4.05e-17 7.22e-15
VCP valosin containing protein 1.11e+00 4.66e-17 8.17e-15
SELENOK selenoprotein K 8.59e-01 9.33e-17 1.61e-14
HMGB3 high mobility group box 3 -1.15e+00 1.56e-16 2.65e-14
SRGN serglycin 1.08e+00 2.77e-16 4.63e-14
PSMB6 proteasome 20S subunit beta 6 5.54e-01 2.85e-16 4.68e-14
SKP1 S-phase kinase associated protein 1 6.62e-01 2.97e-16 4.81e-14
PSMD2 proteasome 26S subunit ubiquitin receptor, non-ATPase 2 8.10e-01 3.76e-16 5.99e-14
UFD1 ubiquitin recognition factor in ER associated degradation 1 9.90e-01 3.95e-16 6.20e-14
PTTG1 PTTG1 regulator of sister chromatid separation, securin -8.89e-01 8.35e-16 1.29e-13
PSMD8 proteasome 26S subunit, non-ATPase 8 7.63e-01 1.14e-15 1.74e-13
HMGB1 high mobility group box 1 -7.19e-01 1.19e-15 1.78e-13
MGST1 microsomal glutathione S-transferase 1 7.93e-01 1.86e-15 2.75e-13
BIRC5 baculoviral IAP repeat containing 5 -1.17e+00 2.01e-15 2.93e-13
PSMD11 proteasome 26S subunit, non-ATPase 11 6.97e-01 4.13e-15 5.95e-13
PSAP prosaposin 8.64e-01 7.90e-15 1.12e-12
MCUR1 mitochondrial calcium uniporter regulator 1 1.11e+00 1.07e-14 1.50e-12
CCNB1 cyclin B1 -1.04e+00 1.31e-14 1.82e-12
MAP1B microtubule associated protein 1B 8.22e-01 1.65e-14 2.25e-12
PSMA5 proteasome 20S subunit alpha 5 7.54e-01 1.89e-14 2.55e-12
GSTP1 glutathione S-transferase pi 1 6.22e-01 2.02e-14 2.69e-12
CYSTM1 cysteine rich transmembrane module containing 1 1.06e+00 2.88e-14 3.79e-12
RIOK3 RIO kinase 3 1.18e+00 3.20e-14 4.15e-12
PSMA4 proteasome 20S subunit alpha 4 6.89e-01 6.26e-14 8.03e-12
TXNRD1 thioredoxin reductase 1 1.00e+00 7.70e-14 9.76e-12
DDIT3 DNA damage inducible transcript 3 1.35e+00 7.91e-14 9.91e-12
LGALS1 galectin 1 -5.99e-01 9.68e-14 1.20e-11
NAMPT nicotinamide phosphoribosyltransferase 9.24e-01 1.40e-13 1.71e-11
TBCA tubulin folding cofactor A 7.09e-01 1.80e-13 2.16e-11
PSMB1 proteasome 20S subunit beta 1 5.63e-01 2.15e-13 2.54e-11
PSMC6 proteasome 26S subunit, ATPase 6 9.03e-01 2.36e-13 2.76e-11
RB1CC1 RB1 inducible coiled-coil 1 1.33e+00 2.64e-13 3.05e-11
NDUFA4 NDUFA4 mitochondrial complex associated 7.66e-01 3.51e-13 4.01e-11
CTSD cathepsin D 8.03e-01 4.27e-13 4.83e-11
DAP3 death associated protein 3 9.92e-01 4.95e-13 5.53e-11
GABARAPL1 GABA type A receptor associated protein like 1 1.44e+00 6.39e-13 7.08e-11
ANXA7 annexin A7 8.48e-01 1.22e-12 1.34e-10
PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 8.45e-01 1.31e-12 1.42e-10
CXCL1 C-X-C motif chemokine ligand 1 1.38e+00 2.25e-12 2.41e-10
SLC25A5 solute carrier family 25 member 5 -5.56e-01 2.53e-12 2.68e-10
SOD2 superoxide dismutase 2 8.60e-01 3.08e-12 3.24e-10
RIT1 Ras like without CAAX 1 1.09e+00 4.53e-12 4.71e-10
PPIA peptidylprolyl isomerase A -5.60e-01 4.95e-12 5.10e-10
GADD45A growth arrest and DNA damage inducible alpha 1.29e+00 8.26e-12 8.44e-10
EEF1A1 eukaryotic translation elongation factor 1 alpha 1 4.15e-01 9.12e-12 9.22e-10
PIR pirin 1.32e+00 1.08e-11 1.08e-09
ANXA2 annexin A2 4.84e-01 1.09e-11 1.08e-09
RPL11 ribosomal protein L11 -6.26e-01 1.23e-11 1.21e-09
TXNL1 thioredoxin like 1 8.18e-01 1.53e-11 1.49e-09
RPS14 ribosomal protein S14 -5.63e-01 1.64e-11 1.58e-09
PSMA6 proteasome 20S subunit alpha 6 7.45e-01 2.05e-11 1.96e-09
SEM1 SEM1 26S proteasome subunit 4.97e-01 2.18e-11 2.07e-09
BSCL2 BSCL2 lipid droplet biogenesis associated, seipin 1.26e+00 2.64e-11 2.47e-09
RALA RAS like proto-oncogene A 1.05e+00 3.37e-11 3.13e-09
AKR1B1 aldo-keto reductase family 1 member B 6.27e-01 6.51e-11 6.01e-09
FEN1 flap structure-specific endonuclease 1 -1.02e+00 7.34e-11 6.71e-09
BEST1 bestrophin 1 1.02e+00 8.50e-11 7.71e-09
AKR1C1 aldo-keto reductase family 1 member C1 1.25e+00 1.20e-10 1.08e-08
TACSTD2 tumor associated calcium signal transducer 2 1.10e+00 1.70e-10 1.52e-08
CALM2 calmodulin 2 -4.16e-01 1.77e-10 1.57e-08
PRDX1 peroxiredoxin 1 7.28e-01 1.81e-10 1.58e-08
GCNT2 glucosaminyl (N-acetyl) transferase 2 (I blood group) 1.06e+00 2.02e-10 1.75e-08
BLOC1S2 biogenesis of lysosomal organelles complex 1 subunit 2 1.03e+00 2.13e-10 1.84e-08
GHITM growth hormone inducible transmembrane protein 6.17e-01 2.66e-10 2.28e-08
PLAT plasminogen activator, tissue type 7.48e-01 3.09e-10 2.62e-08
PSMA1 proteasome 20S subunit alpha 1 6.49e-01 3.19e-10 2.69e-08
TMA7 translation machinery associated 7 homolog -4.41e-01 4.37e-10 3.65e-08
PSMD13 proteasome 26S subunit, non-ATPase 13 8.49e-01 4.42e-10 3.66e-08
YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma 1.04e+00 4.81e-10 3.95e-08
SLCO4A1 solute carrier organic anion transporter family member 4A1 -1.26e+00 6.47e-10 5.27e-08
CCND1 cyclin D1 -7.47e-01 6.80e-10 5.50e-08
CENPF centromere protein F -9.16e-01 6.85e-10 5.50e-08
IL24 interleukin 24 1.33e+00 7.16e-10 5.71e-08
GCLM glutamate-cysteine ligase modifier subunit 1.05e+00 7.63e-10 6.03e-08
PSMC1 proteasome 26S subunit, ATPase 1 7.38e-01 8.36e-10 6.56e-08
DEK DEK proto-oncogene -8.27e-01 9.18e-10 7.10e-08
NUCKS1 nuclear casein kinase and cyclin dependent kinase substrate 1 -6.73e-01 9.13e-10 7.10e-08
TMEM159 lipid droplet assembly factor 1 1.01e+00 1.02e-09 7.80e-08
TAGLN2 transgelin 2 -7.65e-01 1.14e-09 8.65e-08
HSPH1 heat shock protein family H (Hsp110) member 1 1.09e+00 1.21e-09 9.15e-08
DNAJC2 DnaJ heat shock protein family (Hsp40) member C2 1.18e+00 1.28e-09 9.65e-08
EGR1 early growth response 1 1.22e+00 1.58e-09 1.18e-07
ACTG1 actin gamma 1 -3.75e-01 2.16e-09 1.60e-07
ORC3 origin recognition complex subunit 3 1.19e+00 2.61e-09 1.92e-07
TK1 thymidine kinase 1 -9.65e-01 3.09e-09 2.26e-07
RTN4 reticulon 4 6.96e-01 3.45e-09 2.50e-07
TMEM167A transmembrane protein 167A 6.40e-01 3.53e-09 2.54e-07
SPANXC SPANX family member C 4.84e-01 3.66e-09 2.62e-07
TUBA1B tubulin alpha 1b -4.88e-01 3.69e-09 2.63e-07
ZFP36L1 ZFP36 ring finger protein like 1 8.69e-01 4.34e-09 3.07e-07
TOP2A DNA topoisomerase II alpha -1.19e+00 4.59e-09 3.22e-07
MT2A metallothionein 2A 5.44e-01 5.74e-09 4.00e-07
ABL2 ABL proto-oncogene 2, non-receptor tyrosine kinase 9.57e-01 7.51e-09 5.20e-07
ME1 malic enzyme 1 9.90e-01 8.13e-09 5.59e-07
DPH3 diphthamide biosynthesis 3 9.11e-01 8.41e-09 5.74e-07
FAM241B family with sequence similarity 241 member B 1.14e+00 8.63e-09 5.86e-07
GSR glutathione-disulfide reductase 1.05e+00 1.04e-08 7.04e-07
H2AZ1 H2A.Z variant histone 1 -5.37e-01 1.14e-08 7.65e-07
H2AZ2 H2A.Z variant histone 2 -8.38e-01 1.46e-08 9.70e-07
MED13 mediator complex subunit 13 1.15e+00 1.72e-08 1.14e-06
SPANXA1 sperm protein associated with the nucleus, X-linked, family member A1 6.17e-01 1.88e-08 1.23e-06
CKS1B CDC28 protein kinase regulatory subunit 1B -6.42e-01 1.96e-08 1.28e-06
TIPRL TOR signaling pathway regulator 7.64e-01 2.02e-08 1.31e-06
PSMD3 proteasome 26S subunit, non-ATPase 3 9.10e-01 2.13e-08 1.37e-06
AHSA1 activator of HSP90 ATPase activity 1 8.93e-01 2.30e-08 1.48e-06
MAFG MAF bZIP transcription factor G 1.03e+00 2.59e-08 1.65e-06
KIAA1191 KIAA1191 8.99e-01 3.20e-08 2.03e-06
PSMD12 proteasome 26S subunit, non-ATPase 12 7.17e-01 3.44e-08 2.17e-06
DOCK7 dedicator of cytokinesis 7 3.52e-01 3.67e-08 2.30e-06
NUPR1 nuclear protein 1, transcriptional regulator 8.57e-01 4.08e-08 2.52e-06
YPEL5 yippee like 5 9.51e-01 4.05e-08 2.52e-06
AXL AXL receptor tyrosine kinase -7.18e-01 4.41e-08 2.71e-06
STIP1 stress induced phosphoprotein 1 7.19e-01 4.57e-08 2.79e-06
MYC MYC proto-oncogene, bHLH transcription factor 9.23e-01 5.54e-08 3.37e-06
PHLDA1 pleckstrin homology like domain family A member 1 5.53e-01 5.59e-08 3.38e-06
MORN2 MORN repeat containing 2 1.04e+00 5.88e-08 3.53e-06
WDR83OS WD repeat domain 83 opposite strand 4.33e-01 5.98e-08 3.58e-06
UBXN4 UBX domain protein 4 6.67e-01 6.25e-08 3.72e-06
MKI67 marker of proliferation Ki-67 -1.10e+00 6.45e-08 3.81e-06
VPS53 VPS53 subunit of GARP complex 8.02e-01 6.61e-08 3.88e-06
KIAA1217 KIAA1217 1.02e+00 6.91e-08 4.04e-06
RPL29 ribosomal protein L29 -5.18e-01 7.63e-08 4.43e-06
SLC7A11 solute carrier family 7 member 11 9.75e-01 7.72e-08 4.44e-06
TAF13 TATA-box binding protein associated factor 13 8.33e-01 7.69e-08 4.44e-06
DNAJB6 DnaJ heat shock protein family (Hsp40) member B6 6.14e-01 7.86e-08 4.49e-06
LDHA lactate dehydrogenase A -4.66e-01 8.49e-08 4.83e-06
ABHD4 abhydrolase domain containing 4, N-acyl phospholipase B 9.55e-01 8.59e-08 4.86e-06
DAB2 DAB adaptor protein 2 1.01e+00 9.16e-08 5.15e-06
DYNC1H1 dynein cytoplasmic 1 heavy chain 1 5.89e-01 1.04e-07 5.82e-06
NUSAP1 nucleolar and spindle associated protein 1 -8.83e-01 1.15e-07 6.42e-06
CDC20 cell division cycle 20 -1.01e+00 1.17e-07 6.46e-06
IMPDH2 inosine monophosphate dehydrogenase 2 -7.16e-01 1.20e-07 6.59e-06
ERRFI1 ERBB receptor feedback inhibitor 1 7.69e-01 1.35e-07 7.39e-06
PLAU plasminogen activator, urokinase -9.10e-01 1.42e-07 7.74e-06
S100A10 S100 calcium binding protein A10 -4.50e-01 1.71e-07 9.30e-06
PRXL2C peroxiredoxin like 2C 8.37e-01 1.82e-07 9.82e-06
PLEKHB2 pleckstrin homology domain containing B2 7.70e-01 2.26e-07 1.21e-05
CLIP1 CAP-Gly domain containing linker protein 1 7.69e-01 2.30e-07 1.23e-05
RPLP0 ribosomal protein lateral stalk subunit P0 -4.46e-01 2.42e-07 1.28e-05
RPS8 ribosomal protein S8 -3.75e-01 2.60e-07 1.37e-05
IQGAP3 IQ motif containing GTPase activating protein 3 -1.07e+00 2.78e-07 1.46e-05
MTND1P23 MT-ND1 pseudogene 23 4.39e-01 3.08e-07 1.61e-05
NOG noggin -1.10e+00 3.26e-07 1.70e-05
ZPR1 ZPR1 zinc finger 8.81e-01 3.32e-07 1.72e-05
SNRPD1 small nuclear ribonucleoprotein D1 polypeptide -4.76e-01 3.52e-07 1.82e-05
TUBB2A tubulin beta 2A class IIa 9.10e-01 3.56e-07 1.83e-05
PPIF peptidylprolyl isomerase F 8.62e-01 3.63e-07 1.85e-05
RHOQ ras homolog family member Q 1.05e+00 3.90e-07 1.98e-05
PALM2AKAP2 PALM2 and AKAP2 fusion 8.59e-01 4.01e-07 2.03e-05
CASP4 caspase 4 8.74e-01 4.06e-07 2.04e-05
ARL6IP1 ADP ribosylation factor like GTPase 6 interacting protein 1 -6.64e-01 4.57e-07 2.29e-05
S100A2 S100 calcium binding protein A2 -1.10e+00 4.86e-07 2.42e-05
UBE2V1 ubiquitin conjugating enzyme E2 V1 7.60e-01 4.88e-07 2.42e-05
DNMT1 DNA methyltransferase 1 -7.73e-01 5.46e-07 2.70e-05
TMEM59 transmembrane protein 59 5.62e-01 5.74e-07 2.82e-05
KIF21A kinesin family member 21A 9.02e-01 6.10e-07 2.99e-05
BSDC1 BSD domain containing 1 9.26e-01 6.50e-07 3.15e-05
DUSP5 dual specificity phosphatase 5 9.31e-01 6.48e-07 3.15e-05
ZWINT ZW10 interacting kinetochore protein -8.46e-01 8.25e-07 3.98e-05
HNRNPK heterogeneous nuclear ribonucleoprotein K -5.65e-01 8.46e-07 4.06e-05
SUPT16H SPT16 homolog, facilitates chromatin remodeling subunit -8.12e-01 8.72e-07 4.17e-05
CDCA3 cell division cycle associated 3 -1.16e+00 9.07e-07 4.32e-05
CRK CRK proto-oncogene, adaptor protein 8.28e-01 9.36e-07 4.43e-05
BAG3 BAG cochaperone 3 8.53e-01 9.48e-07 4.47e-05
BABAM1 BRISC and BRCA1 A complex member 1 7.12e-01 1.00e-06 4.70e-05
AKR1C3 aldo-keto reductase family 1 member C3 6.92e-01 1.03e-06 4.81e-05
TM4SF19 transmembrane 4 L six family member 19 9.96e-01 1.04e-06 4.85e-05
PSMB5 proteasome 20S subunit beta 5 4.59e-01 1.38e-06 6.37e-05
SUMO2 small ubiquitin like modifier 2 -4.00e-01 1.38e-06 6.37e-05
H3-3B H3.3 histone B -3.38e-01 1.43e-06 6.53e-05
PSMD14 proteasome 26S subunit, non-ATPase 14 -8.21e-01 1.43e-06 6.53e-05
NT5C2 5'-nucleotidase, cytosolic II 8.94e-01 1.60e-06 7.28e-05
RRAGC Ras related GTP binding C 9.50e-01 1.71e-06 7.73e-05
MAPK10 mitogen-activated protein kinase 10 9.66e-01 1.88e-06 8.49e-05
DUSP10 dual specificity phosphatase 10 9.93e-01 1.90e-06 8.55e-05
AKIRIN1 akirin 1 9.22e-01 1.97e-06 8.78e-05
HNRNPA1 heterogeneous nuclear ribonucleoprotein A1 -5.16e-01 1.97e-06 8.78e-05
PSMA3 proteasome 20S subunit alpha 3 4.82e-01 2.44e-06 1.08e-04
XRCC5 X-ray repair cross complementing 5 -6.35e-01 2.45e-06 1.08e-04
NPLOC4 NPL4 homolog, ubiquitin recognition factor 7.34e-01 2.56e-06 1.13e-04
SCPEP1 serine carboxypeptidase 1 8.67e-01 2.59e-06 1.13e-04
UBE2T ubiquitin conjugating enzyme E2 T -8.77e-01 2.68e-06 1.16e-04
ZC3H12C zinc finger CCCH-type containing 12C 9.76e-01 2.67e-06 1.16e-04
COX6C cytochrome c oxidase subunit 6C 3.97e-01 2.79e-06 1.21e-04
UQCC2 ubiquinol-cytochrome c reductase complex assembly factor 2 -6.01e-01 2.98e-06 1.29e-04
RPS6 ribosomal protein S6 -4.26e-01 3.08e-06 1.32e-04
PELO pelota mRNA surveillance and ribosome rescue factor 7.85e-01 3.38e-06 1.44e-04
MTPN myotrophin 5.22e-01 3.49e-06 1.49e-04
CTH cystathionine gamma-lyase 9.32e-01 3.63e-06 1.54e-04
AKAP2 A-kinase anchoring protein 2 7.76e-01 3.71e-06 1.56e-04
EPAS1 endothelial PAS domain protein 1 9.35e-01 3.71e-06 1.56e-04
FAM32A family with sequence similarity 32 member A 5.51e-01 3.73e-06 1.56e-04
GPATCH2 G-patch domain containing 2 8.52e-01 3.74e-06 1.56e-04
SMG1 SMG1 nonsense mediated mRNA decay associated PI3K related kinase 8.15e-01 3.82e-06 1.59e-04
AP1G1 adaptor related protein complex 1 subunit gamma 1 7.21e-01 3.96e-06 1.64e-04
RAB5IF RAB5 interacting factor 7.47e-01 4.23e-06 1.74e-04
CACYBP calcyclin binding protein 4.29e-01 4.46e-06 1.83e-04
APOL2 apolipoprotein L2 8.31e-01 4.86e-06 1.99e-04
TMEM50B transmembrane protein 50B 8.62e-01 5.08e-06 2.07e-04
DPCD deleted in primary ciliary dyskinesia homolog (mouse) 9.49e-01 5.32e-06 2.16e-04
CLTC clathrin heavy chain 7.61e-01 5.47e-06 2.20e-04
LSM5 LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated -7.38e-01 5.45e-06 2.20e-04
TAX1BP1 Tax1 binding protein 1 6.25e-01 5.72e-06 2.29e-04
TXNL4B thioredoxin like 4B 8.30e-01 5.70e-06 2.29e-04
PPP1R15A protein phosphatase 1 regulatory subunit 15A 8.04e-01 5.83e-06 2.32e-04
RPL24 ribosomal protein L24 -5.67e-01 5.88e-06 2.33e-04
TXN thioredoxin 3.28e-01 5.89e-06 2.33e-04
LAPTM4B lysosomal protein transmembrane 4 beta 7.73e-01 5.96e-06 2.35e-04
BUB3 BUB3 mitotic checkpoint protein -4.35e-01 6.05e-06 2.37e-04
FBXO32 F-box protein 32 8.87e-01 6.28e-06 2.46e-04
FLYWCH1 FLYWCH-type zinc finger 1 8.52e-01 6.99e-06 2.72e-04
TMCO1 transmembrane and coiled-coil domains 1 5.54e-01 7.31e-06 2.84e-04
CAVIN3 caveolae associated protein 3 -6.98e-01 7.43e-06 2.88e-04
PSMD4 proteasome 26S subunit ubiquitin receptor, non-ATPase 4 4.06e-01 7.76e-06 2.99e-04
DNTTIP2 deoxynucleotidyltransferase terminal interacting protein 2 6.11e-01 7.81e-06 3.00e-04
AKR1C2 aldo-keto reductase family 1 member C2 7.77e-01 8.07e-06 3.09e-04
BNIP3L BCL2 interacting protein 3 like 4.89e-01 8.32e-06 3.17e-04
FAM111A FAM111 trypsin like peptidase A -1.03e+00 8.36e-06 3.17e-04
CD59 CD59 molecule (CD59 blood group) -5.04e-01 8.86e-06 3.35e-04
HSPE1 heat shock protein family E (Hsp10) member 1 4.40e-01 9.28e-06 3.50e-04
DCBLD2 discoidin, CUB and LCCL domain containing 2 5.11e-01 9.34e-06 3.51e-04
ATP6V1G1 ATPase H+ transporting V1 subunit G1 5.21e-01 9.45e-06 3.54e-04
COX19 cytochrome c oxidase assembly factor COX19 7.80e-01 9.69e-06 3.59e-04
TEX2 testis expressed 2 8.99e-01 9.69e-06 3.59e-04
TNFRSF10A TNF receptor superfamily member 10a 8.78e-01 9.68e-06 3.59e-04
ATP2B1 ATPase plasma membrane Ca2+ transporting 1 5.71e-01 9.89e-06 3.65e-04
PSMC3 proteasome 26S subunit, ATPase 3 4.07e-01 1.02e-05 3.77e-04
RPL27A ribosomal protein L27a -3.69e-01 1.04e-05 3.81e-04
PRC1 protein regulator of cytokinesis 1 -7.42e-01 1.06e-05 3.86e-04
EIF1 eukaryotic translation initiation factor 1 3.91e-01 1.08e-05 3.92e-04
C6orf62 chromosome 6 open reading frame 62 5.70e-01 1.11e-05 4.02e-04
DNAJB4 DnaJ heat shock protein family (Hsp40) member B4 8.55e-01 1.13e-05 4.08e-04
NDUFB9 NADH:ubiquinone oxidoreductase subunit B9 5.38e-01 1.17e-05 4.19e-04
MT-ND2 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 3.28e-01 1.19e-05 4.26e-04
SHOC2 SHOC2 leucine rich repeat scaffold protein 7.06e-01 1.21e-05 4.30e-04
RPL37A ribosomal protein L37a -5.16e-01 1.21e-05 4.30e-04
ARPP19 cAMP regulated phosphoprotein 19 7.39e-01 1.25e-05 4.44e-04
TP53 tumor protein p53 -9.03e-01 1.28e-05 4.53e-04
ACTB actin beta -3.63e-01 1.33e-05 4.68e-04
NSFL1C NSFL1 cofactor 8.00e-01 1.42e-05 4.98e-04
RPL8 ribosomal protein L8 -2.93e-01 1.45e-05 5.07e-04
RNASEH2A ribonuclease H2 subunit A -6.00e-01 1.47e-05 5.11e-04
PLIN2 perilipin 2 6.44e-01 1.49e-05 5.17e-04
PLP2 proteolipid protein 2 -6.05e-01 1.49e-05 5.17e-04
H3-3A H3.3 histone A -4.85e-01 1.61e-05 5.55e-04
PITHD1 PITH domain containing 1 8.20e-01 1.68e-05 5.78e-04
MED10 mediator complex subunit 10 6.23e-01 1.72e-05 5.90e-04
DOCK9 dedicator of cytokinesis 9 9.05e-01 1.77e-05 6.05e-04
XAGE1A X antigen family member 1A 3.15e-01 1.82e-05 6.21e-04
CCNB2 cyclin B2 -9.13e-01 1.83e-05 6.22e-04
GMNN geminin DNA replication inhibitor -7.15e-01 1.91e-05 6.46e-04
UACA uveal autoantigen with coiled-coil domains and ankyrin repeats -7.96e-01 1.93e-05 6.51e-04
CCDC186 coiled-coil domain containing 186 7.97e-01 1.95e-05 6.56e-04
CHMP5 charged multivesicular body protein 5 6.24e-01 1.97e-05 6.60e-04
CCDC80 coiled-coil domain containing 80 7.63e-01 1.99e-05 6.61e-04
ZNF556 zinc finger protein 556 8.31e-01 1.98e-05 6.61e-04
SNX29 sorting nexin 29 8.87e-01 2.10e-05 6.97e-04
ARIH1 ariadne RBR E3 ubiquitin protein ligase 1 5.28e-01 2.11e-05 6.97e-04
BEX3 brain expressed X-linked 3 -3.63e-01 2.12e-05 6.98e-04
ZNF114 zinc finger protein 114 8.53e-01 2.19e-05 7.20e-04
BLZF1 basic leucine zipper nuclear factor 1 8.18e-01 2.30e-05 7.53e-04
TGFB2 transforming growth factor beta 2 8.85e-01 2.35e-05 7.68e-04
RPS25 ribosomal protein S25 -3.93e-01 2.39e-05 7.79e-04
PFN1 profilin 1 -4.17e-01 2.50e-05 8.13e-04
GSTM3 glutathione S-transferase mu 3 5.83e-01 2.54e-05 8.21e-04
PSME4 proteasome activator subunit 4 8.11e-01 2.58e-05 8.31e-04
ST13 ST13 Hsp70 interacting protein 6.14e-01 2.59e-05 8.31e-04
PLEC plectin -7.36e-01 2.64e-05 8.45e-04
VIM vimentin -4.53e-01 2.64e-05 8.45e-04
SH3GLB1 SH3 domain containing GRB2 like, endophilin B1 6.89e-01 2.66e-05 8.48e-04
MRPS16 mitochondrial ribosomal protein S16 -5.75e-01 2.71e-05 8.61e-04
RACK1 receptor for activated C kinase 1 -2.79e-01 2.72e-05 8.61e-04
MACO1 macoilin 1 8.81e-01 2.82e-05 8.91e-04
ITPRIP inositol 1,4,5-trisphosphate receptor interacting protein 8.27e-01 3.06e-05 9.60e-04
RABEP1 rabaptin, RAB GTPase binding effector protein 1 7.70e-01 3.05e-05 9.60e-04
SEL1L SEL1L adaptor subunit of ERAD E3 ubiquitin ligase 6.96e-01 3.10e-05 9.69e-04
UBE2M ubiquitin conjugating enzyme E2 M 7.18e-01 3.10e-05 9.69e-04
PCYT1A phosphate cytidylyltransferase 1A, choline 7.48e-01 3.25e-05 1.01e-03
TMEM106C transmembrane protein 106C -7.45e-01 3.44e-05 1.07e-03
PIH1D1 PIH1 domain containing 1 -7.03e-01 3.45e-05 1.07e-03
MAP4 microtubule associated protein 4 6.69e-01 3.51e-05 1.08e-03
LRRC75A leucine rich repeat containing 75A -4.33e-01 3.60e-05 1.11e-03
BOLA3 bolA family member 3 -6.52e-01 3.61e-05 1.11e-03
ZRANB2 zinc finger RANBP2-type containing 2 6.10e-01 3.96e-05 1.21e-03
KCMF1 potassium channel modulatory factor 1 7.01e-01 4.61e-05 1.40e-03
MRPL33 mitochondrial ribosomal protein L33 -4.99e-01 4.66e-05 1.42e-03
ZSWIM6 zinc finger SWIM-type containing 6 8.94e-01 4.93e-05 1.49e-03
HUWE1 HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 7.30e-01 5.07e-05 1.53e-03
RPL28 ribosomal protein L28 -7.35e-01 5.54e-05 1.67e-03
MXD1 MAX dimerization protein 1 7.99e-01 5.58e-05 1.68e-03
OSER1 oxidative stress responsive serine rich 1 6.40e-01 5.68e-05 1.70e-03
TANGO2 transport and golgi organization 2 homolog 8.32e-01 5.68e-05 1.70e-03
TMEM258 transmembrane protein 258 -4.57e-01 5.91e-05 1.76e-03
PSMD6 proteasome 26S subunit, non-ATPase 6 5.60e-01 5.96e-05 1.77e-03
KLHL21 kelch like family member 21 7.17e-01 6.17e-05 1.83e-03
NEK1 NIMA related kinase 1 7.22e-01 6.18e-05 1.83e-03
PNRC1 proline rich nuclear receptor coactivator 1 8.33e-01 6.25e-05 1.84e-03
JKAMP JNK1/MAPK8 associated membrane protein 6.49e-01 6.32e-05 1.86e-03
MCM3 minichromosome maintenance complex component 3 -7.71e-01 6.69e-05 1.96e-03
S100A6 S100 calcium binding protein A6 -3.54e-01 6.83e-05 2.00e-03
NUFIP2 nuclear FMR1 interacting protein 2 7.18e-01 7.00e-05 2.04e-03
USP14 ubiquitin specific peptidase 14 6.72e-01 7.25e-05 2.11e-03
NSUN3 NOP2/Sun RNA methyltransferase 3 8.16e-01 7.45e-05 2.16e-03
OXR1 oxidation resistance 1 8.31e-01 7.65e-05 2.21e-03
VLDLR very low density lipoprotein receptor 7.60e-01 7.85e-05 2.26e-03
TUBG1 tubulin gamma 1 -5.56e-01 7.90e-05 2.27e-03
PBK PDZ binding kinase -7.97e-01 8.08e-05 2.31e-03
ATAD2 ATPase family AAA domain containing 2 -7.01e-01 8.13e-05 2.32e-03
ARL1 ADP ribosylation factor like GTPase 1 5.98e-01 8.59e-05 2.45e-03
CDKL5 cyclin dependent kinase like 5 6.83e-01 8.60e-05 2.45e-03
RPS27 ribosomal protein S27 -3.11e-01 8.63e-05 2.45e-03
KCNG4 potassium voltage-gated channel modifier subfamily G member 4 7.61e-01 8.82e-05 2.49e-03
UBE2H ubiquitin conjugating enzyme E2 H 6.88e-01 8.82e-05 2.49e-03
PFDN5 prefoldin subunit 5 3.99e-01 8.91e-05 2.50e-03
ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 -9.32e-01 9.00e-05 2.52e-03
DEPDC1 DEP domain containing 1 -8.20e-01 9.43e-05 2.64e-03
MACF1 microtubule actin crosslinking factor 1 5.97e-01 9.47e-05 2.64e-03
VPS29 VPS29 retromer complex component 3.72e-01 9.87e-05 2.75e-03
WASHC2A WASH complex subunit 2A 7.92e-01 9.91e-05 2.75e-03
SIRT7 sirtuin 7 7.47e-01 9.99e-05 2.76e-03
IL6ST interleukin 6 cytokine family signal transducer 6.15e-01 1.00e-04 2.77e-03
GPATCH2L G-patch domain containing 2 like 7.79e-01 1.02e-04 2.81e-03
TRAM1 translocation associated membrane protein 1 6.70e-01 1.03e-04 2.83e-03
EMC3 ER membrane protein complex subunit 3 5.32e-01 1.07e-04 2.92e-03
HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 6.77e-01 1.07e-04 2.93e-03
TOX4 TOX high mobility group box family member 4 6.21e-01 1.08e-04 2.95e-03
RPL13A ribosomal protein L13a -3.27e-01 1.09e-04 2.96e-03
NDRG1 N-myc downstream regulated 1 6.78e-01 1.10e-04 2.99e-03
CDK1 cyclin dependent kinase 1 -8.61e-01 1.11e-04 2.99e-03
NXPE3 neurexophilin and PC-esterase domain family member 3 7.86e-01 1.13e-04 3.04e-03
ARL6IP4 ADP ribosylation factor like GTPase 6 interacting protein 4 -7.39e-01 1.14e-04 3.06e-03
SESN2 sestrin 2 6.90e-01 1.17e-04 3.14e-03
KCTD5 potassium channel tetramerization domain containing 5 7.35e-01 1.20e-04 3.17e-03
KIF1B kinesin family member 1B 6.81e-01 1.20e-04 3.17e-03
LRR1 leucine rich repeat protein 1 -6.98e-01 1.19e-04 3.17e-03
PSMC2 proteasome 26S subunit, ATPase 2 5.21e-01 1.19e-04 3.17e-03
TM2D2 TM2 domain containing 2 6.78e-01 1.20e-04 3.17e-03
ZNF271P zinc finger protein 271, pseudogene 6.15e-01 1.19e-04 3.17e-03
SRXN1 sulfiredoxin 1 5.94e-01 1.23e-04 3.25e-03
RPL36AL ribosomal protein L36a like -2.70e-01 1.25e-04 3.29e-03
SGO1 shugoshin 1 -1.00e+00 1.28e-04 3.37e-03
GDF15 growth differentiation factor 15 7.32e-01 1.31e-04 3.42e-03
IBTK inhibitor of Bruton tyrosine kinase 7.46e-01 1.33e-04 3.46e-03
PCLAF PCNA clamp associated factor -6.37e-01 1.33e-04 3.46e-03
RRM2 ribonucleotide reductase regulatory subunit M2 -6.24e-01 1.33e-04 3.46e-03
SRSF3 serine and arginine rich splicing factor 3 -3.66e-01 1.33e-04 3.46e-03
SLC3A2 solute carrier family 3 member 2 6.45e-01 1.38e-04 3.56e-03
IST1 IST1 factor associated with ESCRT-III 6.81e-01 1.47e-04 3.78e-03
TPX2 TPX2 microtubule nucleation factor -6.32e-01 1.48e-04 3.81e-03
PLBD2 phospholipase B domain containing 2 7.73e-01 1.50e-04 3.84e-03
ARID3A AT-rich interaction domain 3A 4.21e-01 1.53e-04 3.90e-03
RHEB Ras homolog, mTORC1 binding 4.98e-01 1.55e-04 3.94e-03
SERPINB10 serpin family B member 10 9.49e-01 1.55e-04 3.94e-03
TNPO1 transportin 1 6.00e-01 1.55e-04 3.94e-03
GTF2F1 general transcription factor IIF subunit 1 6.18e-01 1.59e-04 4.02e-03
TIMP3 TIMP metallopeptidase inhibitor 3 -5.35e-01 1.61e-04 4.07e-03
NSA2 NSA2 ribosome biogenesis factor 6.00e-01 1.62e-04 4.09e-03
PFDN4 prefoldin subunit 4 5.35e-01 1.67e-04 4.21e-03
FLCN folliculin 6.10e-01 1.69e-04 4.25e-03
TIMP1 TIMP metallopeptidase inhibitor 1 -3.97e-01 1.75e-04 4.38e-03
RTF2 replication termination factor 2 4.53e-01 1.78e-04 4.43e-03
USP34 ubiquitin specific peptidase 34 6.58e-01 1.78e-04 4.43e-03
UBE2C ubiquitin conjugating enzyme E2 C -6.95e-01 1.79e-04 4.46e-03
MARCKSL1 MARCKS like 1 -9.68e-01 1.90e-04 4.70e-03
ECI2 enoyl-CoA delta isomerase 2 4.14e-01 1.90e-04 4.71e-03
VIPAS39 VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog 7.36e-01 1.94e-04 4.79e-03
ITGB1 integrin subunit beta 1 -4.26e-01 1.99e-04 4.91e-03
RHBG Rh family B glycoprotein 7.46e-01 2.01e-04 4.94e-03
EEF1D eukaryotic translation elongation factor 1 delta -7.03e-01 2.14e-04 5.26e-03
NAMPTP1 nicotinamide phosphoribosyltransferase pseudogene 1 6.05e-01 2.28e-04 5.56e-03
ETFDH electron transfer flavoprotein dehydrogenase 5.87e-01 2.28e-04 5.56e-03
RSL24D1 ribosomal L24 domain containing 1 5.91e-01 2.30e-04 5.60e-03
ZFAND3 zinc finger AN1-type containing 3 6.80e-01 2.33e-04 5.65e-03
ENAH ENAH actin regulator 7.22e-01 2.38e-04 5.77e-03
ANAPC11 anaphase promoting complex subunit 11 -4.09e-01 2.40e-04 5.80e-03
ISG15 ISG15 ubiquitin like modifier -5.91e-01 2.46e-04 5.92e-03
SUPV3L1 Suv3 like RNA helicase 7.02e-01 2.48e-04 5.97e-03
ILF2 interleukin enhancer binding factor 2 -4.41e-01 2.49e-04 5.97e-03
EIF3F eukaryotic translation initiation factor 3 subunit F 5.42e-01 2.50e-04 5.98e-03
JMJD6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase 7.24e-01 2.53e-04 6.04e-03
RPS2 ribosomal protein S2 -5.12e-01 2.58e-04 6.14e-03
LHFPL2 LHFPL tetraspan subfamily member 2 7.86e-01 2.59e-04 6.15e-03
SLC13A5 solute carrier family 13 member 5 6.69e-01 2.60e-04 6.16e-03
TBC1D1 TBC1 domain family member 1 7.52e-01 2.72e-04 6.42e-03
RFC4 replication factor C subunit 4 -6.92e-01 2.80e-04 6.60e-03
WIPI2 WD repeat domain, phosphoinositide interacting 2 6.69e-01 2.80e-04 6.60e-03
PTGIR prostaglandin I2 receptor 7.69e-01 2.87e-04 6.72e-03
TRIM11 tripartite motif containing 11 5.90e-01 2.87e-04 6.72e-03
RPL38 ribosomal protein L38 -3.66e-01 2.91e-04 6.79e-03
UEVLD UEV and lactate/malate dehyrogenase domains 7.16e-01 2.91e-04 6.79e-03
SPANXD SPANX family member D 6.29e-01 2.96e-04 6.89e-03
ADORA2B adenosine A2b receptor -8.06e-01 2.99e-04 6.94e-03
XPO4 exportin 4 7.63e-01 3.01e-04 6.97e-03
PHKB phosphorylase kinase regulatory subunit beta 7.25e-01 3.02e-04 6.99e-03
AFMID arylformamidase 5.14e-01 3.03e-04 7.00e-03
IRF2BPL interferon regulatory factor 2 binding protein like 3.52e-01 3.23e-04 7.43e-03
SNRPG small nuclear ribonucleoprotein polypeptide G -4.38e-01 3.24e-04 7.44e-03
ATP6V1B2 ATPase H+ transporting V1 subunit B2 6.69e-01 3.26e-04 7.47e-03
DHDDS dehydrodolichyl diphosphate synthase subunit 7.08e-01 3.27e-04 7.47e-03
MTRNR2L12 MT-RNR2 like 12 4.00e-01 3.28e-04 7.47e-03
CSF3 colony stimulating factor 3 8.02e-01 3.30e-04 7.51e-03
KIF20B kinesin family member 20B -8.07e-01 3.30e-04 7.51e-03
SLC29A1 solute carrier family 29 member 1 (Augustine blood group) -6.87e-01 3.35e-04 7.60e-03
PLAC8 placenta associated 8 -6.38e-01 3.38e-04 7.65e-03
AIDA axin interactor, dorsalization associated 6.96e-01 3.40e-04 7.67e-03
HSD17B12 hydroxysteroid 17-beta dehydrogenase 12 6.46e-01 3.41e-04 7.69e-03
ELOVL6 ELOVL fatty acid elongase 6 -7.60e-01 3.53e-04 7.89e-03
GABRG2 gamma-aminobutyric acid type A receptor subunit gamma2 6.91e-01 3.53e-04 7.89e-03
TGFBRAP1 transforming growth factor beta receptor associated protein 1 6.47e-01 3.52e-04 7.89e-03
TMSB10 thymosin beta 10 -3.04e-01 3.52e-04 7.89e-03
FNDC3B fibronectin type III domain containing 3B 6.81e-01 3.55e-04 7.90e-03
FAM217B family with sequence similarity 217 member B 7.04e-01 3.73e-04 8.25e-03
GOLGA3 golgin A3 5.12e-01 3.73e-04 8.25e-03
MRPL34 mitochondrial ribosomal protein L34 -7.69e-01 3.73e-04 8.25e-03
WASHC2C WASH complex subunit 2C 7.51e-01 3.73e-04 8.25e-03
HSP90AB1 heat shock protein 90 alpha family class B member 1 5.66e-01 3.80e-04 8.38e-03
CDCA8 cell division cycle associated 8 -6.80e-01 3.85e-04 8.47e-03
SOX4 SRY-box transcription factor 4 -7.44e-01 3.89e-04 8.54e-03
DCP1A decapping mRNA 1A 4.16e-01 3.95e-04 8.61e-03
H2AC14 H2A clustered histone 14 -8.62e-01 3.94e-04 8.61e-03
CHMP1B charged multivesicular body protein 1B 6.13e-01 3.97e-04 8.64e-03
TMED5 transmembrane p24 trafficking protein 5 5.98e-01 4.01e-04 8.72e-03
RHBDD3 rhomboid domain containing 3 8.18e-01 4.03e-04 8.73e-03
CKLF chemokine like factor -5.44e-01 4.16e-04 8.99e-03
CLU clusterin 6.60e-01 4.16e-04 8.99e-03
PPHLN1 periphilin 1 6.37e-01 4.21e-04 9.07e-03
STMN1 stathmin 1 -3.23e-01 4.29e-04 9.22e-03
TFG trafficking from ER to golgi regulator 5.52e-01 4.30e-04 9.24e-03
CEP290 centrosomal protein 290 6.74e-01 4.34e-04 9.30e-03
NFAT5 nuclear factor of activated T cells 5 7.15e-01 4.40e-04 9.41e-03
SAMD4B sterile alpha motif domain containing 4B 6.79e-01 4.45e-04 9.48e-03
SEC14L1 SEC14 like lipid binding 1 5.30e-01 4.50e-04 9.55e-03
HYLS1 HYLS1 centriolar and ciliogenesis associated -7.49e-01 4.59e-04 9.73e-03
EPDR1 ependymin related 1 7.39e-01 4.62e-04 9.77e-03
HSBP1 heat shock factor binding protein 1 3.46e-01 4.65e-04 9.83e-03
AURKB aurora kinase B -6.55e-01 4.67e-04 9.85e-03
MYL12A myosin light chain 12A -2.93e-01 4.89e-04 1.03e-02
COLGALT1 collagen beta(1-O)galactosyltransferase 1 -5.99e-01 5.07e-04 1.06e-02
ZNF22 zinc finger protein 22 -6.70e-01 5.07e-04 1.06e-02
DST dystonin 5.33e-01 5.14e-04 1.07e-02
NENF neudesin neurotrophic factor 5.60e-01 5.14e-04 1.07e-02
MT-CO3 mitochondrially encoded cytochrome c oxidase III 2.03e-01 5.16e-04 1.07e-02
C2CD3 C2 domain containing 3 centriole elongation regulator 6.75e-01 5.18e-04 1.08e-02
RPS3A ribosomal protein S3A -3.41e-01 5.26e-04 1.09e-02
EIF1AX eukaryotic translation initiation factor 1A X-linked 4.28e-01 5.31e-04 1.10e-02
TMEM33 transmembrane protein 33 5.10e-01 5.34e-04 1.10e-02
CD63 CD63 molecule 3.25e-01 5.42e-04 1.12e-02
NFE2L2 nuclear factor, erythroid 2 like 2 5.96e-01 5.46e-04 1.12e-02
NIT2 nitrilase family member 2 5.38e-01 5.53e-04 1.14e-02
GAS6 growth arrest specific 6 -6.98e-01 5.62e-04 1.15e-02
SCIMP SLP adaptor and CSK interacting membrane protein 7.04e-01 5.61e-04 1.15e-02
MYEOV myeloma overexpressed -7.71e-01 5.64e-04 1.15e-02
GPAA1 glycosylphosphatidylinositol anchor attachment 1 -7.92e-01 5.69e-04 1.16e-02
NMT1 N-myristoyltransferase 1 5.80e-01 5.69e-04 1.16e-02
CACNB4 calcium voltage-gated channel auxiliary subunit beta 4 6.87e-01 5.71e-04 1.16e-02
NDUFAB1 NADH:ubiquinone oxidoreductase subunit AB1 4.58e-01 5.74e-04 1.16e-02
RPA3 replication protein A3 -6.81e-01 5.74e-04 1.16e-02
GOLGA5 golgin A5 7.34e-01 5.78e-04 1.17e-02
HSP90AA2P heat shock protein 90 alpha family class A member 2, pseudogene 6.69e-01 5.80e-04 1.17e-02
EVI5 ecotropic viral integration site 5 5.61e-01 5.85e-04 1.18e-02
KRT18 keratin 18 -5.27e-01 5.93e-04 1.19e-02
HSBP1L1 heat shock factor binding protein 1 like 1 8.28e-01 6.02e-04 1.21e-02
ETNK2 ethanolamine kinase 2 8.43e-01 6.14e-04 1.23e-02
POP1 POP1 homolog, ribonuclease P/MRP subunit 7.47e-01 6.14e-04 1.23e-02
PCSK1N proprotein convertase subtilisin/kexin type 1 inhibitor 5.77e-01 6.22e-04 1.24e-02
SELENOF selenoprotein F 4.16e-01 6.25e-04 1.24e-02
TSC22D2 TSC22 domain family member 2 7.41e-01 6.30e-04 1.25e-02
SETD2 SET domain containing 2, histone lysine methyltransferase 7.04e-01 6.32e-04 1.25e-02
SNX24 sorting nexin 24 5.96e-01 6.31e-04 1.25e-02
MCM4 minichromosome maintenance complex component 4 -8.62e-01 6.40e-04 1.26e-02
SMC1A structural maintenance of chromosomes 1A -5.98e-01 6.42e-04 1.26e-02
RNF19B ring finger protein 19B 6.48e-01 6.48e-04 1.27e-02
ADRM1 ADRM1 26S proteasome ubiquitin receptor 6.82e-01 6.64e-04 1.30e-02
FOXC1 forkhead box C1 6.63e-01 6.67e-04 1.31e-02
KRT7 keratin 7 -8.33e-01 6.74e-04 1.32e-02
MTHFD1 methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 -6.39e-01 6.75e-04 1.32e-02
KPNA2 karyopherin subunit alpha 2 -3.94e-01 6.78e-04 1.32e-02
MMACHC metabolism of cobalamin associated C 5.15e-01 7.02e-04 1.37e-02
ARRDC2 arrestin domain containing 2 6.24e-01 7.08e-04 1.37e-02
KRTCAP2 keratinocyte associated protein 2 -5.19e-01 7.06e-04 1.37e-02
MT-ATP6 mitochondrially encoded ATP synthase membrane subunit 6 2.04e-01 7.07e-04 1.37e-02
IKZF5 IKAROS family zinc finger 5 4.85e-01 7.12e-04 1.37e-02
MTX3 metaxin 3 6.94e-01 7.15e-04 1.38e-02
GBF1 golgi brefeldin A resistant guanine nucleotide exchange factor 1 6.92e-01 7.17e-04 1.38e-02
YIPF1 Yip1 domain family member 1 6.61e-01 7.25e-04 1.39e-02
WASL WASP like actin nucleation promoting factor 7.58e-01 7.30e-04 1.40e-02
MRPL23 mitochondrial ribosomal protein L23 -9.13e-01 7.36e-04 1.41e-02
HS1BP3 HCLS1 binding protein 3 7.39e-01 7.44e-04 1.42e-02
RPL23 ribosomal protein L23 -3.18e-01 7.43e-04 1.42e-02
PPA1 inorganic pyrophosphatase 1 -4.43e-01 7.46e-04 1.42e-02
ARMCX3 armadillo repeat containing X-linked 3 6.41e-01 7.57e-04 1.44e-02
BEX2 brain expressed X-linked 2 7.25e-01 7.66e-04 1.45e-02
RLIM ring finger protein, LIM domain interacting 5.61e-01 7.69e-04 1.46e-02
ODC1 ornithine decarboxylase 1 5.06e-01 7.82e-04 1.48e-02
XAGE1B X antigen family member 1B 4.73e-01 7.86e-04 1.48e-02
H2AJ H2A.J histone -6.80e-01 7.97e-04 1.50e-02
EXOC5 exocyst complex component 5 6.07e-01 8.01e-04 1.50e-02
PTPN21 protein tyrosine phosphatase non-receptor type 21 6.54e-01 8.04e-04 1.51e-02
TMEM127 transmembrane protein 127 6.46e-01 8.06e-04 1.51e-02
TEX264 testis expressed 264, ER-phagy receptor -5.90e-01 8.13e-04 1.52e-02
YWHAQ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta 4.78e-01 8.14e-04 1.52e-02
RPL23A ribosomal protein L23a -5.00e-01 8.17e-04 1.52e-02
LBHD1 LBH domain containing 1 -5.07e-01 8.19e-04 1.52e-02
ATP5ME ATP synthase membrane subunit e -3.88e-01 8.27e-04 1.53e-02
HSF2 heat shock transcription factor 2 7.13e-01 8.26e-04 1.53e-02
CTNNAL1 catenin alpha like 1 -5.92e-01 8.29e-04 1.53e-02
CAMLG calcium modulating ligand 6.23e-01 8.31e-04 1.53e-02
KRT8 keratin 8 -4.34e-01 8.34e-04 1.54e-02
ATG12 autophagy related 12 5.42e-01 8.45e-04 1.55e-02
TOGARAM1 TOG array regulator of axonemal microtubules 1 6.42e-01 8.44e-04 1.55e-02
FOXK1 forkhead box K1 6.10e-01 8.55e-04 1.57e-02
PRPS2 phosphoribosyl pyrophosphate synthetase 2 -6.90e-01 8.70e-04 1.59e-02
MRPL51 mitochondrial ribosomal protein L51 -4.42e-01 8.76e-04 1.60e-02
NTNG1 netrin G1 6.84e-01 8.84e-04 1.61e-02
SEC62 SEC62 homolog, preprotein translocation factor 3.81e-01 8.89e-04 1.61e-02
SPINT2 serine peptidase inhibitor, Kunitz type 2 -4.63e-01 8.88e-04 1.61e-02
PPP1R12A protein phosphatase 1 regulatory subunit 12A 5.18e-01 8.92e-04 1.62e-02
TRIM6 tripartite motif containing 6 5.98e-01 8.94e-04 1.62e-02
MT-ND1 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 2.36e-01 8.97e-04 1.62e-02
RPL10A ribosomal protein L10a 4.13e-01 9.04e-04 1.63e-02
MTLN mitoregulin -5.11e-01 9.16e-04 1.65e-02
HSPB1 heat shock protein family B (small) member 1 5.42e-01 9.23e-04 1.66e-02
CSDE1 cold shock domain containing E1 4.68e-01 9.29e-04 1.67e-02
RRAS2 RAS related 2 6.07e-01 9.37e-04 1.68e-02
LRRIQ1 leucine rich repeats and IQ motif containing 1 5.23e-01 9.39e-04 1.68e-02
SREK1IP1 SREK1 interacting protein 1 5.20e-01 9.53e-04 1.70e-02
GOLGB1 golgin B1 5.68e-01 9.58e-04 1.71e-02
THBS1 thrombospondin 1 -4.87e-01 9.64e-04 1.71e-02
COX8A cytochrome c oxidase subunit 8A -2.87e-01 9.72e-04 1.72e-02
FAM118A family with sequence similarity 118 member A 5.87e-01 9.70e-04 1.72e-02
LSM4 LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated -5.85e-01 9.71e-04 1.72e-02
FOXJ3 forkhead box J3 6.31e-01 9.80e-04 1.72e-02
MRPL17 mitochondrial ribosomal protein L17 -4.42e-01 9.79e-04 1.72e-02
TRIM2 tripartite motif containing 2 6.58e-01 9.79e-04 1.72e-02
ZNF687 zinc finger protein 687 5.58e-01 9.78e-04 1.72e-02
TWNK twinkle mtDNA helicase 6.12e-01 9.85e-04 1.73e-02
BBS4 Bardet-Biedl syndrome 4 7.04e-01 9.96e-04 1.75e-02
BCL2L13 BCL2 like 13 7.39e-01 1.02e-03 1.79e-02
HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase 6.30e-01 1.03e-03 1.79e-02
TMEM14A transmembrane protein 14A -5.45e-01 1.04e-03 1.82e-02
VMP1 vacuole membrane protein 1 4.82e-01 1.05e-03 1.82e-02
HSPA9 heat shock protein family A (Hsp70) member 9 4.08e-01 1.06e-03 1.83e-02
HTATIP2 HIV-1 Tat interactive protein 2 5.94e-01 1.05e-03 1.83e-02
MORC4 MORC family CW-type zinc finger 4 -6.67e-01 1.06e-03 1.83e-02
TMEM223 transmembrane protein 223 -7.26e-01 1.06e-03 1.83e-02
HNRNPC heterogeneous nuclear ribonucleoprotein C -4.17e-01 1.06e-03 1.83e-02
UBTF upstream binding transcription factor -8.43e-01 1.06e-03 1.83e-02
GNPDA1 glucosamine-6-phosphate deaminase 1 6.41e-01 1.07e-03 1.84e-02
GOT2 glutamic-oxaloacetic transaminase 2 6.14e-01 1.08e-03 1.86e-02
REXO2 RNA exonuclease 2 4.43e-01 1.08e-03 1.86e-02
CEBPG CCAAT enhancer binding protein gamma 6.09e-01 1.09e-03 1.86e-02
CST2 cystatin SA 6.20e-01 1.09e-03 1.86e-02
SHLD2 shieldin complex subunit 2 7.50e-01 1.09e-03 1.86e-02
GLRX2 glutaredoxin 2 5.68e-01 1.09e-03 1.86e-02
CYB561D2 cytochrome b561 family member D2 5.50e-01 1.10e-03 1.86e-02
ADK adenosine kinase 4.35e-01 1.11e-03 1.88e-02
NFKBIB NFKB inhibitor beta 6.25e-01 1.10e-03 1.88e-02
RAB10 RAB10, member RAS oncogene family 5.93e-01 1.11e-03 1.88e-02
SPAG1 sperm associated antigen 1 -7.91e-01 1.11e-03 1.88e-02
GTF2H5 general transcription factor IIH subunit 5 -5.13e-01 1.12e-03 1.89e-02
PRR11 proline rich 11 -6.20e-01 1.13e-03 1.91e-02
RRN3P3 RRN3 pseudogene 3 4.55e-01 1.13e-03 1.91e-02
AAK1 AP2 associated kinase 1 5.46e-01 1.14e-03 1.91e-02
CDC6 cell division cycle 6 -7.39e-01 1.14e-03 1.91e-02
HMGA2 high mobility group AT-hook 2 6.23e-01 1.15e-03 1.92e-02
DPM3 dolichyl-phosphate mannosyltransferase subunit 3, regulatory -6.00e-01 1.17e-03 1.96e-02
GOLIM4 golgi integral membrane protein 4 -7.18e-01 1.18e-03 1.97e-02
PHC3 polyhomeotic homolog 3 5.51e-01 1.18e-03 1.97e-02
SEC61B SEC61 translocon subunit beta 3.11e-01 1.20e-03 1.99e-02
BLOC1S3 biogenesis of lysosomal organelles complex 1 subunit 3 5.93e-01 1.21e-03 2.01e-02
SLC25A16 solute carrier family 25 member 16 6.21e-01 1.21e-03 2.01e-02
UBE2D3 ubiquitin conjugating enzyme E2 D3 4.69e-01 1.23e-03 2.04e-02
MGST3 microsomal glutathione S-transferase 3 4.45e-01 1.24e-03 2.04e-02
SBNO1 strawberry notch homolog 1 4.45e-01 1.24e-03 2.04e-02
FADS1 fatty acid desaturase 1 -5.66e-01 1.24e-03 2.05e-02
CDK2 cyclin dependent kinase 2 -7.36e-01 1.28e-03 2.11e-02
WDR43 WD repeat domain 43 4.79e-01 1.29e-03 2.12e-02
SMC4 structural maintenance of chromosomes 4 -6.27e-01 1.30e-03 2.13e-02
SNX12 sorting nexin 12 -6.05e-01 1.30e-03 2.13e-02
FAM136A family with sequence similarity 136 member A -5.09e-01 1.32e-03 2.16e-02
PLPP2 phospholipid phosphatase 2 5.65e-01 1.33e-03 2.17e-02
CITED2 Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 6.18e-01 1.34e-03 2.18e-02
RAB9A RAB9A, member RAS oncogene family 6.09e-01 1.36e-03 2.22e-02
UPRT uracil phosphoribosyltransferase homolog 4.81e-01 1.36e-03 2.22e-02
PEX26 peroxisomal biogenesis factor 26 5.52e-01 1.38e-03 2.25e-02
ARHGAP21 Rho GTPase activating protein 21 6.22e-01 1.39e-03 2.25e-02
HK1 hexokinase 1 5.46e-01 1.41e-03 2.28e-02
IL6 interleukin 6 6.83e-01 1.43e-03 2.31e-02
MAD2L1 mitotic arrest deficient 2 like 1 -5.09e-01 1.43e-03 2.31e-02
COPS4 COP9 signalosome subunit 4 4.95e-01 1.44e-03 2.32e-02
SHISA2 shisa family member 2 -7.68e-01 1.45e-03 2.32e-02
TMEM237 transmembrane protein 237 -6.02e-01 1.45e-03 2.32e-02
PIMREG PICALM interacting mitotic regulator -7.68e-01 1.45e-03 2.33e-02
CDA cytidine deaminase 4.61e-01 1.46e-03 2.33e-02
IGDCC4 immunoglobulin superfamily DCC subclass member 4 6.04e-01 1.46e-03 2.33e-02
TMPO thymopoietin -6.97e-01 1.46e-03 2.33e-02
UBE4A ubiquitination factor E4A 5.69e-01 1.47e-03 2.34e-02
ZNF350 zinc finger protein 350 6.83e-01 1.47e-03 2.34e-02
CST4 cystatin S 4.34e-01 1.49e-03 2.36e-02
CRIPT CXXC repeat containing interactor of PDZ3 domain 5.17e-01 1.49e-03 2.36e-02
ADM adrenomedullin 6.18e-01 1.50e-03 2.38e-02
MPZL1 myelin protein zero like 1 5.82e-01 1.55e-03 2.46e-02
TMEM38A transmembrane protein 38A -6.33e-01 1.56e-03 2.46e-02
SAP18 Sin3A associated protein 18 3.73e-01 1.57e-03 2.47e-02
COA8 cytochrome c oxidase assembly factor 8 5.22e-01 1.59e-03 2.49e-02
PCMT1 protein-L-isoaspartate (D-aspartate) O-methyltransferase 4.15e-01 1.58e-03 2.49e-02
BCAP31 B cell receptor associated protein 31 2.94e-01 1.64e-03 2.57e-02
UTP11 UTP11 small subunit processome component 4.08e-01 1.64e-03 2.57e-02
CAV1 caveolin 1 -4.69e-01 1.65e-03 2.58e-02
IFITM1 interferon induced transmembrane protein 1 -6.89e-01 1.65e-03 2.58e-02
PALLD palladin, cytoskeletal associated protein 5.57e-01 1.65e-03 2.58e-02
ACBD6 acyl-CoA binding domain containing 6 5.56e-01 1.67e-03 2.59e-02
CETN2 centrin 2 5.10e-01 1.66e-03 2.59e-02
NEUROD2 neuronal differentiation 2 1.96e-01 1.71e-03 2.65e-02
ADIPOR1 adiponectin receptor 1 5.64e-01 1.71e-03 2.65e-02
TROAP trophinin associated protein -7.58e-01 1.71e-03 2.65e-02
YWHAH tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta -6.72e-01 1.76e-03 2.72e-02
RAB1A RAB1A, member RAS oncogene family 5.45e-01 1.76e-03 2.72e-02
ENY2 ENY2 transcription and export complex 2 subunit -3.84e-01 1.77e-03 2.72e-02
TIA1 TIA1 cytotoxic granule associated RNA binding protein 6.13e-01 1.78e-03 2.74e-02
CREBRF CREB3 regulatory factor 6.44e-01 1.80e-03 2.77e-02
PAFAH1B1 platelet activating factor acetylhydrolase 1b regulatory subunit 1 5.68e-01 1.82e-03 2.79e-02
TBC1D17 TBC1 domain family member 17 6.70e-01 1.82e-03 2.79e-02
CENPE centromere protein E -7.05e-01 1.85e-03 2.83e-02
RPL13 ribosomal protein L13 -3.57e-01 1.85e-03 2.83e-02
ASPM assembly factor for spindle microtubules -6.86e-01 1.86e-03 2.83e-02
IDI1 isopentenyl-diphosphate delta isomerase 1 4.42e-01 1.86e-03 2.83e-02
TCHP trichoplein keratin filament binding -5.44e-01 1.86e-03 2.83e-02
TADA2B transcriptional adaptor 2B 6.86e-01 1.87e-03 2.84e-02
RESF1 retroelement silencing factor 1 6.06e-01 1.88e-03 2.85e-02
ADGRE5 adhesion G protein-coupled receptor E5 -5.59e-01 1.89e-03 2.86e-02
GOSR1 golgi SNAP receptor complex member 1 5.09e-01 1.91e-03 2.88e-02
COP1 COP1 E3 ubiquitin ligase 5.13e-01 1.91e-03 2.88e-02
KCTD9 potassium channel tetramerization domain containing 9 5.75e-01 1.93e-03 2.91e-02
TMEM208 transmembrane protein 208 5.49e-01 1.94e-03 2.92e-02
C3orf33 chromosome 3 open reading frame 33 6.19e-01 1.97e-03 2.96e-02
HIRIP3 HIRA interacting protein 3 -6.93e-01 1.97e-03 2.96e-02
MCOLN3 mucolipin TRP cation channel 3 5.48e-01 1.97e-03 2.96e-02
POLR2L RNA polymerase II, I and III subunit L -3.06e-01 1.97e-03 2.96e-02
RPL36A ribosomal protein L36a -3.81e-01 1.99e-03 2.98e-02
H6PD hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase -7.19e-01 2.00e-03 2.98e-02
PGS1 phosphatidylglycerophosphate synthase 1 6.46e-01 2.00e-03 2.98e-02
MORF4L2 mortality factor 4 like 2 3.12e-01 2.01e-03 2.99e-02
NDUFA7 NADH:ubiquinone oxidoreductase subunit A7 -5.69e-01 2.01e-03 2.99e-02
NRP1 neuropilin 1 -4.62e-01 2.01e-03 2.99e-02
SCOC short coiled-coil protein 5.28e-01 2.03e-03 3.01e-02
PRCC proline rich mitotic checkpoint control factor 6.14e-01 2.05e-03 3.04e-02
RPL36 ribosomal protein L36 -2.95e-01 2.08e-03 3.08e-02
CENPM centromere protein M -6.14e-01 2.09e-03 3.09e-02
SIVA1 SIVA1 apoptosis inducing factor -5.07e-01 2.12e-03 3.12e-02
NDUFB1 NADH:ubiquinone oxidoreductase subunit B1 -4.02e-01 2.14e-03 3.16e-02
UQCR10 ubiquinol-cytochrome c reductase, complex III subunit X -2.43e-01 2.15e-03 3.17e-02
MT1G metallothionein 1G 6.03e-01 2.16e-03 3.17e-02
CCDC167 coiled-coil domain containing 167 4.05e-01 2.17e-03 3.18e-02
STK17A serine/threonine kinase 17a 5.21e-01 2.17e-03 3.18e-02
ASB6 ankyrin repeat and SOCS box containing 6 6.04e-01 2.21e-03 3.23e-02
NCBP1 nuclear cap binding protein subunit 1 6.04e-01 2.21e-03 3.23e-02
GSTO1 glutathione S-transferase omega 1 4.31e-01 2.23e-03 3.25e-02
MAP4K5 mitogen-activated protein kinase kinase kinase kinase 5 5.92e-01 2.23e-03 3.25e-02
GOLGA4 golgin A4 4.52e-01 2.24e-03 3.26e-02
UPP1 uridine phosphorylase 1 5.34e-01 2.24e-03 3.26e-02
ETFB electron transfer flavoprotein subunit beta -4.89e-01 2.25e-03 3.27e-02
CAB39 calcium binding protein 39 5.64e-01 2.30e-03 3.33e-02
RNF103 ring finger protein 103 6.22e-01 2.33e-03 3.37e-02
DDX3X DEAD-box helicase 3 X-linked 3.80e-01 2.36e-03 3.41e-02
UFM1 ubiquitin fold modifier 1 5.31e-01 2.36e-03 3.41e-02
ESAM endothelial cell adhesion molecule -6.80e-01 2.37e-03 3.42e-02
HNRNPH1 heterogeneous nuclear ribonucleoprotein H1 -3.30e-01 2.39e-03 3.43e-02
RTCA RNA 3'-terminal phosphate cyclase 5.57e-01 2.39e-03 3.43e-02
AAR2 AAR2 splicing factor 6.15e-01 2.43e-03 3.49e-02
SAT2 spermidine/spermine N1-acetyltransferase family member 2 6.26e-01 2.45e-03 3.51e-02
PPP1R37 protein phosphatase 1 regulatory subunit 37 5.82e-01 2.47e-03 3.53e-02
RGS19 regulator of G protein signaling 19 -5.87e-01 2.48e-03 3.54e-02
ATP6V0B ATPase H+ transporting V0 subunit b 3.86e-01 2.50e-03 3.56e-02
PARP2 poly(ADP-ribose) polymerase 2 -7.36e-01 2.50e-03 3.57e-02
SLAIN2 SLAIN motif family member 2 6.14e-01 2.54e-03 3.62e-02
C11orf98 chromosome 11 open reading frame 98 -5.15e-01 2.55e-03 3.63e-02
CHRNB4 cholinergic receptor nicotinic beta 4 subunit 5.87e-01 2.57e-03 3.64e-02
ZNF146 zinc finger protein 146 5.26e-01 2.59e-03 3.67e-02
RPL27 ribosomal protein L27 -3.22e-01 2.59e-03 3.67e-02
NEDD8 NEDD8 ubiquitin like modifier 2.39e-01 2.61e-03 3.69e-02
AURKA aurora kinase A -5.60e-01 2.62e-03 3.69e-02
FAM133A family with sequence similarity 133 member A -6.76e-01 2.61e-03 3.69e-02
ZNF844 zinc finger protein 844 6.40e-01 2.62e-03 3.69e-02
DYNLT3 dynein light chain Tctex-type 3 5.58e-01 2.68e-03 3.76e-02
GOLGA7 golgin A7 5.96e-01 2.68e-03 3.76e-02
NONO non-POU domain containing octamer binding -3.91e-01 2.69e-03 3.77e-02
CBX5 chromobox 5 -5.60e-01 2.72e-03 3.79e-02
PSMD7 proteasome 26S subunit, non-ATPase 7 3.08e-01 2.72e-03 3.79e-02
ZFAND5 zinc finger AN1-type containing 5 5.32e-01 2.71e-03 3.79e-02
MKNK2 MAPK interacting serine/threonine kinase 2 5.75e-01 2.74e-03 3.82e-02
TRAPPC2 trafficking protein particle complex subunit 2 5.31e-01 2.77e-03 3.86e-02
CKAP2L cytoskeleton associated protein 2 like -6.51e-01 2.78e-03 3.87e-02
TIMP2 TIMP metallopeptidase inhibitor 2 4.77e-01 2.79e-03 3.87e-02
UHRF1BP1L UHRF1 binding protein 1 like 4.33e-01 2.79e-03 3.87e-02
WDR59 WD repeat domain 59 6.08e-01 2.80e-03 3.87e-02
CAP1 cyclase associated actin cytoskeleton regulatory protein 1 4.98e-01 2.82e-03 3.90e-02
TGIF1 TGFB induced factor homeobox 1 6.15e-01 2.85e-03 3.94e-02
CTNNA1 catenin alpha 1 3.81e-01 2.85e-03 3.94e-02
API5 apoptosis inhibitor 5 5.96e-01 2.88e-03 3.96e-02
RPS5 ribosomal protein S5 -3.02e-01 2.88e-03 3.96e-02
RFC1 replication factor C subunit 1 -6.00e-01 2.92e-03 4.01e-02
SERPINB2 serpin family B member 2 5.35e-01 2.93e-03 4.03e-02
OGFRL1 opioid growth factor receptor like 1 -5.86e-01 2.94e-03 4.03e-02
USP47 ubiquitin specific peptidase 47 5.91e-01 2.96e-03 4.05e-02
NCAPH non-SMC condensin I complex subunit H -7.27e-01 2.97e-03 4.06e-02
H2AC13 H2A clustered histone 13 -7.81e-01 2.99e-03 4.07e-02
NAV3 neuron navigator 3 6.61e-01 2.99e-03 4.07e-02
RHOJ ras homolog family member J -5.71e-01 2.99e-03 4.07e-02
NDUFC1 NADH:ubiquinone oxidoreductase subunit C1 -3.35e-01 3.06e-03 4.16e-02
SNX19 sorting nexin 19 4.36e-01 3.06e-03 4.16e-02
PSMG3 proteasome assembly chaperone 3 -6.16e-01 3.09e-03 4.19e-02
PWWP2B PWWP domain containing 2B 5.95e-01 3.10e-03 4.20e-02
SNW1 SNW domain containing 1 3.71e-01 3.13e-03 4.23e-02
IFIT3 interferon induced protein with tetratricopeptide repeats 3 -5.72e-01 3.17e-03 4.28e-02
CKAP2 cytoskeleton associated protein 2 -6.03e-01 3.18e-03 4.29e-02
SMG7 SMG7 nonsense mediated mRNA decay factor 6.48e-01 3.19e-03 4.29e-02
EPRS1 glutamyl-prolyl-tRNA synthetase 1 5.05e-01 3.19e-03 4.30e-02
HDAC1 histone deacetylase 1 -4.85e-01 3.21e-03 4.31e-02
DNAJC8 DnaJ heat shock protein family (Hsp40) member C8 3.09e-01 3.24e-03 4.33e-02
RCOR1 REST corepressor 1 5.42e-01 3.23e-03 4.33e-02
TYMS thymidylate synthetase -7.36e-01 3.23e-03 4.33e-02
TRIM28 tripartite motif containing 28 -7.14e-01 3.25e-03 4.35e-02
MAPK12 mitogen-activated protein kinase 12 6.10e-01 3.27e-03 4.36e-02
CHPT1 choline phosphotransferase 1 5.29e-01 3.31e-03 4.41e-02
RNF40 ring finger protein 40 5.49e-01 3.32e-03 4.42e-02
VCL vinculin -6.16e-01 3.32e-03 4.42e-02
TRMT10A tRNA methyltransferase 10A 5.02e-01 3.33e-03 4.42e-02
ABHD3 abhydrolase domain containing 3, phospholipase 6.01e-01 3.35e-03 4.45e-02
ACAA2 acetyl-CoA acyltransferase 2 -6.64e-01 3.36e-03 4.45e-02
OAZ1 ornithine decarboxylase antizyme 1 3.24e-01 3.38e-03 4.47e-02
ARMC10 armadillo repeat containing 10 5.94e-01 3.38e-03 4.47e-02
PHPT1 phosphohistidine phosphatase 1 -4.87e-01 3.39e-03 4.48e-02
PSME2 proteasome activator subunit 2 -3.54e-01 3.40e-03 4.48e-02
RPL32 ribosomal protein L32 -3.33e-01 3.41e-03 4.48e-02
BFAR bifunctional apoptosis regulator 5.94e-01 3.41e-03 4.49e-02
ALDOA aldolase, fructose-bisphosphate A 2.56e-01 3.42e-03 4.49e-02
CCNK cyclin K 6.78e-01 3.43e-03 4.49e-02
TMEM50A transmembrane protein 50A 4.30e-01 3.43e-03 4.49e-02
SEC22B SEC22 homolog B, vesicle trafficking protein 3.97e-01 3.43e-03 4.49e-02
OTUD7B OTU deubiquitinase 7B 5.08e-01 3.48e-03 4.55e-02
NFKBIZ NFKB inhibitor zeta 6.23e-01 3.50e-03 4.56e-02
FAM91A1 family with sequence similarity 91 member A1 6.43e-01 3.50e-03 4.56e-02
LRRFIP2 LRR binding FLII interacting protein 2 5.77e-01 3.51e-03 4.57e-02
PINK1 PTEN induced kinase 1 4.48e-01 3.52e-03 4.57e-02
NOP58 NOP58 ribonucleoprotein -4.88e-01 3.54e-03 4.60e-02
CCL5 C-C motif chemokine ligand 5 5.62e-01 3.59e-03 4.65e-02
PPP2CA protein phosphatase 2 catalytic subunit alpha 4.55e-01 3.60e-03 4.66e-02
HNRNPD heterogeneous nuclear ribonucleoprotein D -5.45e-01 3.61e-03 4.68e-02
EPS15 epidermal growth factor receptor pathway substrate 15 5.68e-01 3.63e-03 4.70e-02
PTMAP5 prothymosin alpha pseudogene 5 -5.06e-01 3.64e-03 4.70e-02
HERC1 HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 5.91e-01 3.66e-03 4.72e-02
CTSC cathepsin C -4.54e-01 3.67e-03 4.72e-02
LAPTM4A lysosomal protein transmembrane 4 alpha 3.30e-01 3.68e-03 4.73e-02
HTN1 histatin 1 6.26e-01 3.71e-03 4.76e-02
RNF10 ring finger protein 10 4.55e-01 3.73e-03 4.78e-02
INAVA innate immunity activator 4.24e-01 3.73e-03 4.78e-02
LMNA lamin A/C -4.79e-01 3.75e-03 4.80e-02
METTL8 methyltransferase like 8 4.95e-01 3.76e-03 4.81e-02
HAUS1 HAUS augmin like complex subunit 1 -5.75e-01 3.78e-03 4.83e-02
RUBCN rubicon autophagy regulator 5.58e-01 3.80e-03 4.84e-02
ATP5MC2 ATP synthase membrane subunit c locus 2 -4.37e-01 3.80e-03 4.84e-02
HFE homeostatic iron regulator 5.49e-01 3.82e-03 4.86e-02
PARK7 Parkinsonism associated deglycase -2.75e-01 3.82e-03 4.86e-02
PDE6D phosphodiesterase 6D -5.69e-01 3.83e-03 4.86e-02
ARF4 ADP ribosylation factor 4 2.88e-01 3.85e-03 4.88e-02
H1-10 H1.10 linker histone -6.85e-01 3.88e-03 4.90e-02
PLEKHH3 pleckstrin homology, MyTH4 and FERM domain containing H3 6.39e-01 3.87e-03 4.90e-02
RFC2 replication factor C subunit 2 -7.42e-01 3.87e-03 4.90e-02
HPF1 histone PARylation factor 1 -7.14e-01 3.88e-03 4.90e-02
SRA1 steroid receptor RNA activator 1 -4.23e-01 3.89e-03 4.90e-02
ENO1 enolase 1 -1.84e-01 3.89e-03 4.90e-02
TPRG1L tumor protein p63 regulated 1 like 5.34e-01 3.90e-03 4.90e-02
SAMD1 sterile alpha motif domain containing 1 -7.56e-01 3.91e-03 4.90e-02
KIAA0232 KIAA0232 5.79e-01 3.92e-03 4.91e-02
LOX lysyl oxidase 5.82e-01 3.92e-03 4.91e-02
BMP4 bone morphogenetic protein 4 -5.74e-01 3.95e-03 4.94e-02
PAICS phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase -4.63e-01 3.95e-03 4.94e-02
MSN moesin 4.20e-01 3.97e-03 4.95e-02
PSEN1 presenilin 1 5.71e-01 3.98e-03 4.96e-02
PRRG3 proline rich and Gla domain 3 3.18e-01 4.01e-03 4.99e-02
ZHX1 zinc fingers and homeoboxes 1 5.36e-01 4.02e-03 4.99e-02

Gene Set Enrichment Analysis

The GSEA method was applied for all genes whose knockout resulted in at least 20 significantly differentially expressed genes.

ID Name p-value p-value (adj.) log2 Error ES NES
msig:M5925 HALLMARK_E2F_TARGETS 3.41e-28 1.33e-24 1.38e+00 -6.37e-01 -3.17e+00
go:0005694 chromosome 3.59e-19 7.01e-16 1.13e+00 -3.79e-01 -2.15e+00
msig:M5901 HALLMARK_G2M_CHECKPOINT 6.38e-19 8.31e-16 1.12e+00 -5.66e-01 -2.80e+00
go:0000793 condensed chromosome 2.19e-16 2.14e-13 1.05e+00 -5.75e-01 -2.74e+00
reactome:R-HSA-449147 Signaling by Interleukins 3.82e-15 2.98e-12 9.97e-01 5.14e-01 2.34e+00
go:0005773 vacuole 1.07e-14 7.00e-12 9.87e-01 4.66e-01 2.17e+00
go:0070498 interleukin-1-mediated signaling pathway 1.48e-14 8.29e-12 9.76e-01 7.36e-01 2.73e+00
go:0098687 chromosomal region 2.11e-14 1.03e-11 9.76e-01 -4.68e-01 -2.36e+00
go:0000228 nuclear chromosome 4.27e-14 1.85e-11 9.65e-01 -4.13e-01 -2.19e+00
go:0048285 organelle fission 1.32e-13 5.15e-11 9.44e-01 -4.52e-01 -2.29e+00
go:0051276 chromosome organization 1.53e-13 5.44e-11 9.44e-01 -3.28e-01 -1.86e+00
go:0002764 immune response-regulating signaling pathway 4.19e-13 1.26e-10 9.33e-01 5.12e-01 2.28e+00
reactome:R-HSA-5358346 Hedgehog ligand biogenesis 4.11e-13 1.26e-10 9.33e-01 7.43e-01 2.69e+00
go:1905368 peptidase complex 5.27e-13 1.40e-10 9.21e-01 6.89e-01 2.61e+00
reactome:R-HSA-8953897 Cellular responses to stimuli 5.36e-13 1.40e-10 9.21e-01 4.52e-01 2.11e+00
reactome:R-HSA-446652 Interleukin-1 family signaling 5.96e-13 1.45e-10 9.21e-01 6.76e-01 2.57e+00
go:1905369 endopeptidase complex 6.79e-13 1.56e-10 9.21e-01 7.28e-01 2.66e+00
go:0019221 cytokine-mediated signaling pathway 8.00e-13 1.74e-10 9.21e-01 4.69e-01 2.16e+00
go:0043620 regulation of DNA-templated transcription in response to stress 8.59e-13 1.77e-10 9.21e-01 6.58e-01 2.57e+00
reactome:R-HSA-9020702 Interleukin-1 signaling 9.13e-13 1.78e-10 9.10e-01 6.99e-01 2.62e+00
go:0140014 mitotic nuclear division 1.01e-12 1.88e-10 9.10e-01 -4.92e-01 -2.44e+00
go:0070555 response to interleukin-1 1.18e-12 2.00e-10 9.10e-01 6.28e-01 2.54e+00
reactome:R-HSA-5668541 TNFR2 non-canonical NF-kB pathway 1.13e-12 2.00e-10 9.10e-01 7.17e-01 2.65e+00
go:0061418 regulation of transcription from RNA polymerase II promoter in response to hypoxia 1.23e-12 2.00e-10 9.10e-01 7.01e-01 2.63e+00
go:0001738 morphogenesis of a polarized epithelium 1.49e-12 2.33e-10 9.10e-01 6.70e-01 2.55e+00
reactome:R-HSA-5607761 Dectin-1 mediated noncanonical NF-kB signaling 2.15e-12 3.23e-10 8.99e-01 7.42e-01 2.69e+00
reactome:R-HSA-1280215 Cytokine Signaling in Immune system 2.62e-12 3.79e-10 8.99e-01 4.40e-01 2.05e+00
reactome:R-HSA-5358351 Signaling by Hedgehog 2.92e-12 4.08e-10 8.99e-01 6.49e-01 2.53e+00
reactome:R-HSA-1640170 Cell Cycle 3.65e-12 4.92e-10 8.87e-01 -3.59e-01 -1.96e+00
go:0038093 Fc receptor signaling pathway 4.51e-12 5.87e-10 8.87e-01 6.27e-01 2.50e+00
go:0007059 chromosome segregation 7.76e-12 9.77e-10 8.75e-01 -4.64e-01 -2.32e+00
reactome:R-HSA-450408 AUF1 (hnRNP D0) binds and destabilizes mRNA 8.36e-12 1.02e-09 8.75e-01 7.32e-01 2.65e+00
reactome:R-HSA-168249 Innate Immune System 8.71e-12 1.03e-09 8.75e-01 4.05e-01 1.94e+00
msig:M10680 KEGG_PROTEASOME 9.82e-12 1.06e-09 8.75e-01 7.80e-01 2.66e+00
reactome:R-HSA-5610780 Degradation of GLI1 by the proteasome 9.57e-12 1.06e-09 8.75e-01 7.30e-01 2.64e+00
reactome:R-HSA-2871837 FCERI mediated NF-kB activation 9.42e-12 1.06e-09 8.75e-01 7.04e-01 2.58e+00
reactome:R-HSA-1234174 Cellular response to hypoxia 1.01e-11 1.06e-09 8.75e-01 6.73e-01 2.54e+00
reactome:R-HSA-5607764 CLEC7A (Dectin-1) signaling 1.03e-11 1.06e-09 8.75e-01 6.82e-01 2.56e+00
reactome:R-HSA-169911 Regulation of Apoptosis 1.30e-11 1.30e-09 8.75e-01 7.38e-01 2.63e+00
reactome:R-HSA-8939902 Regulation of RUNX2 expression and activity 1.33e-11 1.30e-09 8.75e-01 7.17e-01 2.59e+00
reactome:R-HSA-202424 Downstream TCR signaling 1.86e-11 1.78e-09 8.63e-01 7.01e-01 2.57e+00
reactome:R-HSA-202403 TCR signaling 1.97e-11 1.79e-09 8.63e-01 6.78e-01 2.54e+00
reactome:R-HSA-1169091 Activation of NF-kappaB in B cells 1.95e-11 1.79e-09 8.63e-01 7.16e-01 2.60e+00
reactome:R-HSA-180585 Vif-mediated degradation of APOBEC3G 2.13e-11 1.89e-09 8.63e-01 7.26e-01 2.63e+00
reactome:R-HSA-69278 Cell Cycle, Mitotic 2.27e-11 1.97e-09 8.63e-01 -3.68e-01 -1.99e+00
reactome:R-HSA-5610787 Hedgehog 'off' state 2.41e-11 2.00e-09 8.63e-01 6.61e-01 2.50e+00
go:0000819 sister chromatid segregation 2.47e-11 2.01e-09 8.63e-01 -5.10e-01 -2.39e+00
reactome:R-HSA-4608870 Asymmetric localization of PCP proteins 2.67e-11 2.13e-09 8.63e-01 7.34e-01 2.61e+00
go:0044257 cellular protein catabolic process 3.55e-11 2.63e-09 8.51e-01 3.99e-01 1.91e+00
reactome:R-HSA-5678895 Defective CFTR causes cystic fibrosis 3.57e-11 2.63e-09 8.51e-01 7.19e-01 2.60e+00
reactome:R-HSA-4641257 Degradation of AXIN 3.45e-11 2.63e-09 8.51e-01 7.37e-01 2.61e+00
reactome:R-HSA-5619084 ABC transporter disorders 4.40e-11 3.17e-09 8.51e-01 7.10e-01 2.58e+00
reactome:R-HSA-9604323 Negative regulation of NOTCH4 signaling 4.47e-11 3.17e-09 8.51e-01 7.15e-01 2.59e+00
reactome:R-HSA-351202 Metabolism of polyamines 4.58e-11 3.19e-09 8.51e-01 7.19e-01 2.60e+00
reactome:R-HSA-2454202 Fc epsilon receptor (FCERI) signaling 4.87e-11 3.34e-09 8.51e-01 6.51e-01 2.48e+00
reactome:R-HSA-450531 Regulation of mRNA stability by proteins that bind AU-rich elements 5.55e-11 3.74e-09 8.51e-01 6.37e-01 2.46e+00
go:0098813 nuclear chromosome segregation 6.76e-11 4.47e-09 8.39e-01 -4.81e-01 -2.34e+00
go:0050852 T cell receptor signaling pathway 7.06e-11 4.59e-09 8.39e-01 6.14e-01 2.42e+00
reactome:R-HSA-5621481 C-type lectin receptors (CLRs) 8.07e-11 5.17e-09 8.39e-01 6.46e-01 2.47e+00
reactome:R-HSA-4641258 Degradation of DVL 9.24e-11 5.74e-09 8.39e-01 7.17e-01 2.58e+00
reactome:R-HSA-4086400 PCP/CE pathway 9.27e-11 5.74e-09 8.39e-01 6.81e-01 2.51e+00
reactome:R-HSA-8948751 Regulation of PTEN stability and activity 9.40e-11 5.74e-09 8.39e-01 6.91e-01 2.53e+00
reactome:R-HSA-1168372 Downstream signaling events of B Cell Receptor (BCR) 1.00e-10 5.75e-09 8.39e-01 6.76e-01 2.51e+00
go:0038095 Fc-epsilon receptor signaling pathway 9.74e-11 5.75e-09 8.39e-01 6.86e-01 2.53e+00
reactome:R-HSA-5619115 Disorders of transmembrane transporters 9.91e-11 5.75e-09 8.39e-01 6.14e-01 2.41e+00
go:0002253 activation of immune response 9.60e-11 5.75e-09 8.39e-01 4.79e-01 2.15e+00
go:0006521 regulation of cellular amino acid metabolic process 1.11e-10 6.27e-09 8.39e-01 7.22e-01 2.57e+00
reactome:R-HSA-983705 Signaling by the B Cell Receptor (BCR) 1.40e-10 7.72e-09 8.27e-01 6.51e-01 2.47e+00
reactome:R-HSA-8941858 Regulation of RUNX3 expression and activity 1.39e-10 7.72e-09 8.27e-01 7.27e-01 2.57e+00
reactome:R-HSA-5632684 Hedgehog 'on' state 1.46e-10 7.79e-09 8.27e-01 6.83e-01 2.51e+00
go:0000070 mitotic sister chromatid segregation 1.45e-10 7.79e-09 8.27e-01 -5.35e-01 -2.46e+00
reactome:R-HSA-195253 Degradation of beta-catenin by the destruction complex 1.89e-10 9.96e-09 8.27e-01 6.64e-01 2.50e+00
reactome:R-HSA-382556 ABC-family proteins mediated transport 1.93e-10 1.01e-08 8.27e-01 6.85e-01 2.53e+00
go:0038061 NIK/NF-kappaB signaling 1.99e-10 1.02e-08 8.27e-01 6.00e-01 2.39e+00
go:0044433 2.29e-10 1.16e-08 8.27e-01 3.62e-01 1.77e+00
reactome:R-HSA-5658442 Regulation of RAS by GAPs 2.31e-10 1.16e-08 8.27e-01 6.95e-01 2.52e+00
reactome:R-HSA-9013694 Signaling by NOTCH4 2.47e-10 1.20e-08 8.14e-01 6.62e-01 2.47e+00
go:0002218 activation of innate immune response 2.44e-10 1.20e-08 8.14e-01 5.37e-01 2.27e+00
reactome:R-HSA-1236978 Cross-presentation of soluble exogenous antigens (endosomes) 2.61e-10 1.26e-08 8.14e-01 7.46e-01 2.58e+00
go:0031329 regulation of cellular catabolic process 2.92e-10 1.39e-08 8.14e-01 3.94e-01 1.89e+00
reactome:R-HSA-3858494 Beta-catenin independent WNT signaling 3.29e-10 1.55e-08 8.14e-01 6.13e-01 2.37e+00
go:0030163 protein catabolic process 3.55e-10 1.65e-08 8.14e-01 3.80e-01 1.83e+00
reactome:R-HSA-5689603 UCH proteinases 3.62e-10 1.66e-08 8.14e-01 6.35e-01 2.43e+00
go:0000779 condensed chromosome, centromeric region 3.89e-10 1.77e-08 8.14e-01 -5.65e-01 -2.46e+00
go:0033238 regulation of cellular amine metabolic process 4.48e-10 2.01e-08 8.14e-01 7.01e-01 2.54e+00
go:0080134 regulation of response to stress 6.29e-10 2.79e-08 8.01e-01 3.64e-01 1.77e+00
go:0050851 antigen receptor-mediated signaling pathway 6.88e-10 2.99e-08 8.01e-01 5.86e-01 2.37e+00
go:0003735 structural constituent of ribosome 6.89e-10 2.99e-08 8.01e-01 -4.65e-01 -2.27e+00
go:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process 1.02e-09 4.27e-08 7.88e-01 6.46e-01 2.42e+00
go:0009894 regulation of catabolic process 1.07e-09 4.38e-08 7.88e-01 3.74e-01 1.80e+00
go:0009308 amine metabolic process 1.09e-09 4.42e-08 7.88e-01 6.35e-01 2.39e+00
reactome:R-HSA-1236975 Antigen processing-Cross presentation 1.10e-09 4.43e-08 7.88e-01 6.60e-01 2.47e+00
go:1901532 regulation of hematopoietic progenitor cell differentiation 1.22e-09 4.88e-08 7.88e-01 6.69e-01 2.47e+00
go:0051301 cell division 1.25e-09 4.94e-08 7.88e-01 -3.49e-01 -1.88e+00
reactome:R-HSA-69541 Stabilization of p53 1.37e-09 5.28e-08 7.88e-01 6.86e-01 2.48e+00
go:0071453 cellular response to oxygen levels 1.36e-09 5.28e-08 7.88e-01 5.28e-01 2.24e+00
reactome:R-HSA-5687128 MAPK6/MAPK4 signaling 1.44e-09 5.50e-08 7.88e-01 6.29e-01 2.38e+00
go:2000736 regulation of stem cell differentiation 1.50e-09 5.69e-08 7.88e-01 6.31e-01 2.39e+00
reactome:R-HSA-8951664 Neddylation 1.60e-09 6.01e-08 7.88e-01 5.25e-01 2.23e+00
reactome:R-HSA-195258 RHO GTPase Effectors 2.23e-09 8.31e-08 7.75e-01 -4.29e-01 -2.15e+00
go:0044391 ribosomal subunit 2.45e-09 9.03e-08 7.75e-01 -4.34e-01 -2.15e+00
go:0060218 hematopoietic stem cell differentiation 2.50e-09 9.12e-08 7.75e-01 6.70e-01 2.44e+00
go:0023056 positive regulation of signaling 2.70e-09 9.77e-08 7.75e-01 3.53e-01 1.73e+00
go:0051783 regulation of nuclear division 2.88e-09 1.03e-07 7.75e-01 -4.94e-01 -2.28e+00
go:0061919 process utilizing autophagic mechanism 3.63e-09 1.29e-07 7.75e-01 4.46e-01 2.03e+00
go:1901565 organonitrogen compound catabolic process 4.06e-09 1.43e-07 7.61e-01 3.55e-01 1.73e+00
go:0010565 regulation of cellular ketone metabolic process 4.21e-09 1.46e-07 7.61e-01 6.14e-01 2.34e+00
go:0010498 proteasomal protein catabolic process 4.23e-09 1.46e-07 7.61e-01 4.18e-01 1.93e+00
go:0034097 response to cytokine 4.42e-09 1.50e-07 7.61e-01 3.74e-01 1.80e+00
go:0045088 regulation of innate immune response 4.43e-09 1.50e-07 7.61e-01 4.82e-01 2.11e+00
go:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I 4.47e-09 1.51e-07 7.61e-01 6.69e-01 2.42e+00
go:0043632 modification-dependent macromolecule catabolic process 4.70e-09 1.57e-07 7.61e-01 3.99e-01 1.88e+00
go:0002474 antigen processing and presentation of peptide antigen via MHC class I 4.76e-09 1.58e-07 7.61e-01 6.36e-01 2.38e+00
go:0048863 stem cell differentiation 5.64e-09 1.82e-07 7.61e-01 5.54e-01 2.24e+00
go:0022626 cytosolic ribosome 6.00e-09 1.92e-07 7.61e-01 -5.17e-01 -2.33e+00
go:0006259 DNA metabolic process 6.51e-09 2.07e-07 7.61e-01 -3.19e-01 -1.78e+00
reactome:R-HSA-382551 Transport of small molecules 6.74e-09 2.12e-07 7.61e-01 4.48e-01 2.03e+00
reactome:R-HSA-187577 SCF(Skp2)-mediated degradation of p27/p21 7.01e-09 2.17e-07 7.61e-01 6.66e-01 2.42e+00
go:0006260 DNA replication 7.19e-09 2.21e-07 7.61e-01 -4.27e-01 -2.12e+00
go:0050778 positive regulation of immune response 8.47e-09 2.58e-07 7.48e-01 4.24e-01 1.94e+00
msig:M5890 HALLMARK_TNFA_SIGNALING_VIA_NFKB 8.85e-09 2.68e-07 7.48e-01 5.52e-01 2.24e+00
go:0048585 negative regulation of response to stimulus 8.91e-09 2.68e-07 7.48e-01 3.53e-01 1.72e+00
go:0070646 protein modification by small protein removal 9.31e-09 2.74e-07 7.48e-01 4.80e-01 2.10e+00
go:0033209 tumor necrosis factor-mediated signaling pathway 9.32e-09 2.74e-07 7.48e-01 5.85e-01 2.28e+00
go:0000775 chromosome, centromeric region 9.22e-09 2.74e-07 7.48e-01 -4.60e-01 -2.19e+00
go:0006323 DNA packaging 1.13e-08 3.28e-07 7.48e-01 -5.11e-01 -2.30e+00
go:0044815 DNA packaging complex 1.34e-08 3.88e-07 7.48e-01 -7.23e-01 -2.56e+00
go:1905330 regulation of morphogenesis of an epithelium 1.47e-08 4.20e-07 7.48e-01 5.76e-01 2.23e+00
go:0042180 cellular ketone metabolic process 1.47e-08 4.20e-07 7.48e-01 5.67e-01 2.27e+00
go:0016236 macroautophagy 1.55e-08 4.39e-07 7.34e-01 4.91e-01 2.12e+00
reactome:R-HSA-69615 G1/S DNA Damage Checkpoints 1.57e-08 4.42e-07 7.34e-01 6.49e-01 2.37e+00
go:0010499 proteasomal ubiquitin-independent protein catabolic process 1.62e-08 4.53e-07 7.34e-01 8.49e-01 2.47e+00
go:0023057 negative regulation of signaling 1.64e-08 4.54e-07 7.34e-01 3.60e-01 1.74e+00
reactome:R-HSA-8878159 Transcriptional regulation by RUNX3 1.65e-08 4.55e-07 7.34e-01 6.21e-01 2.34e+00
reactome:R-HSA-5683057 MAPK family signaling cascades 1.79e-08 4.87e-07 7.34e-01 4.95e-01 2.11e+00
reactome:R-HSA-194315 Signaling by Rho GTPases 1.80e-08 4.87e-07 7.34e-01 -4.04e-01 -2.04e+00
msig:M189 KEGG_RIBOSOME 1.81e-08 4.89e-07 7.34e-01 -5.41e-01 -2.35e+00
reactome:R-HSA-5688426 Deubiquitination 1.87e-08 4.99e-07 7.34e-01 4.74e-01 2.05e+00
msig:M5893 HALLMARK_MITOTIC_SPINDLE 1.97e-08 5.23e-07 7.34e-01 -4.47e-01 -2.15e+00
go:2000027 regulation of animal organ morphogenesis 2.54e-08 6.70e-07 7.34e-01 5.42e-01 2.19e+00
go:0051304 chromosome separation 2.58e-08 6.76e-07 7.34e-01 -6.00e-01 -2.41e+00
go:0002684 positive regulation of immune system process 2.64e-08 6.87e-07 7.34e-01 3.99e-01 1.87e+00
reactome:R-HSA-69017 CDK-mediated phosphorylation and removal of Cdc6 3.12e-08 8.06e-07 7.20e-01 6.29e-01 2.32e+00
go:0044437 3.54e-08 9.11e-07 7.20e-01 4.12e-01 1.88e+00
go:0034612 response to tumor necrosis factor 3.60e-08 9.19e-07 7.20e-01 5.10e-01 2.16e+00
reactome:R-HSA-8852276 The role of GTSE1 in G2/M progression after G2 checkpoint 3.86e-08 9.80e-07 7.20e-01 6.17e-01 2.31e+00
reactome:R-HSA-5689880 Ub-specific processing proteases 4.32e-08 1.09e-06 7.20e-01 5.29e-01 2.20e+00
go:0005840 ribosome 4.72e-08 1.18e-06 7.20e-01 -3.93e-01 -1.99e+00
go:1902750 negative regulation of cell cycle G2/M phase transition 4.72e-08 1.18e-06 7.20e-01 5.92e-01 2.27e+00
go:0035567 non-canonical Wnt signaling pathway 4.82e-08 1.19e-06 7.20e-01 5.92e-01 2.26e+00
go:0006520 cellular amino acid metabolic process 5.26e-08 1.29e-06 7.20e-01 4.67e-01 2.03e+00
go:0030177 positive regulation of Wnt signaling pathway 5.23e-08 1.29e-06 7.20e-01 5.57e-01 2.20e+00
reactome:R-HSA-449836 Other interleukin signaling 6.11e-08 1.48e-06 7.05e-01 5.05e-01 2.14e+00
go:0050776 regulation of immune response 6.78e-08 1.64e-06 7.05e-01 3.96e-01 1.85e+00
go:0051321 meiotic cell cycle 6.88e-08 1.65e-06 7.05e-01 -4.93e-01 -2.23e+00
reactome:R-HSA-68877 Mitotic Prometaphase 7.36e-08 1.75e-06 7.05e-01 -4.33e-01 -2.11e+00
go:0031349 positive regulation of defense response 7.42e-08 1.76e-06 7.05e-01 4.53e-01 1.98e+00
go:0000209 protein polyubiquitination 7.56e-08 1.78e-06 7.05e-01 4.53e-01 1.98e+00
reactome:R-HSA-8878166 Transcriptional regulation by RUNX2 8.19e-08 1.92e-06 7.05e-01 5.85e-01 2.23e+00
reactome:R-HSA-162909 Host Interactions of HIV factors 9.03e-08 2.10e-06 7.05e-01 5.34e-01 2.17e+00
go:0015934 large ribosomal subunit 9.41e-08 2.17e-06 7.05e-01 -4.77e-01 -2.20e+00
reactome:R-HSA-73886 Chromosome Maintenance 1.04e-07 2.38e-06 7.05e-01 -5.82e-01 -2.37e+00
reactome:R-HSA-2500257 Resolution of Sister Chromatid Cohesion 1.20e-07 2.72e-06 6.90e-01 -4.84e-01 -2.18e+00
go:0005819 spindle 1.29e-07 2.91e-06 6.90e-01 -3.84e-01 -1.93e+00
go:0006310 DNA recombination 1.33e-07 2.99e-06 6.90e-01 -4.31e-01 -2.08e+00
go:0006457 protein folding 1.53e-07 3.42e-06 6.90e-01 4.89e-01 2.09e+00
go:0000776 kinetochore 1.56e-07 3.46e-06 6.90e-01 -4.86e-01 -2.20e+00
reactome:R-HSA-68949 Orc1 removal from chromatin 1.72e-07 3.79e-06 6.90e-01 6.01e-01 2.25e+00
go:0001775 cell activation 1.95e-07 4.25e-06 6.90e-01 3.52e-01 1.70e+00
msig:M16853 KEGG_DNA_REPLICATION 1.94e-07 4.25e-06 6.90e-01 -7.07e-01 -2.48e+00
go:0006952 defense response 1.99e-07 4.32e-06 6.90e-01 3.48e-01 1.68e+00
reactome:R-HSA-983169 Class I MHC mediated antigen processing & presentation 2.17e-07 4.68e-06 6.90e-01 4.33e-01 1.92e+00
reactome:R-HSA-2990846 SUMOylation 2.18e-07 4.68e-06 6.90e-01 -4.80e-01 -2.21e+00
reactome:R-HSA-69190 DNA strand elongation 2.20e-07 4.70e-06 6.90e-01 -7.30e-01 -2.48e+00
go:0009628 response to abiotic stimulus 2.28e-07 4.84e-06 6.90e-01 3.46e-01 1.67e+00
go:0006508 proteolysis 2.82e-07 5.93e-06 6.75e-01 3.15e-01 1.56e+00
reactome:R-HSA-1799339 SRP-dependent cotranslational protein targeting to membrane 3.08e-07 6.44e-06 6.75e-01 -4.63e-01 -2.13e+00
go:0090263 positive regulation of canonical Wnt signaling pathway 3.17e-07 6.55e-06 6.75e-01 5.65e-01 2.18e+00
go:0000781 chromosome, telomeric region 3.17e-07 6.55e-06 6.75e-01 -4.83e-01 -2.16e+00
go:0031347 regulation of defense response 3.38e-07 6.92e-06 6.75e-01 4.10e-01 1.86e+00
reactome:R-HSA-68867 Assembly of the pre-replicative complex 3.38e-07 6.92e-06 6.75e-01 6.07e-01 2.24e+00
reactome:R-HSA-6807070 PTEN Regulation 3.42e-07 6.97e-06 6.75e-01 5.28e-01 2.14e+00
msig:M5924 HALLMARK_MTORC1_SIGNALING 3.68e-07 7.44e-06 6.75e-01 4.47e-01 1.95e+00
go:0005776 autophagosome 3.94e-07 7.94e-06 6.75e-01 6.70e-01 2.32e+00
msig:M15569 KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY 3.97e-07 7.95e-06 6.75e-01 7.48e-01 2.32e+00
go:0002274 myeloid leukocyte activation 4.46e-07 8.85e-06 6.75e-01 3.87e-01 1.79e+00
go:0070482 response to oxygen levels 4.67e-07 9.22e-06 6.75e-01 4.25e-01 1.89e+00
reactome:R-HSA-72613 Eukaryotic Translation Initiation 4.71e-07 9.24e-06 6.75e-01 -4.47e-01 -2.08e+00
go:0033044 regulation of chromosome organization 4.97e-07 9.66e-06 6.59e-01 -3.75e-01 -1.90e+00
go:0022625 cytosolic large ribosomal subunit 5.02e-07 9.70e-06 6.59e-01 -5.64e-01 -2.26e+00
go:0051983 regulation of chromosome segregation 5.19e-07 1.00e-05 6.59e-01 -5.20e-01 -2.22e+00
reactome:R-HSA-2408522 Selenoamino acid metabolism 5.28e-07 1.01e-05 6.59e-01 -4.57e-01 -2.11e+00
reactome:R-HSA-5653656 Vesicle-mediated transport 5.36e-07 1.02e-05 6.59e-01 3.76e-01 1.76e+00
go:0006613 cotranslational protein targeting to membrane 5.64e-07 1.07e-05 6.59e-01 -4.69e-01 -2.11e+00
go:0048002 antigen processing and presentation of peptide antigen 5.74e-07 1.08e-05 6.59e-01 5.02e-01 2.08e+00
go:0006333 chromatin assembly or disassembly 6.06e-07 1.14e-05 6.59e-01 -4.91e-01 -2.14e+00
go:0002682 regulation of immune system process 6.12e-07 1.14e-05 6.59e-01 3.40e-01 1.64e+00
msig:M5938 HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY 6.55e-07 1.22e-05 6.59e-01 6.86e-01 2.31e+00
reactome:R-HSA-9612973 Autophagy 6.81e-07 1.26e-05 6.59e-01 5.68e-01 2.14e+00
go:0062012 regulation of small molecule metabolic process 7.07e-07 1.30e-05 6.59e-01 4.59e-01 1.98e+00
reactome:R-HSA-69052 Switching of origins to a post-replicative state 9.38e-07 1.72e-05 6.59e-01 5.58e-01 2.13e+00
go:1903046 meiotic cell cycle process 9.40e-07 1.72e-05 6.59e-01 -5.04e-01 -2.14e+00
go:0061013 regulation of mRNA catabolic process 9.73e-07 1.77e-05 6.44e-01 4.71e-01 2.00e+00
go:1905818 regulation of chromosome separation 1.04e-06 1.88e-05 6.44e-01 -5.95e-01 -2.27e+00
go:0045087 innate immune response 1.09e-06 1.96e-05 6.44e-01 3.77e-01 1.75e+00
go:0048729 tissue morphogenesis 1.11e-06 1.98e-05 6.44e-01 4.11e-01 1.86e+00
go:0071103 DNA conformation change 1.19e-06 2.13e-05 6.44e-01 -3.88e-01 -1.91e+00
go:0055085 transmembrane transport 1.21e-06 2.15e-05 6.44e-01 3.49e-01 1.67e+00
go:0006281 DNA repair 1.28e-06 2.26e-05 6.44e-01 -3.22e-01 -1.70e+00
reactome:R-HSA-8939236 RUNX1 regulates transcription of genes involved in differentiation of HSCs 1.32e-06 2.32e-05 6.44e-01 5.79e-01 2.17e+00
reactome:R-HSA-2299718 Condensation of Prophase Chromosomes 1.46e-06 2.56e-05 6.44e-01 -7.33e-01 -2.40e+00
go:2001251 negative regulation of chromosome organization 1.59e-06 2.77e-05 6.44e-01 -4.86e-01 -2.12e+00
go:0006261 DNA-dependent DNA replication 1.63e-06 2.83e-05 6.44e-01 -4.62e-01 -2.09e+00
go:0006468 protein phosphorylation 1.67e-06 2.89e-05 6.44e-01 3.13e-01 1.54e+00
go:0019882 antigen processing and presentation 1.72e-06 2.95e-05 6.44e-01 4.74e-01 2.01e+00
reactome:R-HSA-927802 Nonsense-Mediated Decay (NMD) 1.82e-06 3.13e-05 6.44e-01 -4.40e-01 -2.01e+00
reactome:R-HSA-73894 DNA Repair 1.95e-06 3.32e-05 6.27e-01 -3.61e-01 -1.82e+00
reactome:R-HSA-5663220 RHO GTPases Activate Formins 1.96e-06 3.32e-05 6.27e-01 -4.56e-01 -2.07e+00
go:0101002 ficolin-1-rich granule 1.96e-06 3.32e-05 6.27e-01 5.23e-01 2.09e+00
go:0002009 morphogenesis of an epithelium 2.16e-06 3.62e-05 6.27e-01 4.24e-01 1.88e+00
go:0005839 proteasome core complex 2.16e-06 3.62e-05 6.27e-01 8.29e-01 2.27e+00
go:0000794 condensed nuclear chromosome 2.29e-06 3.82e-05 6.27e-01 -5.99e-01 -2.27e+00
reactome:R-HSA-73884 Base Excision Repair 2.29e-06 3.82e-05 6.27e-01 -5.85e-01 -2.23e+00
reactome:R-HSA-69618 Mitotic Spindle Checkpoint 2.52e-06 4.18e-05 6.27e-01 -4.73e-01 -2.07e+00
go:0002244 hematopoietic progenitor cell differentiation 2.66e-06 4.39e-05 6.27e-01 5.32e-01 2.06e+00
go:0044784 metaphase/anaphase transition of cell cycle 2.69e-06 4.41e-05 6.27e-01 -6.18e-01 -2.32e+00
go:0002753 cytoplasmic pattern recognition receptor signaling pathway 2.75e-06 4.49e-05 6.27e-01 7.21e-01 2.25e+00
go:0006325 chromatin organization 2.78e-06 4.53e-05 6.27e-01 -2.96e-01 -1.61e+00
reactome:R-HSA-157579 Telomere Maintenance 3.10e-06 5.02e-05 6.27e-01 -6.17e-01 -2.30e+00
reactome:R-HSA-6798695 Neutrophil degranulation 3.12e-06 5.04e-05 6.27e-01 3.93e-01 1.79e+00
go:0006974 cellular response to DNA damage stimulus 3.20e-06 5.15e-05 6.27e-01 -2.81e-01 -1.56e+00
reactome:R-HSA-162906 HIV Infection 3.34e-06 5.35e-05 6.27e-01 4.26e-01 1.86e+00
go:0000278 mitotic cell cycle 3.87e-06 6.12e-05 6.11e-01 -2.65e-01 -1.49e+00
go:0035966 response to topologically incorrect protein 3.93e-06 6.19e-05 6.11e-01 4.83e-01 2.01e+00
reactome:R-HSA-5693532 DNA Double-Strand Break Repair 4.23e-06 6.63e-05 6.11e-01 -4.61e-01 -2.03e+00
go:0098754 detoxification 4.38e-06 6.84e-05 6.11e-01 6.06e-01 2.19e+00
go:0022402 cell cycle process 4.58e-06 7.10e-05 6.11e-01 -2.53e-01 -1.46e+00
reactome:R-HSA-5357801 Programmed Cell Death 4.66e-06 7.20e-05 6.11e-01 4.65e-01 1.95e+00
reactome:R-HSA-1474165 Reproduction 4.81e-06 7.40e-05 6.11e-01 -5.90e-01 -2.23e+00
reactome:R-HSA-9006925 Intracellular signaling by second messengers 6.44e-06 9.87e-05 6.11e-01 4.52e-01 1.93e+00
go:0060429 epithelium development 6.58e-06 1.00e-04 6.11e-01 3.43e-01 1.64e+00
go:0000922 spindle pole 6.69e-06 1.02e-04 6.11e-01 -4.45e-01 -2.02e+00
go:0006887 exocytosis 7.12e-06 1.07e-04 6.11e-01 3.48e-01 1.65e+00
reactome:R-HSA-912446 Meiotic recombination 7.61e-06 1.14e-04 6.11e-01 -6.75e-01 -2.29e+00
reactome:R-HSA-168255 Influenza Infection 7.84e-06 1.17e-04 5.93e-01 -3.96e-01 -1.91e+00
go:0002444 myeloid leukocyte mediated immunity 8.11e-06 1.21e-04 5.93e-01 3.78e-01 1.73e+00
go:0046903 secretion 8.70e-06 1.29e-04 5.93e-01 3.13e-01 1.52e+00
go:0006873 cellular ion homeostasis 8.79e-06 1.30e-04 5.93e-01 4.12e-01 1.81e+00
go:0005198 structural molecule activity 9.37e-06 1.38e-04 5.93e-01 -3.01e-01 -1.61e+00
go:0045132 meiotic chromosome segregation 9.35e-06 1.38e-04 5.93e-01 -6.36e-01 -2.28e+00
reactome:R-HSA-453274 Mitotic G2-G2/M phases 9.40e-06 1.38e-04 5.93e-01 4.40e-01 1.88e+00
reactome:R-HSA-3371556 Cellular response to heat stress 9.59e-06 1.39e-04 5.93e-01 5.35e-01 2.02e+00
go:0099503 secretory vesicle 9.63e-06 1.39e-04 5.93e-01 3.45e-01 1.63e+00
reactome:R-HSA-69002 DNA Replication Pre-Initiation 9.61e-06 1.39e-04 5.93e-01 5.34e-01 2.04e+00
go:0002443 leukocyte mediated immunity 1.03e-05 1.49e-04 5.93e-01 3.64e-01 1.70e+00
go:0030261 chromosome condensation 1.13e-05 1.63e-04 5.93e-01 -6.55e-01 -2.23e+00
go:0061077 chaperone-mediated protein folding 1.18e-05 1.68e-04 5.93e-01 6.34e-01 2.16e+00
go:0070647 protein modification by small protein conjugation or removal 1.31e-05 1.86e-04 5.93e-01 3.12e-01 1.52e+00
go:0016050 vesicle organization 1.32e-05 1.88e-04 5.93e-01 4.16e-01 1.82e+00
msig:M7963 KEGG_CELL_CYCLE 1.34e-05 1.89e-04 5.93e-01 -4.69e-01 -2.04e+00
go:0003682 chromatin binding 1.35e-05 1.90e-04 5.93e-01 -3.20e-01 -1.66e+00
go:0002252 immune effector process 1.39e-05 1.95e-04 5.93e-01 3.29e-01 1.57e+00
reactome:R-HSA-69205 G1/S-Specific Transcription 1.48e-05 2.07e-04 5.93e-01 -7.50e-01 -2.28e+00
reactome:R-HSA-1500620 Meiosis 1.57e-05 2.19e-04 5.76e-01 -5.89e-01 -2.21e+00
reactome:R-HSA-212300 PRC2 methylates histones and DNA 1.64e-05 2.28e-04 5.76e-01 -6.97e-01 -2.29e+00
go:0019080 viral gene expression 1.69e-05 2.34e-04 5.76e-01 -3.67e-01 -1.80e+00
go:0031098 stress-activated protein kinase signaling cascade 1.72e-05 2.37e-04 5.76e-01 4.73e-01 1.94e+00
go:0030141 secretory granule 1.89e-05 2.60e-04 5.76e-01 3.51e-01 1.64e+00
go:0030178 negative regulation of Wnt signaling pathway 2.05e-05 2.81e-04 5.76e-01 4.89e-01 1.95e+00
go:0050801 ion homeostasis 2.06e-05 2.82e-04 5.76e-01 3.82e-01 1.73e+00
reactome:R-HSA-5693538 Homology Directed Repair 2.25e-05 3.05e-04 5.76e-01 -4.86e-01 -2.04e+00
go:0002263 cell activation involved in immune response 2.25e-05 3.05e-04 5.76e-01 3.63e-01 1.68e+00
go:0010256 endomembrane system organization 2.31e-05 3.12e-04 5.76e-01 3.92e-01 1.74e+00
go:0060070 canonical Wnt signaling pathway 2.58e-05 3.46e-04 5.76e-01 4.38e-01 1.85e+00
reactome:R-HSA-72766 Translation 2.59e-05 3.46e-04 5.76e-01 -3.12e-01 -1.62e+00
go:0000407 phagophore assembly site 2.71e-05 3.60e-04 5.76e-01 7.58e-01 2.16e+00
go:1905037 autophagosome organization 2.71e-05 3.60e-04 5.76e-01 5.90e-01 2.08e+00
go:0051082 unfolded protein binding 2.73e-05 3.62e-04 5.76e-01 5.08e-01 1.96e+00
reactome:R-HSA-1280218 Adaptive Immune System 2.75e-05 3.62e-04 5.76e-01 3.55e-01 1.66e+00
go:0031983 vesicle lumen 2.85e-05 3.74e-04 5.76e-01 4.08e-01 1.77e+00
go:0005775 vacuolar lumen 2.85e-05 3.74e-04 5.76e-01 5.03e-01 1.94e+00
go:0061024 membrane organization 2.86e-05 3.74e-04 5.76e-01 3.38e-01 1.60e+00
reactome:R-HSA-201681 TCF dependent signaling in response to WNT 2.93e-05 3.82e-04 5.76e-01 4.65e-01 1.89e+00
go:0006458 'de novo' protein folding 3.04e-05 3.94e-04 5.76e-01 6.82e-01 2.13e+00
go:1903706 regulation of hemopoiesis 3.04e-05 3.94e-04 5.76e-01 4.06e-01 1.78e+00
reactome:R-HSA-5693579 Homologous DNA Pairing and Strand Exchange 3.10e-05 3.98e-04 5.57e-01 -6.56e-01 -2.18e+00
go:0043687 post-translational protein modification 3.09e-05 3.98e-04 5.57e-01 4.04e-01 1.79e+00
go:0044265 cellular macromolecule catabolic process 3.27e-05 4.19e-04 5.57e-01 2.99e-01 1.47e+00
go:0000184 nuclear-transcribed mRNA catabolic process, nonsense-mediated decay 3.29e-05 4.20e-04 5.57e-01 -4.15e-01 -1.91e+00
go:0051784 negative regulation of nuclear division 3.42e-05 4.35e-04 5.57e-01 -5.79e-01 -2.14e+00
go:0030111 regulation of Wnt signaling pathway 3.69e-05 4.68e-04 5.57e-01 4.21e-01 1.81e+00
go:0016209 antioxidant activity 3.95e-05 5.00e-04 5.57e-01 6.20e-01 2.09e+00
go:0022603 regulation of anatomical structure morphogenesis 4.10e-05 5.17e-04 5.57e-01 3.42e-01 1.61e+00
go:0005657 replication fork 4.17e-05 5.24e-04 5.57e-01 -5.28e-01 -2.06e+00
go:0010639 negative regulation of organelle organization 4.23e-05 5.30e-04 5.57e-01 -3.36e-01 -1.69e+00
go:0022624 proteasome accessory complex 4.32e-05 5.38e-04 5.57e-01 7.01e-01 2.14e+00
go:0016197 endosomal transport 4.54e-05 5.64e-04 5.57e-01 4.52e-01 1.88e+00
go:0005774 vacuolar membrane 5.08e-05 6.28e-04 5.57e-01 3.91e-01 1.73e+00
reactome:R-HSA-453276 Regulation of mitotic cell cycle 5.26e-05 6.48e-04 5.57e-01 5.10e-01 1.95e+00
go:0055065 metal ion homeostasis 5.56e-05 6.83e-04 5.57e-01 3.98e-01 1.74e+00
reactome:R-HSA-5250913 Positive epigenetic regulation of rRNA expression 5.60e-05 6.86e-04 5.57e-01 -5.44e-01 -2.09e+00
reactome:R-HSA-3371571 HSF1-dependent transactivation 5.69e-05 6.94e-04 5.57e-01 7.46e-01 2.13e+00
go:0000785 chromatin 5.75e-05 6.99e-04 5.57e-01 -3.00e-01 -1.57e+00
go:0009887 animal organ morphogenesis 5.96e-05 7.23e-04 5.57e-01 3.54e-01 1.64e+00
go:0006082 organic acid metabolic process 6.13e-05 7.42e-04 5.38e-01 3.29e-01 1.56e+00
reactome:R-HSA-68886 M Phase 6.22e-05 7.50e-04 5.38e-01 -3.01e-01 -1.56e+00
go:0198738 cell-cell signaling by wnt 6.34e-05 7.62e-04 5.38e-01 3.79e-01 1.69e+00
go:0031145 anaphase-promoting complex-dependent catabolic process 6.69e-05 7.99e-04 5.38e-01 5.05e-01 1.91e+00
go:0060968 regulation of gene silencing 7.02e-05 8.36e-04 5.38e-01 -4.32e-01 -1.88e+00
reactome:R-HSA-69473 G2/M DNA damage checkpoint 7.08e-05 8.41e-04 5.38e-01 -5.21e-01 -2.03e+00
go:0007254 JNK cascade 7.13e-05 8.44e-04 5.38e-01 5.07e-01 1.91e+00
go:0009896 positive regulation of catabolic process 7.19e-05 8.49e-04 5.38e-01 3.84e-01 1.71e+00
reactome:R-HSA-195721 Signaling by WNT 7.55e-05 8.88e-04 5.38e-01 4.15e-01 1.77e+00
go:0016241 regulation of macroautophagy 7.61e-05 8.92e-04 5.38e-01 4.84e-01 1.90e+00
reactome:R-HSA-69620 Cell Cycle Checkpoints 7.85e-05 9.18e-04 5.38e-01 -3.27e-01 -1.65e+00
go:1903052 positive regulation of proteolysis involved in cellular protein catabolic process 7.96e-05 9.29e-04 5.38e-01 5.14e-01 1.93e+00
reactome:R-HSA-110373 Resolution of AP sites via the multiple-nucleotide patch replacement pathway 8.01e-05 9.32e-04 5.38e-01 -6.58e-01 -2.16e+00
go:0070997 neuron death 8.25e-05 9.57e-04 5.38e-01 4.16e-01 1.77e+00
go:0045595 regulation of cell differentiation 8.37e-05 9.68e-04 5.38e-01 2.98e-01 1.46e+00
go:0010506 regulation of autophagy 8.65e-05 9.97e-04 5.38e-01 4.16e-01 1.78e+00
go:0009057 macromolecule catabolic process 9.11e-05 1.04e-03 5.38e-01 2.86e-01 1.42e+00
go:0007267 cell-cell signaling 9.11e-05 1.04e-03 5.38e-01 3.19e-01 1.53e+00
reactome:R-HSA-8878171 Transcriptional regulation by RUNX1 9.52e-05 1.08e-03 5.38e-01 4.43e-01 1.83e+00
reactome:R-HSA-2559586 DNA Damage/Telomere Stress Induced Senescence 9.57e-05 1.09e-03 5.38e-01 -6.14e-01 -2.11e+00
go:1903364 positive regulation of cellular protein catabolic process 1.03e-04 1.16e-03 5.38e-01 4.90e-01 1.89e+00
reactome:R-HSA-180786 Extension of Telomeres 1.07e-04 1.20e-03 5.38e-01 -6.30e-01 -2.12e+00
go:0004175 endopeptidase activity 1.09e-04 1.23e-03 5.38e-01 4.45e-01 1.83e+00
go:0097530 granulocyte migration 1.13e-04 1.26e-03 5.38e-01 6.00e-01 2.00e+00
reactome:R-HSA-1221632 Meiotic synapsis 1.13e-04 1.27e-03 5.38e-01 -6.49e-01 -2.15e+00
msig:M4741 KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS 1.14e-04 1.27e-03 5.38e-01 -6.27e-01 -2.09e+00
reactome:R-HSA-68962 Activation of the pre-replicative complex 1.15e-04 1.28e-03 5.38e-01 -6.18e-01 -2.10e+00
go:0034508 centromere complex assembly 1.16e-04 1.29e-03 5.38e-01 -5.69e-01 -2.06e+00
reactome:R-HSA-73772 RNA Polymerase I Promoter Escape 1.18e-04 1.30e-03 5.38e-01 -5.73e-01 -2.08e+00
reactome:R-HSA-8936459 RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function 1.18e-04 1.30e-03 5.38e-01 -6.05e-01 -2.11e+00
reactome:R-HSA-3371568 Attenuation phase 1.27e-04 1.39e-03 5.19e-01 7.58e-01 2.08e+00
go:0051247 positive regulation of protein metabolic process 1.27e-04 1.40e-03 5.19e-01 2.92e-01 1.44e+00
go:0048770 pigment granule 1.28e-04 1.40e-03 5.19e-01 4.94e-01 1.87e+00
msig:M16817 KEGG_OOCYTE_MEIOSIS 1.32e-04 1.44e-03 5.19e-01 -4.77e-01 -1.92e+00
reactome:R-HSA-5625740 RHO GTPases activate PKNs 1.32e-04 1.44e-03 5.19e-01 -5.81e-01 -2.09e+00
reactome:R-HSA-3214858 RMTs methylate histone arginines 1.37e-04 1.48e-03 5.19e-01 -6.06e-01 -2.08e+00
reactome:R-HSA-1912422 Pre-NOTCH Expression and Processing 1.44e-04 1.55e-03 5.19e-01 -5.52e-01 -2.04e+00
go:0010941 regulation of cell death 1.45e-04 1.56e-03 5.19e-01 2.91e-01 1.44e+00
go:0051085 chaperone cofactor-dependent protein refolding 1.46e-04 1.58e-03 5.19e-01 7.11e-01 2.08e+00
go:0001664 G protein-coupled receptor binding 1.47e-04 1.58e-03 5.19e-01 5.33e-01 1.95e+00
reactome:R-HSA-68875 Mitotic Prophase 1.51e-04 1.62e-03 5.19e-01 -4.48e-01 -1.91e+00
go:0046329 negative regulation of JNK cascade 1.56e-04 1.67e-03 5.19e-01 7.43e-01 2.08e+00
go:0006826 iron ion transport 1.59e-04 1.69e-03 5.19e-01 6.19e-01 1.98e+00
reactome:R-HSA-212165 Epigenetic regulation of gene expression 1.67e-04 1.76e-03 5.19e-01 -4.32e-01 -1.84e+00
reactome:R-HSA-73933 Resolution of Abasic Sites (AP sites) 1.68e-04 1.78e-03 5.19e-01 -5.94e-01 -2.09e+00
go:0032446 protein modification by small protein conjugation 1.76e-04 1.85e-03 5.19e-01 3.12e-01 1.50e+00
go:0009266 response to temperature stimulus 1.76e-04 1.85e-03 5.19e-01 4.34e-01 1.80e+00
go:0003684 damaged DNA binding 1.75e-04 1.85e-03 5.19e-01 -5.33e-01 -2.00e+00
go:0034976 response to endoplasmic reticulum stress 1.84e-04 1.92e-03 5.19e-01 3.99e-01 1.73e+00
reactome:R-HSA-176187 Activation of ATR in response to replication stress 1.84e-04 1.92e-03 5.19e-01 -5.97e-01 -2.08e+00
reactome:R-HSA-73864 RNA Polymerase I Transcription 1.88e-04 1.95e-03 5.19e-01 -5.11e-01 -1.99e+00
reactome:R-HSA-174417 Telomere C-strand (Lagging Strand) Synthesis 1.90e-04 1.97e-03 5.19e-01 -6.62e-01 -2.10e+00
go:0038127 ERBB signaling pathway 1.92e-04 1.99e-03 5.19e-01 4.88e-01 1.85e+00
msig:M5941 HALLMARK_UV_RESPONSE_UP 1.94e-04 2.00e-03 5.19e-01 4.59e-01 1.83e+00
go:0044430 1.96e-04 2.01e-03 5.19e-01 -2.40e-01 -1.37e+00
go:0034728 nucleosome organization 2.04e-04 2.10e-03 5.19e-01 -4.22e-01 -1.79e+00
go:0006612 protein targeting to membrane 2.12e-04 2.17e-03 5.19e-01 -3.65e-01 -1.72e+00
go:1901988 negative regulation of cell cycle phase transition 2.14e-04 2.18e-03 5.19e-01 3.95e-01 1.71e+00
go:0046916 cellular transition metal ion homeostasis 2.19e-04 2.22e-03 5.19e-01 5.29e-01 1.92e+00
go:0007093 mitotic cell cycle checkpoint 2.31e-04 2.34e-03 5.19e-01 -3.88e-01 -1.77e+00
go:1905114 cell surface receptor signaling pathway involved in cell-cell signaling 2.41e-04 2.44e-03 5.19e-01 3.66e-01 1.65e+00
go:1902749 regulation of cell cycle G2/M phase transition 2.45e-04 2.48e-03 4.98e-01 4.02e-01 1.72e+00
go:0007033 vacuole organization 2.49e-04 2.50e-03 4.98e-01 4.67e-01 1.82e+00
reactome:R-HSA-157118 Signaling by NOTCH 2.49e-04 2.50e-03 4.98e-01 4.20e-01 1.76e+00
go:0045862 positive regulation of proteolysis 2.50e-04 2.51e-03 4.98e-01 3.85e-01 1.68e+00
go:1903362 regulation of cellular protein catabolic process 2.59e-04 2.58e-03 4.98e-01 3.98e-01 1.70e+00
go:0043005 neuron projection 2.64e-04 2.63e-03 4.98e-01 3.18e-01 1.51e+00
go:0070303 negative regulation of stress-activated protein kinase signaling cascade 2.70e-04 2.68e-03 4.98e-01 6.67e-01 2.00e+00
go:0032201 telomere maintenance via semi-conservative replication 2.77e-04 2.75e-03 4.98e-01 -6.32e-01 -2.07e+00
go:0000790 chromatin 2.80e-04 2.77e-03 4.98e-01 -3.32e-01 -1.65e+00
reactome:R-HSA-375276 Peptide ligand-binding receptors 2.87e-04 2.83e-03 4.98e-01 6.97e-01 2.04e+00
go:0016234 inclusion body 2.96e-04 2.91e-03 4.98e-01 5.80e-01 1.93e+00
go:0034724 DNA replication-independent nucleosome organization 2.96e-04 2.91e-03 4.98e-01 -5.58e-01 -2.02e+00
reactome:R-HSA-69186 Lagging Strand Synthesis 2.97e-04 2.91e-03 4.98e-01 -6.87e-01 -2.07e+00
go:0070192 chromosome organization involved in meiotic cell cycle 3.00e-04 2.93e-03 4.98e-01 -6.49e-01 -2.11e+00
go:0009408 response to heat 3.03e-04 2.95e-03 4.98e-01 4.59e-01 1.83e+00
go:0030001 metal ion transport 3.04e-04 2.95e-03 4.98e-01 3.63e-01 1.63e+00
go:0040029 regulation of gene expression, epigenetic 3.17e-04 3.07e-03 4.98e-01 -3.17e-01 -1.60e+00
go:0045732 positive regulation of protein catabolic process 3.38e-04 3.24e-03 4.98e-01 4.33e-01 1.77e+00
go:0090734 site of DNA damage 3.39e-04 3.24e-03 4.98e-01 -4.91e-01 -1.91e+00
go:1901796 regulation of signal transduction by p53 class mediator 3.38e-04 3.24e-03 4.98e-01 -3.78e-01 -1.73e+00
reactome:R-HSA-917937 Iron uptake and transport 3.37e-04 3.24e-03 4.98e-01 5.94e-01 1.94e+00
go:0045202 synapse 3.44e-04 3.29e-03 4.98e-01 3.21e-01 1.51e+00
reactome:R-HSA-4615885 SUMOylation of DNA replication proteins 3.46e-04 3.29e-03 4.98e-01 -5.26e-01 -1.93e+00
go:0034605 cellular response to heat 3.58e-04 3.40e-03 4.98e-01 4.79e-01 1.83e+00
reactome:R-HSA-3371453 Regulation of HSF1-mediated heat shock response 3.59e-04 3.40e-03 4.98e-01 5.07e-01 1.86e+00
reactome:R-HSA-8856825 Cargo recognition for clathrin-mediated endocytosis 3.75e-04 3.55e-03 4.98e-01 5.14e-01 1.88e+00
go:0032200 telomere organization 3.86e-04 3.64e-03 4.98e-01 -3.89e-01 -1.76e+00
go:0051174 regulation of phosphorus metabolic process 3.86e-04 3.64e-03 4.98e-01 2.89e-01 1.41e+00
go:0032993 protein-DNA complex 3.88e-04 3.65e-03 4.98e-01 -4.16e-01 -1.80e+00
reactome:R-HSA-3299685 Detoxification of Reactive Oxygen Species 3.96e-04 3.70e-03 4.98e-01 6.62e-01 2.00e+00
go:0080135 regulation of cellular response to stress 3.96e-04 3.70e-03 4.98e-01 3.28e-01 1.53e+00
go:0006302 double-strand break repair 3.99e-04 3.72e-03 4.98e-01 -3.63e-01 -1.70e+00
msig:M5902 HALLMARK_APOPTOSIS 4.07e-04 3.78e-03 4.98e-01 4.44e-01 1.79e+00
go:0044839 cell cycle G2/M phase transition 4.12e-04 3.82e-03 4.98e-01 3.76e-01 1.65e+00
go:0043202 lysosomal lumen 4.12e-04 3.82e-03 4.98e-01 5.66e-01 1.93e+00
go:0042592 homeostatic process 4.19e-04 3.87e-03 4.98e-01 2.84e-01 1.39e+00
go:1902100 negative regulation of metaphase/anaphase transition of cell cycle 4.31e-04 3.97e-03 4.98e-01 -5.89e-01 -2.00e+00
go:0000075 cell cycle checkpoint 4.31e-04 3.97e-03 4.98e-01 -3.54e-01 -1.68e+00
go:0072599 establishment of protein localization to endoplasmic reticulum 4.38e-04 4.01e-03 4.98e-01 -3.81e-01 -1.75e+00
go:0031492 nucleosomal DNA binding 4.44e-04 4.06e-03 4.98e-01 -5.72e-01 -1.99e+00
go:0046545 development of primary female sexual characteristics 4.52e-04 4.13e-03 4.98e-01 5.78e-01 1.96e+00
reactome:R-HSA-72312 rRNA processing 4.61e-04 4.20e-03 4.98e-01 -3.17e-01 -1.59e+00
reactome:R-HSA-3371497 HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand 4.75e-04 4.32e-03 4.98e-01 5.73e-01 1.93e+00
go:0055076 transition metal ion homeostasis 4.98e-04 4.51e-03 4.77e-01 4.55e-01 1.73e+00
go:0055006 cardiac cell development 5.15e-04 4.66e-03 4.77e-01 -5.93e-01 -2.00e+00
reactome:R-HSA-168638 NOD1/2 Signaling Pathway 5.21e-04 4.70e-03 4.77e-01 6.98e-01 2.03e+00
go:0044463 5.38e-04 4.84e-03 4.77e-01 3.06e-01 1.47e+00
go:0012506 vesicle membrane 5.41e-04 4.85e-03 4.77e-01 3.29e-01 1.52e+00
reactome:R-HSA-69306 DNA Replication 5.63e-04 5.03e-03 4.77e-01 4.23e-01 1.72e+00
reactome:R-HSA-5578749 Transcriptional regulation by small RNAs 5.95e-04 5.30e-03 4.77e-01 -4.73e-01 -1.86e+00
reactome:R-HSA-5651801 PCNA-Dependent Long Patch Base Excision Repair 5.95e-04 5.30e-03 4.77e-01 -6.52e-01 -2.05e+00
go:0002698 negative regulation of immune effector process 6.08e-04 5.38e-03 4.77e-01 5.60e-01 1.86e+00
go:0016538 cyclin-dependent protein serine/threonine kinase regulator activity 6.07e-04 5.38e-03 4.77e-01 -5.88e-01 -1.96e+00
msig:M14314 KEGG_PURINE_METABOLISM 6.26e-04 5.53e-03 4.77e-01 -4.13e-01 -1.76e+00
go:0090068 positive regulation of cell cycle process 6.35e-04 5.59e-03 4.77e-01 -3.33e-01 -1.62e+00
msig:M16848 KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION 6.45e-04 5.67e-03 4.77e-01 5.66e-01 1.91e+00
go:0031055 chromatin remodeling at centromere 6.60e-04 5.77e-03 4.77e-01 -5.80e-01 -1.97e+00
go:0061912 selective autophagy 6.60e-04 5.77e-03 4.77e-01 6.67e-01 1.97e+00
reactome:R-HSA-8856828 Clathrin-mediated endocytosis 6.88e-04 6.00e-03 4.77e-01 4.55e-01 1.76e+00
go:0048878 chemical homeostasis 7.02e-04 6.10e-03 4.77e-01 3.24e-01 1.51e+00
go:0042175 nuclear outer membrane-endoplasmic reticulum membrane network 7.09e-04 6.14e-03 4.77e-01 3.01e-01 1.45e+00
go:0061136 regulation of proteasomal protein catabolic process 7.10e-04 6.14e-03 4.77e-01 4.27e-01 1.76e+00
go:0031491 nucleosome binding 7.21e-04 6.20e-03 4.77e-01 -4.65e-01 -1.86e+00
go:0070302 regulation of stress-activated protein kinase signaling cascade 7.21e-04 6.20e-03 4.77e-01 4.65e-01 1.78e+00
go:0016233 telomere capping 7.25e-04 6.22e-03 4.77e-01 -6.01e-01 -1.99e+00
go:0000725 recombinational repair 7.28e-04 6.24e-03 4.77e-01 -4.14e-01 -1.72e+00
reactome:R-HSA-5250941 Negative epigenetic regulation of rRNA expression 7.58e-04 6.45e-03 4.77e-01 -4.81e-01 -1.87e+00
go:0045787 positive regulation of cell cycle 7.58e-04 6.45e-03 4.77e-01 -3.09e-01 -1.56e+00
msig:M9809 KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION 7.69e-04 6.53e-03 4.77e-01 5.32e-01 1.87e+00
go:0032467 positive regulation of cytokinesis 7.99e-04 6.77e-03 4.77e-01 -6.45e-01 -2.03e+00
reactome:R-HSA-422475 Axon guidance 8.09e-04 6.84e-03 4.77e-01 3.26e-01 1.50e+00
go:0005813 centrosome 8.15e-04 6.88e-03 4.77e-01 -2.77e-01 -1.45e+00
msig:M11266 KEGG_LYSOSOME 8.19e-04 6.89e-03 4.77e-01 4.53e-01 1.72e+00
go:0042176 regulation of protein catabolic process 8.21e-04 6.90e-03 4.77e-01 3.64e-01 1.61e+00
go:0071384 cellular response to corticosteroid stimulus 8.45e-04 7.08e-03 4.77e-01 5.94e-01 1.92e+00
go:0042582 azurophil granule 8.61e-04 7.20e-03 4.77e-01 4.42e-01 1.75e+00
go:0071559 response to transforming growth factor beta 8.71e-04 7.27e-03 4.77e-01 4.31e-01 1.74e+00
reactome:R-HSA-5685938 HDR through Single Strand Annealing (SSA) 8.75e-04 7.29e-03 4.77e-01 -6.22e-01 -1.98e+00
go:0008608 attachment of spindle microtubules to kinetochore 8.94e-04 7.43e-03 4.77e-01 -5.62e-01 -1.93e+00
go:0005768 endosome 9.03e-04 7.49e-03 4.77e-01 3.11e-01 1.47e+00
go:0035305 negative regulation of dephosphorylation 9.15e-04 7.57e-03 4.77e-01 5.38e-01 1.86e+00
go:0006812 cation transport 9.36e-04 7.73e-03 4.77e-01 3.25e-01 1.51e+00
reactome:R-HSA-427389 ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression 9.60e-04 7.91e-03 4.77e-01 -5.74e-01 -1.91e+00
msig:M5921 HALLMARK_COMPLEMENT 9.68e-04 7.96e-03 4.77e-01 4.35e-01 1.69e+00
reactome:R-HSA-448424 Interleukin-17 signaling 9.81e-04 8.05e-03 4.55e-01 5.50e-01 1.83e+00
go:0008233 peptidase activity 1.00e-03 8.19e-03 4.55e-01 3.61e-01 1.60e+00
msig:M3261 KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 1.01e-03 8.22e-03 4.55e-01 5.80e-01 1.85e+00
go:0046660 female sex differentiation 1.02e-03 8.27e-03 4.55e-01 5.33e-01 1.84e+00
go:0051087 chaperone binding 1.03e-03 8.36e-03 4.55e-01 4.89e-01 1.80e+00
go:0044281 small molecule metabolic process 1.03e-03 8.38e-03 4.55e-01 2.74e-01 1.35e+00
go:0072686 mitotic spindle 1.04e-03 8.40e-03 4.55e-01 -4.14e-01 -1.71e+00
go:0051668 localization within membrane 1.05e-03 8.44e-03 4.55e-01 4.88e-01 1.79e+00
go:0070848 response to growth factor 1.07e-03 8.61e-03 4.55e-01 3.21e-01 1.48e+00
go:0070059 intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress 1.07e-03 8.64e-03 4.55e-01 5.49e-01 1.83e+00
go:1900034 regulation of cellular response to heat 1.09e-03 8.74e-03 4.55e-01 4.97e-01 1.81e+00
go:0044843 cell cycle G1/S phase transition 1.10e-03 8.82e-03 4.55e-01 -3.19e-01 -1.56e+00
msig:M5905 HALLMARK_ADIPOGENESIS 1.12e-03 8.93e-03 4.55e-01 4.05e-01 1.71e+00
reactome:R-HSA-9614085 FOXO-mediated transcription 1.14e-03 9.10e-03 4.55e-01 5.55e-01 1.82e+00
go:0035967 cellular response to topologically incorrect protein 1.16e-03 9.21e-03 4.55e-01 4.35e-01 1.74e+00
msig:M13515 KEGG_MISMATCH_REPAIR 1.17e-03 9.23e-03 4.55e-01 -6.52e-01 -1.97e+00
go:0005788 endoplasmic reticulum lumen 1.16e-03 9.23e-03 4.55e-01 -3.61e-01 -1.67e+00
go:0097529 myeloid leukocyte migration 1.17e-03 9.23e-03 4.55e-01 5.04e-01 1.82e+00
go:0005770 late endosome 1.17e-03 9.24e-03 4.55e-01 4.03e-01 1.70e+00
msig:M5500 KEGG_BASE_EXCISION_REPAIR 1.18e-03 9.32e-03 4.55e-01 -5.90e-01 -1.95e+00
go:0045814 negative regulation of gene expression, epigenetic 1.19e-03 9.35e-03 4.55e-01 -4.16e-01 -1.70e+00
reactome:R-HSA-199992 trans-Golgi Network Vesicle Budding 1.19e-03 9.36e-03 4.55e-01 4.93e-01 1.79e+00
msig:M5951 HALLMARK_SPERMATOGENESIS 1.21e-03 9.45e-03 4.55e-01 -5.07e-01 -1.89e+00
go:0051648 vesicle localization 1.22e-03 9.50e-03 4.55e-01 3.97e-01 1.67e+00
go:0006984 ER-nucleus signaling pathway 1.23e-03 9.63e-03 4.55e-01 5.45e-01 1.81e+00
go:0030424 axon 1.24e-03 9.65e-03 4.55e-01 3.58e-01 1.57e+00
go:0035872 nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway 1.25e-03 9.75e-03 4.55e-01 6.92e-01 1.93e+00
go:0006879 cellular iron ion homeostasis 1.28e-03 9.86e-03 4.55e-01 5.69e-01 1.84e+00
msig:M18937 KEGG_NUCLEOTIDE_EXCISION_REPAIR 1.27e-03 9.86e-03 4.55e-01 -5.04e-01 -1.88e+00
go:0071824 protein-DNA complex subunit organization 1.29e-03 9.95e-03 4.55e-01 -3.25e-01 -1.58e+00
go:0090100 positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway 1.29e-03 9.96e-03 4.55e-01 5.30e-01 1.81e+00
go:0005929 cilium 1.30e-03 1.00e-02 4.55e-01 3.61e-01 1.58e+00
go:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport 1.32e-03 1.01e-02 4.55e-01 4.01e-01 1.66e+00
reactome:R-HSA-2559583 Cellular Senescence 1.35e-03 1.03e-02 4.55e-01 -3.65e-01 -1.63e+00
go:0002520 immune system development 1.37e-03 1.05e-02 4.55e-01 3.21e-01 1.51e+00
go:0044092 negative regulation of molecular function 1.38e-03 1.05e-02 4.55e-01 2.98e-01 1.42e+00
go:0006270 DNA replication initiation 1.39e-03 1.06e-02 4.55e-01 -5.60e-01 -1.90e+00
reactome:R-HSA-446203 Asparagine N-linked glycosylation 1.39e-03 1.06e-02 4.55e-01 3.61e-01 1.57e+00
go:0072507 divalent inorganic cation homeostasis 1.40e-03 1.06e-02 4.55e-01 4.10e-01 1.70e+00
go:0043408 regulation of MAPK cascade 1.40e-03 1.06e-02 4.55e-01 3.32e-01 1.51e+00
reactome:R-HSA-418594 G alpha (i) signalling events 1.42e-03 1.07e-02 4.55e-01 4.55e-01 1.71e+00
go:0051383 kinetochore organization 1.44e-03 1.09e-02 4.55e-01 -6.46e-01 -1.96e+00
reactome:R-HSA-376176 Signaling by ROBO receptors 1.54e-03 1.16e-02 4.55e-01 3.60e-01 1.57e+00
go:0034401 chromatin organization involved in regulation of transcription 1.57e-03 1.17e-02 4.55e-01 -4.30e-01 -1.75e+00
go:1990266 neutrophil migration 1.56e-03 1.17e-02 4.55e-01 5.95e-01 1.88e+00
msig:M10792 KEGG_MAPK_SIGNALING_PATHWAY 1.56e-03 1.17e-02 4.55e-01 4.21e-01 1.70e+00
go:1902532 negative regulation of intracellular signal transduction 1.58e-03 1.18e-02 4.55e-01 3.40e-01 1.53e+00
reactome:R-HSA-3371511 HSF1 activation 1.68e-03 1.25e-02 4.55e-01 6.44e-01 1.89e+00
go:0005730 nucleolus 1.68e-03 1.25e-02 4.55e-01 -2.31e-01 -1.31e+00
reactome:R-HSA-168643 Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways 1.69e-03 1.26e-02 4.55e-01 6.11e-01 1.89e+00
go:0016482 cytosolic transport 1.72e-03 1.27e-02 4.55e-01 4.36e-01 1.68e+00
reactome:R-HSA-373076 Class A/1 (Rhodopsin-like receptors) 1.72e-03 1.28e-02 4.55e-01 6.11e-01 1.89e+00
reactome:R-HSA-75893 TNF signaling 1.75e-03 1.29e-02 4.55e-01 6.36e-01 1.88e+00
go:0051129 negative regulation of cellular component organization 1.75e-03 1.29e-02 4.55e-01 -2.67e-01 -1.41e+00
go:0032434 regulation of proteasomal ubiquitin-dependent protein catabolic process 1.83e-03 1.34e-02 4.55e-01 4.37e-01 1.66e+00
reactome:R-HSA-5663205 Infectious disease 1.84e-03 1.35e-02 4.55e-01 3.16e-01 1.46e+00
go:0072522 purine-containing compound biosynthetic process 1.87e-03 1.37e-02 4.55e-01 -3.48e-01 -1.61e+00
go:0005794 Golgi apparatus 1.91e-03 1.39e-02 4.55e-01 2.73e-01 1.33e+00
go:0051233 spindle midzone 1.91e-03 1.39e-02 4.55e-01 -5.55e-01 -1.87e+00
go:0061659 ubiquitin-like protein ligase activity 1.93e-03 1.40e-02 4.55e-01 3.99e-01 1.62e+00
go:0005102 signaling receptor binding 1.94e-03 1.40e-02 4.55e-01 2.95e-01 1.41e+00
go:0000226 microtubule cytoskeleton organization 1.96e-03 1.41e-02 4.32e-01 -2.70e-01 -1.40e+00
go:0000041 transition metal ion transport 1.96e-03 1.41e-02 4.32e-01 4.95e-01 1.78e+00
go:0051402 neuron apoptotic process 1.96e-03 1.41e-02 4.32e-01 3.99e-01 1.61e+00
go:0045930 negative regulation of mitotic cell cycle 1.96e-03 1.41e-02 4.32e-01 3.46e-01 1.53e+00
go:1990868 response to chemokine 1.97e-03 1.41e-02 4.32e-01 6.71e-01 1.91e+00
go:0005125 cytokine activity 2.00e-03 1.43e-02 4.32e-01 5.53e-01 1.79e+00
go:0034404 nucleobase-containing small molecule biosynthetic process 2.00e-03 1.43e-02 4.32e-01 -4.39e-01 -1.75e+00
go:0045815 positive regulation of gene expression, epigenetic 2.02e-03 1.44e-02 4.32e-01 -4.88e-01 -1.79e+00
go:0045935 positive regulation of nucleobase-containing compound metabolic process 2.06e-03 1.47e-02 4.32e-01 -3.29e-01 -1.55e+00
go:0002683 negative regulation of immune system process 2.06e-03 1.47e-02 4.32e-01 3.72e-01 1.57e+00
go:0010608 posttranscriptional regulation of gene expression 2.09e-03 1.48e-02 4.32e-01 2.96e-01 1.40e+00
reactome:R-HSA-2980766 Nuclear Envelope Breakdown 2.10e-03 1.48e-02 4.32e-01 -4.66e-01 -1.76e+00
go:0006275 regulation of DNA replication 2.10e-03 1.48e-02 4.32e-01 -4.11e-01 -1.68e+00
go:1901987 regulation of cell cycle phase transition 2.12e-03 1.49e-02 4.32e-01 3.23e-01 1.48e+00
go:0006903 vesicle targeting 2.13e-03 1.50e-02 4.32e-01 4.73e-01 1.74e+00
go:0001816 cytokine production 2.20e-03 1.55e-02 4.32e-01 3.27e-01 1.49e+00
go:0005876 spindle microtubule 2.24e-03 1.57e-02 4.32e-01 -4.70e-01 -1.78e+00
reactome:R-HSA-69481 G2/M Checkpoints 2.35e-03 1.64e-02 4.32e-01 4.05e-01 1.67e+00
go:0001818 negative regulation of cytokine production 2.35e-03 1.64e-02 4.32e-01 4.30e-01 1.66e+00
go:0031401 positive regulation of protein modification process 2.42e-03 1.69e-02 4.32e-01 2.85e-01 1.36e+00
go:0060590 ATPase regulator activity 2.44e-03 1.70e-02 4.32e-01 5.55e-01 1.77e+00
go:0043086 negative regulation of catalytic activity 2.46e-03 1.70e-02 4.32e-01 3.10e-01 1.44e+00
go:0051984 positive regulation of chromosome segregation 2.46e-03 1.70e-02 4.32e-01 -5.65e-01 -1.87e+00
go:0060548 negative regulation of cell death 2.47e-03 1.71e-02 4.32e-01 2.95e-01 1.41e+00
go:0019725 cellular homeostasis 2.50e-03 1.73e-02 4.32e-01 3.07e-01 1.43e+00
go:0060420 regulation of heart growth 2.54e-03 1.75e-02 4.32e-01 -5.48e-01 -1.85e+00
go:0051881 regulation of mitochondrial membrane potential 2.54e-03 1.75e-02 4.32e-01 5.21e-01 1.79e+00
msig:M5910 HALLMARK_PROTEIN_SECRETION 2.55e-03 1.75e-02 4.32e-01 4.48e-01 1.71e+00
reactome:R-HSA-500792 GPCR ligand binding 2.56e-03 1.76e-02 4.32e-01 5.11e-01 1.77e+00
go:0030433 ubiquitin-dependent ERAD pathway 2.58e-03 1.77e-02 4.32e-01 4.85e-01 1.75e+00
go:0045910 negative regulation of DNA recombination 2.61e-03 1.79e-02 4.32e-01 -6.29e-01 -1.91e+00
reactome:R-HSA-69242 S Phase 2.63e-03 1.80e-02 4.32e-01 3.81e-01 1.62e+00
go:0030522 intracellular receptor signaling pathway 2.69e-03 1.83e-02 4.32e-01 3.84e-01 1.61e+00
go:0010562 positive regulation of phosphorus metabolic process 2.70e-03 1.84e-02 4.32e-01 3.06e-01 1.44e+00
msig:M5898 HALLMARK_DNA_REPAIR 2.76e-03 1.88e-02 4.32e-01 -3.47e-01 -1.60e+00
go:0007051 spindle organization 2.77e-03 1.88e-02 4.32e-01 -3.54e-01 -1.63e+00
go:0043044 ATP-dependent chromatin remodeling 2.81e-03 1.90e-02 4.32e-01 -4.29e-01 -1.71e+00
go:0005815 microtubule organizing center 2.85e-03 1.93e-02 4.32e-01 -2.52e-01 -1.36e+00
go:0007034 vacuolar transport 2.87e-03 1.94e-02 4.32e-01 4.33e-01 1.67e+00
go:0008284 positive regulation of cell population proliferation 2.89e-03 1.95e-02 4.32e-01 -2.61e-01 -1.38e+00
go:0030219 megakaryocyte differentiation 2.95e-03 1.98e-02 4.32e-01 -4.92e-01 -1.78e+00
go:0007041 lysosomal transport 2.96e-03 1.99e-02 4.32e-01 4.65e-01 1.71e+00
go:2001252 positive regulation of chromosome organization 2.97e-03 1.99e-02 4.32e-01 -3.55e-01 -1.63e+00
reactome:R-HSA-9018519 Estrogen-dependent gene expression 2.99e-03 1.99e-02 4.32e-01 -4.01e-01 -1.64e+00
reactome:R-HSA-9616222 Transcriptional regulation of granulopoiesis 3.00e-03 2.00e-02 4.32e-01 -5.43e-01 -1.83e+00
go:0050660 flavin adenine dinucleotide binding 2.99e-03 2.00e-02 4.32e-01 5.45e-01 1.77e+00
go:0055001 muscle cell development 3.01e-03 2.00e-02 4.32e-01 -4.30e-01 -1.72e+00
reactome:R-HSA-5693607 Processing of DNA double-strand break ends 3.05e-03 2.02e-02 4.32e-01 -4.42e-01 -1.72e+00
go:1901215 negative regulation of neuron death 3.07e-03 2.02e-02 4.32e-01 4.32e-01 1.66e+00
go:0019898 extrinsic component of membrane 3.14e-03 2.07e-02 4.32e-01 4.03e-01 1.63e+00
reactome:R-HSA-199977 ER to Golgi Anterograde Transport 3.19e-03 2.10e-02 4.32e-01 4.06e-01 1.63e+00
reactome:R-HSA-5633007 Regulation of TP53 Activity 3.25e-03 2.13e-02 4.32e-01 -3.49e-01 -1.57e+00
go:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway 3.27e-03 2.14e-02 4.32e-01 3.80e-01 1.59e+00
go:1901137 carbohydrate derivative biosynthetic process 3.28e-03 2.15e-02 4.32e-01 -2.64e-01 -1.38e+00
go:0002221 pattern recognition receptor signaling pathway 3.29e-03 2.15e-02 4.32e-01 4.49e-01 1.69e+00
go:0070972 protein localization to endoplasmic reticulum 3.43e-03 2.23e-02 4.32e-01 -3.34e-01 -1.55e+00
reactome:R-HSA-5205647 Mitophagy 3.52e-03 2.28e-02 4.32e-01 6.07e-01 1.83e+00
go:0061982 meiosis I cell cycle process 3.51e-03 2.28e-02 4.32e-01 -4.76e-01 -1.77e+00
go:0036503 ERAD pathway 3.57e-03 2.31e-02 4.32e-01 4.65e-01 1.72e+00
reactome:R-HSA-5675221 Negative regulation of MAPK pathway 3.58e-03 2.31e-02 4.32e-01 5.92e-01 1.83e+00
go:0006970 response to osmotic stress 3.69e-03 2.38e-02 4.32e-01 5.29e-01 1.73e+00
go:0051187 3.72e-03 2.40e-02 4.32e-01 6.20e-01 1.82e+00
go:0060191 regulation of lipase activity 3.74e-03 2.41e-02 4.32e-01 6.62e-01 1.85e+00
go:0044093 positive regulation of molecular function 3.84e-03 2.47e-02 4.32e-01 2.66e-01 1.31e+00
msig:M5932 HALLMARK_INFLAMMATORY_RESPONSE 3.88e-03 2.49e-02 4.32e-01 4.14e-01 1.57e+00
go:0015630 microtubule cytoskeleton 3.94e-03 2.52e-02 4.07e-01 -2.25e-01 -1.26e+00
go:0009124 nucleoside monophosphate biosynthetic process 4.01e-03 2.56e-02 4.07e-01 -5.06e-01 -1.79e+00
go:0031072 heat shock protein binding 4.01e-03 2.56e-02 4.07e-01 4.47e-01 1.68e+00
go:0030968 endoplasmic reticulum unfolded protein response 4.14e-03 2.64e-02 4.07e-01 4.22e-01 1.61e+00
go:0031012 extracellular matrix 4.20e-03 2.67e-02 4.07e-01 3.85e-01 1.56e+00
go:0022602 ovulation cycle process 4.21e-03 2.67e-02 4.07e-01 6.60e-01 1.81e+00
go:0000803 sex chromosome 4.24e-03 2.69e-02 4.07e-01 -5.79e-01 -1.84e+00
go:0038066 p38MAPK cascade 4.26e-03 2.70e-02 4.07e-01 6.59e-01 1.81e+00
go:0010942 positive regulation of cell death 4.27e-03 2.70e-02 4.07e-01 3.05e-01 1.41e+00
go:0050900 leukocyte migration 4.30e-03 2.71e-02 4.07e-01 3.90e-01 1.63e+00
msig:M5939 HALLMARK_P53_PATHWAY 4.31e-03 2.71e-02 4.07e-01 3.86e-01 1.58e+00
reactome:R-HSA-9010553 Regulation of expression of SLITs and ROBOs 4.37e-03 2.75e-02 4.07e-01 3.64e-01 1.55e+00
go:0046332 SMAD binding 4.41e-03 2.77e-02 4.07e-01 4.97e-01 1.69e+00
go:0055007 cardiac muscle cell differentiation 4.42e-03 2.77e-02 4.07e-01 -4.90e-01 -1.78e+00
reactome:R-HSA-75153 Apoptotic execution phase 4.48e-03 2.80e-02 4.07e-01 -4.75e-01 -1.73e+00
go:0061458 reproductive system development 4.55e-03 2.84e-02 4.07e-01 3.58e-01 1.55e+00
go:0010563 negative regulation of phosphorus metabolic process 4.56e-03 2.84e-02 4.07e-01 3.25e-01 1.47e+00
go:0046685 response to arsenic-containing substance 4.56e-03 2.84e-02 4.07e-01 6.49e-01 1.85e+00
msig:M5109 KEGG_PYRIMIDINE_METABOLISM 4.60e-03 2.85e-02 4.07e-01 -3.87e-01 -1.58e+00
go:0005905 clathrin-coated pit 4.61e-03 2.86e-02 4.07e-01 5.31e-01 1.72e+00
go:0031490 chromatin DNA binding 4.68e-03 2.90e-02 4.07e-01 -4.40e-01 -1.72e+00
go:0035308 negative regulation of protein dephosphorylation 4.70e-03 2.90e-02 4.07e-01 5.90e-01 1.80e+00
go:0000307 cyclin-dependent protein kinase holoenzyme complex 4.74e-03 2.92e-02 4.07e-01 -5.28e-01 -1.80e+00
go:0043604 amide biosynthetic process 4.78e-03 2.95e-02 4.07e-01 -2.29e-01 -1.27e+00
go:0030234 enzyme regulator activity 4.80e-03 2.95e-02 4.07e-01 2.86e-01 1.36e+00
go:0051049 regulation of transport 4.83e-03 2.96e-02 4.07e-01 2.72e-01 1.32e+00
go:0002200 somatic diversification of immune receptors 4.83e-03 2.96e-02 4.07e-01 -5.27e-01 -1.79e+00
go:1902807 negative regulation of cell cycle G1/S phase transition 4.84e-03 2.97e-02 4.07e-01 -3.91e-01 -1.59e+00
reactome:R-HSA-141405 Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components 4.85e-03 2.97e-02 4.07e-01 -6.07e-01 -1.83e+00
go:0055024 regulation of cardiac muscle tissue development 4.90e-03 2.99e-02 4.07e-01 -5.07e-01 -1.76e+00
reactome:R-HSA-73887 Death Receptor Signalling 5.01e-03 3.05e-02 4.07e-01 4.57e-01 1.69e+00
go:0043405 regulation of MAP kinase activity 5.05e-03 3.07e-02 4.07e-01 3.73e-01 1.57e+00
msig:M15902 KEGG_GLYCEROLIPID_METABOLISM 5.08e-03 3.08e-02 4.07e-01 6.37e-01 1.86e+00
reactome:R-HSA-8863795 Downregulation of ERBB2 signaling 5.12e-03 3.10e-02 4.07e-01 6.53e-01 1.83e+00
go:0010508 positive regulation of autophagy 5.12e-03 3.10e-02 4.07e-01 4.61e-01 1.67e+00
go:0009719 response to endogenous stimulus 5.13e-03 3.10e-02 4.07e-01 2.70e-01 1.32e+00
go:0050777 negative regulation of immune response 5.19e-03 3.12e-02 4.07e-01 5.09e-01 1.71e+00
reactome:R-HSA-1227986 Signaling by ERBB2 5.18e-03 3.12e-02 4.07e-01 5.77e-01 1.79e+00
reactome:R-HSA-5357905 Regulation of TNFR1 signaling 5.19e-03 3.12e-02 4.07e-01 6.37e-01 1.85e+00
go:0120163 negative regulation of cold-induced thermogenesis 5.30e-03 3.17e-02 4.07e-01 6.53e-01 1.79e+00
reactome:R-HSA-2559582 Senescence-Associated Secretory Phenotype (SASP) 5.31e-03 3.18e-02 4.07e-01 -4.35e-01 -1.66e+00
go:0032147 activation of protein kinase activity 5.38e-03 3.22e-02 4.07e-01 3.74e-01 1.58e+00
go:0030139 endocytic vesicle 5.51e-03 3.28e-02 4.07e-01 3.67e-01 1.54e+00
go:1904724 tertiary granule lumen 5.52e-03 3.28e-02 4.07e-01 5.43e-01 1.73e+00
go:0071216 cellular response to biotic stimulus 5.54e-03 3.29e-02 4.07e-01 4.24e-01 1.62e+00
go:0006749 glutathione metabolic process 5.57e-03 3.30e-02 4.07e-01 6.01e-01 1.78e+00
go:0051052 regulation of DNA metabolic process 5.61e-03 3.32e-02 4.07e-01 -2.94e-01 -1.44e+00
go:0000422 autophagy of mitochondrion 5.62e-03 3.32e-02 4.07e-01 4.85e-01 1.69e+00
go:0032594 protein transport within lipid bilayer 5.66e-03 3.34e-02 4.07e-01 6.08e-01 1.78e+00
go:1905898 positive regulation of response to endoplasmic reticulum stress 5.71e-03 3.36e-02 4.07e-01 5.89e-01 1.76e+00
go:0090114 COPII-coated vesicle budding 5.76e-03 3.38e-02 4.07e-01 4.62e-01 1.66e+00
go:1901981 phosphatidylinositol phosphate binding 5.76e-03 3.38e-02 4.07e-01 4.73e-01 1.68e+00
reactome:R-HSA-6785807 Interleukin-4 and Interleukin-13 signaling 5.77e-03 3.38e-02 4.07e-01 5.16e-01 1.68e+00
reactome:R-HSA-983231 Factors involved in megakaryocyte development and platelet production 5.81e-03 3.39e-02 4.07e-01 -3.74e-01 -1.58e+00
go:0022627 cytosolic small ribosomal subunit 5.81e-03 3.39e-02 4.07e-01 -4.55e-01 -1.67e+00
go:0009636 response to toxic substance 5.81e-03 3.39e-02 4.07e-01 3.36e-01 1.48e+00
go:0030162 regulation of proteolysis 5.80e-03 3.39e-02 4.07e-01 3.05e-01 1.42e+00
go:0044450 5.86e-03 3.41e-02 4.07e-01 -3.48e-01 -1.54e+00
go:0042391 regulation of membrane potential 5.89e-03 3.42e-02 4.07e-01 3.82e-01 1.55e+00
go:0000139 Golgi membrane 5.94e-03 3.45e-02 4.07e-01 3.01e-01 1.40e+00
go:0072331 signal transduction by p53 class mediator 5.99e-03 3.46e-02 4.07e-01 -3.04e-01 -1.48e+00
go:0007167 enzyme linked receptor protein signaling pathway 5.98e-03 3.46e-02 4.07e-01 2.88e-01 1.36e+00
go:0003697 single-stranded DNA binding 6.09e-03 3.51e-02 4.07e-01 -3.81e-01 -1.60e+00
go:0043524 negative regulation of neuron apoptotic process 6.12e-03 3.52e-02 4.07e-01 4.55e-01 1.65e+00
msig:M6370 KEGG_P53_SIGNALING_PATHWAY 6.17e-03 3.54e-02 4.07e-01 -4.38e-01 -1.66e+00
go:0072523 purine-containing compound catabolic process 6.17e-03 3.54e-02 4.07e-01 -5.88e-01 -1.85e+00
go:0032838 plasma membrane bounded cell projection cytoplasm 6.20e-03 3.54e-02 4.07e-01 4.30e-01 1.63e+00
go:0071897 DNA biosynthetic process 6.19e-03 3.54e-02 4.07e-01 -3.32e-01 -1.52e+00
reactome:R-HSA-211000 Gene Silencing by RNA 6.21e-03 3.54e-02 4.07e-01 -3.99e-01 -1.62e+00
go:0140097 catalytic activity, acting on DNA 6.23e-03 3.55e-02 4.07e-01 -3.34e-01 -1.47e+00
go:2000058 regulation of ubiquitin-dependent protein catabolic process 6.27e-03 3.55e-02 4.07e-01 4.01e-01 1.57e+00
go:1901293 nucleoside phosphate biosynthetic process 6.27e-03 3.55e-02 4.07e-01 -3.02e-01 -1.47e+00
go:0000313 organellar ribosome 6.26e-03 3.55e-02 4.07e-01 -3.51e-01 -1.53e+00
reactome:R-HSA-432722 Golgi Associated Vesicle Biogenesis 6.28e-03 3.55e-02 4.07e-01 4.81e-01 1.68e+00
go:0008202 steroid metabolic process 6.32e-03 3.57e-02 4.07e-01 3.77e-01 1.54e+00
go:0031399 regulation of protein modification process 6.31e-03 3.57e-02 4.07e-01 2.60e-01 1.28e+00
go:0006413 translational initiation 6.39e-03 3.59e-02 4.07e-01 -2.95e-01 -1.46e+00
reactome:R-HSA-983712 Ion channel transport 6.39e-03 3.59e-02 4.07e-01 4.79e-01 1.66e+00
go:0043486 histone exchange 6.42e-03 3.60e-02 4.07e-01 -4.77e-01 -1.71e+00
go:0006338 chromatin remodeling 6.47e-03 3.63e-02 4.07e-01 -3.45e-01 -1.57e+00
go:0048871 multicellular organismal homeostasis 6.57e-03 3.67e-02 4.07e-01 3.70e-01 1.56e+00
reactome:R-HSA-187687 Signalling to ERKs 6.68e-03 3.73e-02 4.07e-01 6.31e-01 1.84e+00
go:0035861 site of double-strand break 6.72e-03 3.74e-02 4.07e-01 -4.46e-01 -1.65e+00
reactome:R-HSA-168898 Toll-like Receptor Cascades 6.73e-03 3.74e-02 4.07e-01 4.29e-01 1.61e+00
go:1903008 organelle disassembly 6.79e-03 3.77e-02 4.07e-01 4.43e-01 1.63e+00
go:0097237 cellular response to toxic substance 6.82e-03 3.78e-02 4.07e-01 3.93e-01 1.58e+00
reactome:R-HSA-1538133 G0 and Early G1 6.83e-03 3.78e-02 4.07e-01 -6.18e-01 -1.83e+00
go:0006629 lipid metabolic process 6.86e-03 3.79e-02 4.07e-01 2.86e-01 1.36e+00
reactome:R-HSA-532668 N-glycan trimming in the ER and Calnexin/Calreticulin cycle 6.87e-03 3.79e-02 4.07e-01 5.61e-01 1.77e+00
go:0000151 ubiquitin ligase complex 6.87e-03 3.79e-02 4.07e-01 3.53e-01 1.51e+00
go:0002228 natural killer cell mediated immunity 6.88e-03 3.79e-02 4.07e-01 6.35e-01 1.81e+00
go:0042110 T cell activation 6.91e-03 3.80e-02 4.07e-01 3.70e-01 1.56e+00
reactome:R-HSA-166520 Signaling by NTRKs 6.94e-03 3.81e-02 4.07e-01 4.67e-01 1.66e+00
go:0055072 iron ion homeostasis 6.94e-03 3.81e-02 4.07e-01 4.67e-01 1.66e+00
reactome:R-HSA-73929 Base-Excision Repair, AP Site Formation 6.96e-03 3.81e-02 4.07e-01 -5.83e-01 -1.83e+00
reactome:R-HSA-5685942 HDR through Homologous Recombination (HRR) 6.98e-03 3.82e-02 4.07e-01 -4.53e-01 -1.70e+00
go:0030705 cytoskeleton-dependent intracellular transport 7.10e-03 3.86e-02 4.07e-01 4.02e-01 1.59e+00
go:0050871 positive regulation of B cell activation 7.10e-03 3.86e-02 4.07e-01 -5.16e-01 -1.74e+00
reactome:R-HSA-5693571 Nonhomologous End-Joining (NHEJ) 7.10e-03 3.86e-02 4.07e-01 -5.04e-01 -1.73e+00
reactome:R-HSA-597592 Post-translational protein modification 7.15e-03 3.87e-02 4.07e-01 2.63e-01 1.29e+00
go:0051225 spindle assembly 7.14e-03 3.87e-02 4.07e-01 -3.77e-01 -1.58e+00
go:0090329 regulation of DNA-dependent DNA replication 7.15e-03 3.87e-02 4.07e-01 -4.85e-01 -1.72e+00
go:0045454 cell redox homeostasis 7.22e-03 3.91e-02 4.07e-01 4.54e-01 1.65e+00
go:1904018 positive regulation of vasculature development 7.32e-03 3.94e-02 4.07e-01 4.42e-01 1.63e+00
go:0043043 peptide biosynthetic process 7.31e-03 3.94e-02 4.07e-01 -2.29e-01 -1.27e+00
go:0097731 9+0 non-motile cilium 7.31e-03 3.94e-02 4.07e-01 5.62e-01 1.74e+00
go:0007173 epidermal growth factor receptor signaling pathway 7.33e-03 3.94e-02 4.07e-01 4.42e-01 1.63e+00
go:0051053 negative regulation of DNA metabolic process 7.35e-03 3.95e-02 4.07e-01 -4.18e-01 -1.63e+00
go:0007179 transforming growth factor beta receptor signaling pathway 7.38e-03 3.96e-02 4.07e-01 4.18e-01 1.61e+00
go:0008088 axo-dendritic transport 7.43e-03 3.97e-02 4.07e-01 5.06e-01 1.66e+00
msig:M1979 KEGG_GNRH_SIGNALING_PATHWAY 7.43e-03 3.97e-02 4.07e-01 5.07e-01 1.66e+00
go:0000956 nuclear-transcribed mRNA catabolic process 7.43e-03 3.97e-02 4.07e-01 -2.94e-01 -1.45e+00
go:0032637 interleukin-8 production 7.47e-03 3.99e-02 4.07e-01 6.01e-01 1.76e+00
go:1901701 cellular response to oxygen-containing compound 7.59e-03 4.05e-02 4.07e-01 2.80e-01 1.33e+00
go:0071396 cellular response to lipid 7.78e-03 4.14e-02 4.07e-01 3.26e-01 1.45e+00
go:0071496 cellular response to external stimulus 7.79e-03 4.14e-02 4.07e-01 3.48e-01 1.48e+00
go:0072593 reactive oxygen species metabolic process 8.00e-03 4.23e-02 3.81e-01 4.18e-01 1.59e+00
go:0035282 segmentation 8.05e-03 4.26e-02 3.81e-01 -5.58e-01 -1.77e+00
reactome:R-HSA-512988 Interleukin-3, Interleukin-5 and GM-CSF signaling 8.08e-03 4.26e-02 3.81e-01 6.28e-01 1.79e+00
go:0031348 negative regulation of defense response 8.10e-03 4.27e-02 3.81e-01 4.35e-01 1.60e+00
go:0070585 protein localization to mitochondrion 8.12e-03 4.28e-02 3.81e-01 3.85e-01 1.56e+00
go:0045786 negative regulation of cell cycle 8.22e-03 4.30e-02 3.81e-01 2.96e-01 1.38e+00
go:1902850 microtubule cytoskeleton organization involved in mitosis 8.21e-03 4.30e-02 3.81e-01 -3.46e-01 -1.51e+00
go:0043130 ubiquitin binding 8.22e-03 4.30e-02 3.81e-01 4.49e-01 1.63e+00
reactome:R-HSA-1236394 Signaling by ERBB4 8.22e-03 4.30e-02 3.81e-01 5.80e-01 1.74e+00
go:0009267 cellular response to starvation 8.21e-03 4.30e-02 3.81e-01 4.10e-01 1.56e+00
go:0010948 negative regulation of cell cycle process 8.23e-03 4.30e-02 3.81e-01 3.25e-01 1.45e+00
go:0032273 positive regulation of protein polymerization 8.26e-03 4.31e-02 3.81e-01 4.21e-01 1.58e+00
go:1990782 protein tyrosine kinase binding 8.29e-03 4.32e-02 3.81e-01 5.11e-01 1.66e+00
go:0046486 glycerolipid metabolic process 8.33e-03 4.34e-02 3.81e-01 3.98e-01 1.51e+00
go:0000027 ribosomal large subunit assembly 8.41e-03 4.37e-02 3.81e-01 -5.55e-01 -1.80e+00
go:0005996 monosaccharide metabolic process 8.45e-03 4.38e-02 3.81e-01 -3.87e-01 -1.56e+00
go:0090174 organelle membrane fusion 8.46e-03 4.38e-02 3.81e-01 4.72e-01 1.65e+00
go:0031100 animal organ regeneration 8.47e-03 4.38e-02 3.81e-01 -4.38e-01 -1.65e+00
go:0045944 positive regulation of transcription by RNA polymerase II 8.50e-03 4.39e-02 3.81e-01 2.76e-01 1.31e+00
go:0061053 somite development 8.53e-03 4.39e-02 3.81e-01 -5.56e-01 -1.77e+00
go:0002237 response to molecule of bacterial origin 8.53e-03 4.39e-02 3.81e-01 3.88e-01 1.56e+00
go:0070126 mitochondrial translational termination 8.55e-03 4.39e-02 3.81e-01 -3.43e-01 -1.50e+00
go:0006289 nucleotide-excision repair 8.56e-03 4.40e-02 3.81e-01 -3.48e-01 -1.50e+00
go:0090305 nucleic acid phosphodiester bond hydrolysis 8.64e-03 4.43e-02 3.81e-01 -2.85e-01 -1.40e+00
go:1903846 positive regulation of cellular response to transforming growth factor beta stimulus 8.80e-03 4.51e-02 3.81e-01 6.30e-01 1.73e+00
go:0031593 polyubiquitin modification-dependent protein binding 8.83e-03 4.51e-02 3.81e-01 5.24e-01 1.67e+00
go:0071383 cellular response to steroid hormone stimulus 8.83e-03 4.51e-02 3.81e-01 3.70e-01 1.52e+00
reactome:R-HSA-5696398 Nucleotide Excision Repair 8.88e-03 4.52e-02 3.81e-01 -3.27e-01 -1.44e+00
go:0098632 cell-cell adhesion mediator activity 8.87e-03 4.52e-02 3.81e-01 5.88e-01 1.74e+00
go:2000060 positive regulation of ubiquitin-dependent protein catabolic process 8.93e-03 4.54e-02 3.81e-01 4.52e-01 1.63e+00
go:0033673 negative regulation of kinase activity 8.99e-03 4.56e-02 3.81e-01 3.80e-01 1.56e+00
go:0033363 secretory granule organization 9.05e-03 4.57e-02 3.81e-01 6.24e-01 1.78e+00
go:0033866 nucleoside bisphosphate biosynthetic process 9.09e-03 4.59e-02 3.81e-01 -4.35e-01 -1.64e+00
go:0120111 neuron projection cytoplasm 9.17e-03 4.60e-02 3.81e-01 4.69e-01 1.62e+00
go:0071806 protein transmembrane transport 9.17e-03 4.60e-02 3.81e-01 4.77e-01 1.62e+00
go:1905897 regulation of response to endoplasmic reticulum stress 9.17e-03 4.60e-02 3.81e-01 4.49e-01 1.62e+00
go:0048194 Golgi vesicle budding 9.16e-03 4.60e-02 3.81e-01 4.47e-01 1.62e+00
go:0016239 positive regulation of macroautophagy 9.16e-03 4.60e-02 3.81e-01 5.21e-01 1.68e+00
go:0000792 heterochromatin 9.19e-03 4.60e-02 3.81e-01 -4.09e-01 -1.61e+00
go:0006665 sphingolipid metabolic process 9.38e-03 4.69e-02 3.81e-01 5.08e-01 1.65e+00
go:0048634 regulation of muscle organ development 9.40e-03 4.70e-02 3.81e-01 -4.05e-01 -1.57e+00
go:0042446 hormone biosynthetic process 9.42e-03 4.70e-02 3.81e-01 5.96e-01 1.75e+00
go:0030595 leukocyte chemotaxis 9.57e-03 4.77e-02 3.81e-01 4.31e-01 1.59e+00
go:0043596 nuclear replication fork 9.67e-03 4.81e-02 3.81e-01 -4.85e-01 -1.69e+00
reactome:R-HSA-948021 Transport to the Golgi and subsequent modification 9.82e-03 4.88e-02 3.81e-01 3.74e-01 1.52e+00
msig:M4844 KEGG_CHEMOKINE_SIGNALING_PATHWAY 9.84e-03 4.88e-02 3.81e-01 4.43e-01 1.60e+00
go:1902751 positive regulation of cell cycle G2/M phase transition 9.87e-03 4.90e-02 3.81e-01 -5.74e-01 -1.80e+00
go:0019079 viral genome replication 1.00e-02 4.97e-02 3.81e-01 -3.63e-01 -1.53e+00
go:0006921 cellular component disassembly involved in execution phase of apoptosis 1.01e-02 4.98e-02 3.81e-01 -5.87e-01 -1.82e+00
reactome:R-HSA-5368287 Mitochondrial translation 1.01e-02 4.98e-02 3.81e-01 -3.25e-01 -1.43e+00
go:0044786 cell cycle DNA replication 1.02e-02 5.02e-02 3.81e-01 -4.01e-01 -1.60e+00
go:0051651 maintenance of location in cell 1.04e-02 5.12e-02 3.81e-01 4.43e-01 1.60e+00
go:0010939 regulation of necrotic cell death 1.04e-02 5.12e-02 3.81e-01 6.20e-01 1.80e+00
go:0007052 mitotic spindle organization 1.04e-02 5.13e-02 3.81e-01 -3.62e-01 -1.52e+00
go:0007032 endosome organization 1.05e-02 5.13e-02 3.81e-01 4.64e-01 1.63e+00
go:0030136 clathrin-coated vesicle 1.05e-02 5.13e-02 3.81e-01 4.11e-01 1.56e+00
go:0050806 positive regulation of synaptic transmission 1.06e-02 5.17e-02 3.81e-01 4.84e-01 1.61e+00
go:0045652 regulation of megakaryocyte differentiation 1.07e-02 5.20e-02 3.81e-01 -4.95e-01 -1.68e+00
go:0097352 autophagosome maturation 1.07e-02 5.20e-02 3.81e-01 5.83e-01 1.72e+00
go:0051235 maintenance of location 1.07e-02 5.23e-02 3.81e-01 3.65e-01 1.52e+00
go:0002931 response to ischemia 1.08e-02 5.24e-02 3.81e-01 5.92e-01 1.73e+00
go:0035578 azurophil granule lumen 1.08e-02 5.25e-02 3.81e-01 4.42e-01 1.60e+00
go:0000152 nuclear ubiquitin ligase complex 1.10e-02 5.34e-02 3.81e-01 -4.93e-01 -1.67e+00
go:0002020 protease binding 1.10e-02 5.35e-02 3.81e-01 4.43e-01 1.61e+00
go:1904666 regulation of ubiquitin protein ligase activity 1.11e-02 5.35e-02 3.81e-01 -6.02e-01 -1.78e+00
go:0006415 translational termination 1.11e-02 5.36e-02 3.81e-01 -3.26e-01 -1.48e+00
go:1901184 regulation of ERBB signaling pathway 1.13e-02 5.44e-02 3.81e-01 4.46e-01 1.61e+00
msig:M7399 KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM 1.14e-02 5.51e-02 3.81e-01 6.17e-01 1.76e+00
msig:M5934 HALLMARK_XENOBIOTIC_METABOLISM 1.16e-02 5.57e-02 3.81e-01 3.86e-01 1.53e+00
reactome:R-HSA-5357956 TNFR1-induced NFkappaB signaling pathway 1.17e-02 5.61e-02 3.81e-01 6.23e-01 1.71e+00
go:0045137 development of primary sexual characteristics 1.18e-02 5.66e-02 3.81e-01 3.87e-01 1.52e+00
reactome:R-HSA-5654732 Negative regulation of FGFR3 signaling 1.19e-02 5.69e-02 3.81e-01 6.20e-01 1.70e+00
msig:M12467 KEGG_ERBB_SIGNALING_PATHWAY 1.19e-02 5.69e-02 3.81e-01 4.88e-01 1.66e+00
reactome:R-HSA-5654727 Negative regulation of FGFR2 signaling 1.19e-02 5.69e-02 3.81e-01 6.20e-01 1.70e+00
go:0002377 immunoglobulin production 1.19e-02 5.69e-02 3.81e-01 -4.44e-01 -1.60e+00
go:0098780 response to mitochondrial depolarisation 1.19e-02 5.69e-02 3.81e-01 6.22e-01 1.70e+00
reactome:R-HSA-1474228 Degradation of the extracellular matrix 1.21e-02 5.75e-02 3.81e-01 4.77e-01 1.59e+00
go:0000726 non-recombinational repair 1.23e-02 5.83e-02 3.81e-01 -4.12e-01 -1.57e+00
go:0042826 histone deacetylase binding 1.24e-02 5.87e-02 3.81e-01 -3.93e-01 -1.57e+00
go:0035051 cardiocyte differentiation 1.24e-02 5.87e-02 3.81e-01 -4.16e-01 -1.59e+00
go:0042594 response to starvation 1.25e-02 5.93e-02 3.81e-01 3.89e-01 1.54e+00
go:0044389 ubiquitin-like protein ligase binding 1.26e-02 5.93e-02 3.81e-01 3.20e-01 1.41e+00
go:0002685 regulation of leukocyte migration 1.26e-02 5.93e-02 3.81e-01 4.22e-01 1.55e+00
go:0007062 sister chromatid cohesion 1.26e-02 5.95e-02 3.81e-01 -4.22e-01 -1.59e+00
go:0051091 positive regulation of DNA-binding transcription factor activity 1.28e-02 6.02e-02 3.81e-01 3.76e-01 1.50e+00
msig:M5923 HALLMARK_PI3K_AKT_MTOR_SIGNALING 1.29e-02 6.05e-02 3.81e-01 4.28e-01 1.58e+00
go:0009617 response to bacterium 1.30e-02 6.11e-02 3.81e-01 3.38e-01 1.44e+00
go:0006401 RNA catabolic process 1.31e-02 6.12e-02 3.81e-01 2.95e-01 1.36e+00
go:0000932 P-body 1.31e-02 6.12e-02 3.81e-01 4.34e-01 1.57e+00
go:0015849 organic acid transport 1.31e-02 6.13e-02 3.81e-01 3.97e-01 1.51e+00
go:0099536 synaptic signaling 1.33e-02 6.21e-02 3.81e-01 3.37e-01 1.43e+00
go:0031935 regulation of chromatin silencing 1.33e-02 6.21e-02 3.81e-01 -5.69e-01 -1.73e+00
go:0048193 Golgi vesicle transport 1.34e-02 6.22e-02 3.81e-01 3.22e-01 1.43e+00
go:0009055 electron transfer activity 1.34e-02 6.23e-02 3.81e-01 3.98e-01 1.52e+00
go:0098793 presynapse 1.35e-02 6.27e-02 3.81e-01 3.52e-01 1.49e+00
go:0045934 negative regulation of nucleobase-containing compound metabolic process 1.35e-02 6.28e-02 3.81e-01 -3.34e-01 -1.46e+00
reactome:R-HSA-6782135 Dual incision in TC-NER 1.36e-02 6.28e-02 3.81e-01 -3.76e-01 -1.52e+00
go:0030155 regulation of cell adhesion 1.36e-02 6.28e-02 3.81e-01 3.03e-01 1.37e+00
go:0032527 protein exit from endoplasmic reticulum 1.36e-02 6.28e-02 3.81e-01 5.10e-01 1.64e+00
reactome:R-HSA-2555396 Mitotic Metaphase and Anaphase 1.37e-02 6.33e-02 3.81e-01 3.33e-01 1.44e+00
go:0005126 cytokine receptor binding 1.38e-02 6.36e-02 3.81e-01 4.05e-01 1.54e+00
go:0072665 protein localization to vacuole 1.38e-02 6.37e-02 3.81e-01 4.70e-01 1.56e+00
go:0006900 vesicle budding from membrane 1.39e-02 6.41e-02 3.81e-01 4.01e-01 1.51e+00
reactome:R-HSA-6804756 Regulation of TP53 Activity through Phosphorylation 1.40e-02 6.42e-02 3.81e-01 -3.76e-01 -1.51e+00
go:0006954 inflammatory response 1.41e-02 6.48e-02 3.81e-01 3.24e-01 1.41e+00
reactome:R-HSA-193704 p75 NTR receptor-mediated signalling 1.42e-02 6.50e-02 3.81e-01 4.69e-01 1.60e+00
go:0044770 cell cycle phase transition 1.42e-02 6.51e-02 3.81e-01 2.82e-01 1.33e+00
go:0032870 cellular response to hormone stimulus 1.44e-02 6.58e-02 3.81e-01 3.02e-01 1.38e+00
go:0016491 oxidoreductase activity 1.45e-02 6.63e-02 3.81e-01 2.90e-01 1.35e+00
go:0003006 developmental process involved in reproduction 1.46e-02 6.66e-02 3.81e-01 3.14e-01 1.42e+00
go:0061025 membrane fusion 1.46e-02 6.66e-02 3.81e-01 4.32e-01 1.60e+00
go:0050863 regulation of T cell activation 1.48e-02 6.73e-02 3.81e-01 3.79e-01 1.49e+00
go:0051130 positive regulation of cellular component organization 1.50e-02 6.81e-02 3.81e-01 2.65e-01 1.28e+00
go:0032432 actin filament bundle 1.50e-02 6.81e-02 3.81e-01 -4.50e-01 -1.62e+00
go:0005814 centriole 1.50e-02 6.81e-02 3.81e-01 -3.56e-01 -1.49e+00
go:0006644 phospholipid metabolic process 1.50e-02 6.81e-02 3.81e-01 4.01e-01 1.52e+00
go:0018022 peptidyl-lysine methylation 1.51e-02 6.83e-02 3.81e-01 -3.75e-01 -1.52e+00
go:0040011 locomotion 1.52e-02 6.85e-02 3.81e-01 2.62e-01 1.27e+00
reactome:R-HSA-5654726 Negative regulation of FGFR1 signaling 1.53e-02 6.91e-02 3.81e-01 6.04e-01 1.69e+00
go:0001678 cellular glucose homeostasis 1.53e-02 6.91e-02 3.81e-01 -3.73e-01 -1.50e+00
go:0045071 negative regulation of viral genome replication 1.54e-02 6.94e-02 3.81e-01 -4.68e-01 -1.63e+00
go:0090092 regulation of transmembrane receptor protein serine/threonine kinase signaling pathway 1.56e-02 6.99e-02 3.81e-01 3.87e-01 1.49e+00
go:1904115 axon cytoplasm 1.56e-02 7.00e-02 3.81e-01 4.85e-01 1.57e+00
go:0003690 double-stranded DNA binding 1.57e-02 7.06e-02 3.52e-01 -2.41e-01 -1.28e+00
reactome:R-HSA-204998 Cell death signalling via NRAGE, NRIF and NADE 1.58e-02 7.07e-02 3.52e-01 5.28e-01 1.67e+00
msig:M16004 KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION 1.58e-02 7.09e-02 3.52e-01 5.38e-01 1.66e+00
reactome:R-HSA-71291 Metabolism of amino acids and derivatives 1.59e-02 7.09e-02 3.52e-01 3.12e-01 1.41e+00
reactome:R-HSA-9006934 Signaling by Receptor Tyrosine Kinases 1.59e-02 7.09e-02 3.52e-01 3.18e-01 1.41e+00
go:0097193 intrinsic apoptotic signaling pathway 1.59e-02 7.09e-02 3.52e-01 3.31e-01 1.43e+00
go:0046622 positive regulation of organ growth 1.63e-02 7.24e-02 3.52e-01 -5.84e-01 -1.73e+00
go:0048199 vesicle targeting, to, from or within Golgi 1.63e-02 7.27e-02 3.52e-01 4.41e-01 1.57e+00
reactome:R-HSA-983189 Kinesins 1.65e-02 7.32e-02 3.52e-01 -4.65e-01 -1.62e+00
go:0042734 presynaptic membrane 1.65e-02 7.32e-02 3.52e-01 5.24e-01 1.64e+00
go:0033043 regulation of organelle organization 1.65e-02 7.32e-02 3.52e-01 -2.11e-01 -1.20e+00
go:0019068 virion assembly 1.67e-02 7.40e-02 3.52e-01 5.02e-01 1.60e+00
msig:M15913 KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY 1.68e-02 7.41e-02 3.52e-01 5.36e-01 1.66e+00
go:0060326 cell chemotaxis 1.69e-02 7.45e-02 3.52e-01 3.92e-01 1.50e+00
msig:M5926 HALLMARK_MYC_TARGETS_V1 1.77e-02 7.80e-02 3.52e-01 -2.62e-01 -1.33e+00
go:0051445 regulation of meiotic cell cycle 1.79e-02 7.88e-02 3.52e-01 -5.51e-01 -1.66e+00
reactome:R-HSA-204005 COPII-mediated vesicle transport 1.79e-02 7.90e-02 3.52e-01 4.48e-01 1.58e+00
go:1901185 negative regulation of ERBB signaling pathway 1.80e-02 7.90e-02 3.52e-01 4.82e-01 1.58e+00
go:0071322 cellular response to carbohydrate stimulus 1.80e-02 7.91e-02 3.52e-01 -3.67e-01 -1.48e+00
go:1901292 nucleoside phosphate catabolic process 1.82e-02 7.98e-02 3.52e-01 -4.59e-01 -1.63e+00
go:0071901 negative regulation of protein serine/threonine kinase activity 1.83e-02 8.03e-02 3.52e-01 4.14e-01 1.52e+00
go:0060291 long-term synaptic potentiation 1.84e-02 8.07e-02 3.52e-01 5.74e-01 1.68e+00
go:1903513 endoplasmic reticulum to cytosol transport 1.85e-02 8.07e-02 3.52e-01 5.62e-01 1.66e+00
go:0006865 amino acid transport 1.88e-02 8.19e-02 3.52e-01 5.00e-01 1.59e+00
go:0007548 sex differentiation 1.88e-02 8.20e-02 3.52e-01 3.60e-01 1.45e+00
reactome:R-HSA-428157 Sphingolipid metabolism 1.88e-02 8.20e-02 3.52e-01 4.52e-01 1.54e+00
go:0061462 protein localization to lysosome 1.89e-02 8.21e-02 3.52e-01 5.61e-01 1.66e+00
go:0045931 positive regulation of mitotic cell cycle 1.89e-02 8.21e-02 3.52e-01 -3.14e-01 -1.39e+00
msig:M1840 KEGG_GLUTATHIONE_METABOLISM 1.90e-02 8.23e-02 3.52e-01 4.99e-01 1.59e+00
go:0036477 somatodendritic compartment 1.92e-02 8.32e-02 3.76e-01 2.92e-01 1.33e+00
go:0030545 receptor regulator activity 1.93e-02 8.33e-02 3.52e-01 3.81e-01 1.47e+00
go:0030544 Hsp70 protein binding 1.94e-02 8.37e-02 3.52e-01 5.44e-01 1.66e+00
go:1901863 positive regulation of muscle tissue development 1.94e-02 8.37e-02 3.52e-01 -5.22e-01 -1.66e+00
reactome:R-HSA-5696400 Dual Incision in GG-NER 1.94e-02 8.37e-02 3.52e-01 -4.06e-01 -1.50e+00
go:1903201 regulation of oxidative stress-induced cell death 1.94e-02 8.37e-02 3.52e-01 4.65e-01 1.57e+00
msig:M3578 KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION 1.95e-02 8.37e-02 3.52e-01 -4.13e-01 -1.55e+00
go:0098655 cation transmembrane transport 1.96e-02 8.43e-02 3.76e-01 3.01e-01 1.36e+00
go:0097190 apoptotic signaling pathway 1.98e-02 8.49e-02 3.52e-01 2.86e-01 1.33e+00
reactome:R-HSA-168138 Toll Like Receptor 9 (TLR9) Cascade 2.01e-02 8.62e-02 3.52e-01 4.45e-01 1.57e+00
go:0030496 midbody 2.03e-02 8.69e-02 3.52e-01 -3.02e-01 -1.40e+00
reactome:R-HSA-176412 Phosphorylation of the APC/C 2.04e-02 8.73e-02 3.52e-01 -5.70e-01 -1.69e+00
go:0051438 regulation of ubiquitin-protein transferase activity 2.05e-02 8.74e-02 3.52e-01 -4.20e-01 -1.53e+00
go:0033572 transferrin transport 2.07e-02 8.83e-02 3.52e-01 5.92e-01 1.72e+00
go:0030133 transport vesicle 2.08e-02 8.83e-02 3.52e-01 3.35e-01 1.42e+00
go:0051186 2.08e-02 8.84e-02 3.52e-01 3.12e-01 1.40e+00
go:1990778 protein localization to cell periphery 2.08e-02 8.85e-02 3.76e-01 3.38e-01 1.43e+00
go:0006959 humoral immune response 2.09e-02 8.88e-02 3.52e-01 4.97e-01 1.60e+00
go:0005875 microtubule associated complex 2.10e-02 8.89e-02 3.52e-01 -3.38e-01 -1.42e+00
reactome:R-HSA-3301854 Nuclear Pore Complex (NPC) Disassembly 2.10e-02 8.89e-02 3.52e-01 -4.62e-01 -1.59e+00
reactome:R-HSA-69273 Cyclin A/B1/B2 associated events during G2/M transition 2.11e-02 8.92e-02 3.52e-01 -5.44e-01 -1.71e+00
go:0101031 chaperone complex 2.12e-02 8.92e-02 3.52e-01 5.91e-01 1.65e+00
go:0032465 regulation of cytokinesis 2.11e-02 8.92e-02 3.52e-01 -3.80e-01 -1.48e+00
go:0045069 regulation of viral genome replication 2.13e-02 8.97e-02 3.52e-01 -3.50e-01 -1.41e+00
go:0009994 oocyte differentiation 2.13e-02 8.98e-02 3.52e-01 -5.40e-01 -1.63e+00
reactome:R-HSA-15869 Metabolism of nucleotides 2.17e-02 9.10e-02 3.52e-01 -3.58e-01 -1.45e+00
go:1902235 regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway 2.17e-02 9.10e-02 3.52e-01 5.61e-01 1.64e+00
reactome:R-HSA-6807878 COPI-mediated anterograde transport 2.17e-02 9.12e-02 3.52e-01 4.13e-01 1.53e+00
go:0032182 ubiquitin-like protein binding 2.19e-02 9.19e-02 3.52e-01 4.00e-01 1.50e+00
go:0005680 anaphase-promoting complex 2.19e-02 9.19e-02 3.52e-01 -5.65e-01 -1.68e+00
go:0071985 multivesicular body sorting pathway 2.21e-02 9.23e-02 3.52e-01 5.27e-01 1.63e+00
go:0010469 regulation of signaling receptor activity 2.21e-02 9.24e-02 3.52e-01 3.54e-01 1.45e+00
go:0050000 chromosome localization 2.23e-02 9.28e-02 3.52e-01 -3.78e-01 -1.47e+00
go:0048525 negative regulation of viral process 2.23e-02 9.29e-02 3.52e-01 -3.84e-01 -1.50e+00
go:0042147 retrograde transport, endosome to Golgi 2.23e-02 9.29e-02 3.52e-01 4.41e-01 1.55e+00
go:0033500 carbohydrate homeostasis 2.24e-02 9.30e-02 3.52e-01 -3.26e-01 -1.40e+00
go:0030666 endocytic vesicle membrane 2.24e-02 9.30e-02 3.52e-01 3.98e-01 1.49e+00
go:1901652 response to peptide 2.26e-02 9.39e-02 3.52e-01 3.10e-01 1.37e+00
go:0007030 Golgi organization 2.27e-02 9.39e-02 3.76e-01 3.96e-01 1.48e+00
go:0051249 regulation of lymphocyte activation 2.27e-02 9.40e-02 3.52e-01 3.47e-01 1.46e+00
go:0001659 temperature homeostasis 2.29e-02 9.46e-02 3.76e-01 4.05e-01 1.47e+00
go:0045178 basal part of cell 2.29e-02 9.46e-02 3.52e-01 5.55e-01 1.64e+00
go:0007346 regulation of mitotic cell cycle 2.29e-02 9.46e-02 3.32e-01 2.74e-01 1.29e+00
go:1903844 regulation of cellular response to transforming growth factor beta stimulus 2.29e-02 9.46e-02 3.76e-01 4.10e-01 1.47e+00
go:0005871 kinesin complex 2.31e-02 9.51e-02 3.52e-01 -4.71e-01 -1.59e+00
go:0006414 translational elongation 2.33e-02 9.59e-02 3.52e-01 -2.93e-01 -1.36e+00
go:0000018 regulation of DNA recombination 2.34e-02 9.59e-02 3.52e-01 -3.74e-01 -1.45e+00
reactome:R-HSA-3214841 PKMTs methylate histone lysines 2.34e-02 9.60e-02 3.52e-01 -4.81e-01 -1.64e+00
go:0010906 regulation of glucose metabolic process 2.34e-02 9.60e-02 3.52e-01 -4.97e-01 -1.64e+00
go:0009607 response to biotic stimulus 2.35e-02 9.62e-02 3.32e-01 2.80e-01 1.30e+00
go:0008289 lipid binding 2.37e-02 9.67e-02 3.42e-01 3.02e-01 1.35e+00
go:1904029 regulation of cyclin-dependent protein kinase activity 2.38e-02 9.68e-02 3.52e-01 -3.60e-01 -1.45e+00
go:0045023 G0 to G1 transition 2.39e-02 9.71e-02 3.52e-01 -4.58e-01 -1.57e+00
go:0007249 I-kappaB kinase/NF-kappaB signaling 2.39e-02 9.71e-02 3.52e-01 3.42e-01 1.43e+00
go:0007017 microtubule-based process 2.40e-02 9.71e-02 3.52e-01 -2.22e-01 -1.20e+00
go:0099513 polymeric cytoskeletal fiber 2.40e-02 9.71e-02 3.52e-01 -2.47e-01 -1.28e+00
go:0009799 specification of symmetry 2.40e-02 9.71e-02 3.52e-01 4.62e-01 1.57e+00
reactome:R-HSA-2559580 Oxidative Stress Induced Senescence 2.40e-02 9.71e-02 3.52e-01 -3.63e-01 -1.45e+00
go:0046649 lymphocyte activation 2.41e-02 9.73e-02 3.42e-01 3.07e-01 1.36e+00
reactome:R-HSA-556833 Metabolism of lipids 2.41e-02 9.73e-02 3.32e-01 2.86e-01 1.32e+00
reactome:R-HSA-177929 Signaling by EGFR 2.42e-02 9.75e-02 3.76e-01 4.80e-01 1.55e+00
go:1903409 reactive oxygen species biosynthetic process 2.42e-02 9.75e-02 3.76e-01 4.74e-01 1.54e+00
go:0016875 ligase activity, forming carbon-oxygen bonds 2.43e-02 9.78e-02 3.76e-01 4.95e-01 1.56e+00
go:0098586 cellular response to virus 2.45e-02 9.86e-02 3.52e-01 5.41e-01 1.63e+00
msig:M5891 HALLMARK_HYPOXIA 2.46e-02 9.86e-02 3.52e-01 3.59e-01 1.48e+00
go:0010632 regulation of epithelial cell migration 2.46e-02 9.86e-02 3.52e-01 3.59e-01 1.44e+00
go:0090066 regulation of anatomical structure size 2.47e-02 9.90e-02 3.42e-01 3.19e-01 1.38e+00
go:1903039 positive regulation of leukocyte cell-cell adhesion 2.47e-02 9.90e-02 3.52e-01 4.06e-01 1.48e+00
go:0010921 regulation of phosphatase activity 2.47e-02 9.90e-02 3.52e-01 3.79e-01 1.44e+00
go:0010821 regulation of mitochondrion organization 2.47e-02 9.90e-02 3.52e-01 3.62e-01 1.45e+00

Literature Mining

INDRA was used to automatically assemble known mechanisms related to PSMD14 from literature and knowledge bases. The first section shows only DUB activity and the second shows all other results.

Deubiquitinase Activity

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
PSMD14 deubiquitinates E2F1. 8 / 8
| 8

reach
This finding led us to hypothesize that POH1 may interact with and deubiquitinate E2F1.

reach
Our present study provides evidence that POH1 deubiquitinates and stabilizes the master transcription factor E2F1 and functions as a tumour promoting protein in HCCs.

reach
We demonstrated that POH1 efficiently deubiquitinates E2F1 by removing the K-63 polyubiquitin chains, and this observation is consistent with previous studies revealing that the JAMM domain within POH1 is responsible for removing K63 linked ubiquitin chains XREF_BIBR XREF_BIBR XREF_BIBR.

reach
In addition, in MG132 treated cells, wherein the global proteasomal activity was inhibited, ectopic POH1 expression was able to deubiquitinate E2F1 (XREF_SUPPLEMENTARY), suggesting that this effect is independent of the overall proteasome function.

reach
Of note, although E2F1 deubiquitination by POH1 has been revealed to be important for E2F1 stabilization, the molecular details of the regulation remain to be defined.

reach
We propose that the deubiquitination of E2F1 by POH1 primarily occurs in the nucleus; as a consequence, the prosurvival genes, including Survivin and FOXM1, are transcriptionally activated.

reach
POH1 knockdown significantly enhanced the levels of E2F1 ubiquitination (XREF_FIG).

reach
In line with our results, a previous study revealed that POH1, a deubiquitinase, binds to and deubiquitinates E2F1, contributing to its stabilization.
PSMD14 deubiquitinates ERBB2. 2 / 2
1 | 1

ubibrowser
POH1 regulates ErbB2, an EGFR family member

reach
We propose that POH1 may deubiquitinate ErbB2 and that this activity is not necessarily coupled to proteasomal degradation.
PSMD14 deubiquitinates TGFB. 2 / 2
| 2

reach
In hepatocellular carcinoma, PSMD14 enhanced the activation of TGF-beta signaling and tumor metastasis by deubiquitinating TGF-beta receptors and caveolin-1 XREF_BIBR.

reach
Mechanistically, POH1 deubiquitinates the TGF-beta receptors and CAV1, therefore negatively regulates lysosome pathway mediated turnover of TGF-beta receptors.
PSMD14 deubiquitinates TGFBR. 2 / 2
| 2

reach
In hepatocellular carcinoma, PSMD14 enhanced the activation of TGF-beta signaling and tumor metastasis by deubiquitinating TGF-beta receptors and caveolin-1 XREF_BIBR.

reach
Mechanistically, POH1 deubiquitinates the TGF-beta receptors and CAV1, therefore negatively regulates lysosome pathway mediated turnover of TGF-beta receptors.
PSMD14 deubiquitinates CAV1. 2 / 2
| 2

reach
Mechanistically, POH1 deubiquitinates the TGF-beta receptors and CAV1, therefore negatively regulates lysosome pathway mediated turnover of TGF-beta receptors.

reach
In hepatocellular carcinoma, PSMD14 enhanced the activation of TGF-beta signaling and tumor metastasis by deubiquitinating TGF-beta receptors and caveolin-1 XREF_BIBR.
Modified PSMD14 leads to the deubiquitination of JUN. 2 / 2
| 2

reach
Ectopic expression of POH1 in HEK293 cells decreased the level of c-Jun ubiquitination, leading to significant accumulation of the protein and a corresponding increase in AP1 mediated gene expression.

reach
A previous study indicated that POH1 overexpression in HEK293 cells downregulates c-Jun ubiquitination, resulting in c-Jun accumulation and upregulation of AP1 mediated gene expression XREF_BIBR.
PSMD14 deubiquitinates GRB2. 1 / 1
1 |

ubibrowser
PSMD14 inhibits degradation of GRB2 via deubiquitinating this oncoprotein in HCC cells.
PSMD14 leads to the deubiquitination of bortezomib. 1 / 1
| 1

reach
Together with the finding that POH1 inhibition induced a distinctly different change in the ubiquitination profile from bortezomib, this compound may have potential as a treatment modality in patients previously treated with bortezomib.
PSMD14 deubiquitinates SNAIL. 1 / 1
| 1

reach
In ESCC, PSMD14 deubiquitinates and stabilizes SNAIL to promote tumor metastasis XREF_BIBR.
PSMD14 deubiquitinates EGFR. 1 / 1
| 1

reach
It is also possible that POH1 may de-ubiquitinate EGFR under steady-state conditions, in which case the receptor will be rescued from degradation in the lysosomal pathway.
PSMD14 deubiquitinates IL1B. 1 / 1
| 1

reach
In addition, IL-1beta is also deubiquitinated by POH1 inhibiting its cleavage by caspase-1 [XREF_BIBR].
PSMD14 leads to the deubiquitination of RNF8. 1 / 1
| 1

reach
These findings are consistent with the previous conclusion that POH1 activity antagonizes RNF8 and RNF168 dependent ubiquitylation and restricts 53BP1 foci size.
PSMD14 deubiquitinates SNAI1. 1 / 1
1 |

ubibrowser
Furthermore, knockdown of PSMD14 significantly blocks SNAIL-induced EMT and then suppresses tumor cell migration and invasion in vitro and tumor metastasis in vivo.
PSMD14 leads to the deubiquitination of RNF168. 1 / 1
| 1

reach
These findings are consistent with the previous conclusion that POH1 activity antagonizes RNF8 and RNF168 dependent ubiquitylation and restricts 53BP1 foci size.
PSMD14 deubiquitinates TRIM21. 1 / 1
| 1

reach
Concurrently, with proteasome-mediated degradation, Poh1 de-ubiquitinates TRIM21 [12].
PSMD14 deubiquitinates POU5F1. 1 / 1
1 |

ubibrowser
Review
PSMD14 deubiquitinates Proteasome. 1 / 1
| 1

reach
It is also speculated that DSF inhibits POH1, a protein which plays an important role in deubiquitinating function of the proteasome lid rather than the actual core proteasome (Chen et al., 2006; Cvek and Dvorak, 2007; Gallery et al., 2007; Yu et al., 2007; Cvek et al., 2008; Yoshino et al., 2020).
| PMC

Other Statements

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
| 2 33
| 18

reach
Inversely, PSMD14 depletion weakened E2F1 expression and promoted the apoptosis of SCC15 and UM1 cells treated with CDDP (XREF_SUPPLEMENTARY A-B).

reach
POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim 1 2 3 4 5.

reach
POH1 Knockdown Induces Apoptosis of Cancer Cells via Mitochondrial Pathway.

reach
POH1 depletion, on the other hand, induces cell apoptosis by increasing stability and inhibiting ubiquitination of p53 and Bim.

reach
Intratumoral injection of POH1 small interfering RNA (siRNA) significantly reduced the progression of tumor growth and induced apoptosis in vivo.

reach
In addition, the intratumoral injection of POH1 siRNAs decreased tumor growth and induced apoptosis in vivo.

reach
We assessed if p53 and Bim were involved in apoptosis mediated by POH1 depletion.

reach
Furthermore, p53 or Bim siRNA markedly attenuated the apoptosis induced by POH1 depletion.

reach
Knockdown of p53 or Bim Decreased Apoptosis Mediated by POH1 Depletion.

reach
We observed that p53 and Bim siRNA markedly decreased the apoptosis driven by POH1 depletion.
| 2 15

reach
PSMD14 knockdown induces cell cycle arrest, senescence and apoptosis by regulating cell cycle proteins in H1299 cells XREF_BIBR.
| PMC

reach
Taken together, POH1 knockdown may induce apoptosis mediated via mitochondrial pathway.

reach
Similarly, PSMD14 knockdown led to apoptosis in both KYSE 30 and KYSE 150 cells (XREF_SUPPLEMENTARY).

reach
PSMD14 knockdown also promoted cell apoptosis by increasing cleaved caspase-3 levels in H1299 cells.

eidos
PSMD14 knockdown induces cell cycle arrest , senescence and apoptosis by regulating cell cycle proteins in H1299 cells 30 .
| PMC

reach
Overall, POH1 knockdown induced cell apoptosis through increased expression of p53 and Bim via enhanced protein stability and attenuated degradation.

reach
POH1 knockdown induced HCC cell apoptosis.

reach
Furthermore, the knockdown of POH1 inhibited tumor progression and induced apoptosis in mitochondria in vitro and RNAi of POH1 achieved similar results in vivo [173].

reach
Furthermore, we observed that POH1 silencing induced cell apoptosis through an increase in the expression of p53 and Bim mediated by enhanced protein stability.

reach
JC-1 staining showed that POH1 knockdown increased the red-to-green fluorescence intensity ratio, indicative of the damage of the mitochondrial transmembrane potential -- one of the signatures of apoptosis mediated by the mitochondrial pathway (XREF_FIG E).
PSMD14 affects E2F1
| 3 20
PSMD14 activates E2F1.
| 1 13
PSMD14 activates E2F1. 10 / 19
| 1 13

reach
Accordingly, depletion of Poh1 in poh1 f/f MEFs could cause an acceleration of E2F1 protein turnover that apparently was not due to the change in E2F1 mRNA levels (XREF_SUPPLEMENTARY).

reach
Moreover, PSMD14 mediated E2F1 stabilization could promote tumor formation in liver cancer XREF_BIBR.

reach
POH1 overexpression positively regulated E2F1 activity, as monitored by an E2F1 binding element-luciferase reporter, whereas POH1 deletion yielded an opposite effect (XREF_FIG).

reach
Therefore, our data indicate that PSMD14 mediated increase of E2F1 directly promotes the transcription activation of SOX2.

reach
Overexpression of the K63 resistant form of ubiquitin (K63R) attenuated POH1 knockdown induced E2F1 downregulation, indicating that K63 linked polyubiquitination is important for POH1 mediated E2F1 turnover (XREF_FIG).

reach
XREF_BIBR proposed that the aberrant upregulation of nuclear POH1 mediated E2F1 stabilization promotes tumor formation in hepatocellular carcinoma (HCC).

reach
In summary, we propose that the aberrant upregulation of nuclear POH1 mediated E2F1 stabilization is an important event in the development of liver cancer and that targeting POH1 might serve as a promising strategy for cancer treatment.

eidos
Through immunoblotting assay , we confirmed that PSMD14 blocking inhibited the expression of E2F1 ( Figure 5A ) , while no obvious change was found in E2F1 mRNA level ( Figure S5 ) .

reach
Briefly, PSMD14 suppressed the degradation of E2F1, and then E2F1 promoted AKT and SOX2 positive feedback loop.

reach
The results indicate that forced POH1 expression significantly potentiates E2F1 protein stability (XREF_FIG).
PSMD14 inhibits E2F1.
| 2 2
PSMD14 inhibits E2F1. 4 / 5
| 2 2

eidos
Then , we validated that the ubiquitination level of E2F1 was greatly elevated in HNSCC cells stably transfected with shPSMD14 ( Figure 5E ) , indicating that PSMD14 prevented the degradation of E2F1 through ubiquitin-proteasome system ( UPS ) .

reach
Furthermore, we generated different siRNA resistant (siR-R) POH1 constructs for rescue assays, and the results showed that restoration of POH1 expression with the C120S-, H113Q- and DeltaJAMM POH1 mutants did not attenuate the inhibition of E2F1 caused by the deletion of endogenous POH1 (XREF_FIG).

eidos
Briefly , PSMD14 suppressed the degradation of E2F1 , and then E2F1 promoted AKT / SOX2 positive feedback loop .

reach
Overexpression of the K63 resistant form of ubiquitin (K63R) attenuated POH1 knockdown induced E2F1 downregulation, indicating that K63 linked polyubiquitination is important for POH1 mediated E2F1 turnover (XREF_FIG).
PSMD14 increases the amount of E2F1.
| 4
PSMD14 increases the amount of E2F1. 2 / 2
| 2

reach
The results of the relative quantification of E2F1 protein levels, as assembled in rank order, showed that knockdown of POH1 markedly repressed E2F1 expression (XREF_FIG).

reach
Through immunoblotting assay, we confirmed that PSMD14 blocking inhibited the expression of E2F1, while no obvious change was found in E2F1 mRNA level (XREF_SUPPLEMENTARY).
Modified PSMD14 increases the amount of E2F1. 1 / 1
| 1

reach
Then, we found that PSMD14 overexpression elevated the level of E2F1 and decreased CDDP induced apoptosis in vitro, while E2F1 silencing circumvented the resistance to CDDP mediated by PSMD14.
Mutated PSMD14 increases the amount of E2F1. 1 / 1
| 1

reach
In addition, the POH1 mutant protein (POH1 (NL)-Flag) with a predominant distribution in cell nucleus efficiently upregulated the expression of E2F1 protein (XREF_FIG).
PSMD14 decreases the amount of E2F1.
| 1
PSMD14 decreases the amount of E2F1. 1 / 1
| 1

reach
We further validated the downregulation of E2F1 expression by POH1 knowdown in different liver cancer cell lines (XREF_FIG; XREF_SUPPLEMENTARY).
PSMD14 affects Ubiquitin
| 18
PSMD14 activates Ubiquitin.
| 14
| 14

reach
Poh1 activates aggresome clearance by producing unanchored K63 ubiquitin chains.

reach
Co-depletion of POH1 and RAP80, BRCC36 or ABRAXAS allows establishment of the 53BP1 and ubiquitin chain-devoid core.

reach
In principle, free ubiquitin chains can also be produced by Poh1 (RPN11), a JAMM and MPN + -domain containing deubiquitinating enzyme that cleaves off ubiquitin chains en bloc from substrates targeted to the proteasome.

reach
Although Poh1 is best characterized for its essential role in 26S proteasome dependent proteolysis, several lines of evidence indicate that Poh1 activates aggresome clearance mainly by producing free K63 ubiquitin chains.

reach
Finally, K63 linked chains might in some instances promote proteasomal degradation, as suggested by another recent study in The EMBO Journal, and Poh1 could allow recycling of ubiquitin.

reach
POH1 is recruited to the IRIF core in a BRCA1 dependent manner, and promotes the clearance of RAP80, the ubiquitin chain and 53BP1 from the IRIF core in G2 phase cells in the late stages of DDR [XREF_BIBR].

reach
Depletion of POH1, a DUB and proteasome subunit, prevents removal of ubiquitin from the core of DSB foci, whereas depletion of both POH1 and RAP80 enables ubiquitin to be removed, consistent with the model that RAP80 preserves polyubiquitin modifications on chromatin [XREF_BIBR].

reach
These findings support the idea that HDAC6 binds K63-linkage containing free ubiquitin chains produced by Poh1 during aggresome clearance.

reach
Although it may seem a bit contradictory, we demonstrate that knockdown of POH1 (a deubiquitining enzyme) could diminish the ubiquitin modification of p53 and Bim, and we speculated there were some reasons.

reach
POH1 (PSMD14, RPN11) is located close to the entrance to the 20S core, and promotes substrate degradation by cleaving entire Ub chains from substrates, allowing the protein to enter the pore for degradation.
PSMD14 inhibits Ubiquitin.
| 4
| 4

reach
Depletion of POH1, a DUB and proteasome subunit, prevents removal of ubiquitin from the core of DSB foci, whereas depletion of both POH1 and RAP80 enables ubiquitin to be removed, consistent with the model that RAP80 preserves polyubiquitin modifications on chromatin [XREF_BIBR].

reach
Attenuation of the ubiquitin conjugate DNA damage signal by the proteasomal DUB POH1.

reach
In addition to an influence on global Ub conjugates, we found the enzymatic activity of POH1 was also required to restrict Ub accumulation at sites of DNA damage following HU and irradiation (IR).

reach
RAP80 and ubiquitin chains persist at the IRIF core in POH1 depleted cells, but the ubiquitin chains are removed from the IRIF core when POH1 and RAP80 are simultaneously depleted [XREF_BIBR], suggesting that DUBs but not POH1 degrade ubiquitin chains.
TCHH affects PSMD14
| 4 10
TCHH inhibits PSMD14.
| 4 9
| 4 9

reach
Besides, the mRNA level of PSMD14 was not affected significantly in both ESCC cell lines tested, indicating that THL only inhibited the DUB activity of PSMD14.

sparser
Despite of the potential inhibition on other JAMM proteases at high concentration, THL could inhibit PSMD14 with a minimum IC 50 xref .

sparser
Together the data indicate that THL inhibits Rpn11 via chelation of its Zn 2+ - ion.

reach
We found that Thiolutin (THL, Figure XREF_FIG A), a disulfide containing antibiotic and anti-angiogenic compound XREF_BIBR, dramatically inhibited DUB activity of PSMD14 (compared with other JAMM DUBs) in a dose-manner dependent using Ubiquitin-AMC assay (XREF_SUPPLEMENTARY), which was in line with the results of previous studies XREF_BIBR.

reach
The data of this study demonstrated that THL significantly suppressed DUB activity of PSMD14 in a dose dependent manner, while neither the protein expression nor mRNA level of PSMD14 was affected.

reach
Taken together, these results indicate that THL blocks the DUB activity of PSMD14 to prevent it from interacting with SNAIL, resulting in the ubiquitination and instability of SNAIL.

sparser
It is possible that free AMC was still produced by Rpn8, which is also a DUB, even though Rpn11 was inhibited by THL.

reach
In addition, THL also prevented PSMD14 from interacting with SNAIL.

reach
Despite of the potential inhibition on other JAMM proteases at high concentration, THL could inhibit PSMD14 with a minimum IC 50 XREF_BIBR.

reach
Overall, these findings indicate that THL could serve as a promising adjuvant to increase chemosensitivity in HNSCC by targeting PSMD14.
TCHH activates PSMD14.
| 1
TCHH activates PSMD14. 1 / 1
| 1

reach
These results verified that THL indeed suppressed SNAIL at the posttranslational level by blocking PSMD14 DUB activity.
PSMD14 affects Proteasome
| 1 7
PSMD14 inhibits Proteasome.
| 5
| 5

reach
Koulich et al. recently demonstrated that siRNA interference of PSMD14 remarkably decreased cellular proteasome activity via disrupted 26S proteasome assembly and inhibited cellular protein degradatio[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
These data confirmed that POH1 depletion attenuates the proteasome mediated degradation of p53 and Bim.

reach
In cancer cells, RNAi of PSMD14 decreased proteasome activity and inhibited cell growth.

reach
One of the proteasome genes overexpressed here, PSMD14, when depleted, severely decreased proteasome proteolytic activity and led to significant inhibition of FANCD2 monoubiquitination [59].

reach
In summary, we propose a simplified mode of action regarding the effects of PSMD14 knockdown in H1299 cells as follow : down-regulation of PSMD14 with siRNA disrupts the function of 26S proteasome and[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
PSMD14 activates Proteasome.
| 1 2
| 1 2

eidos
As SKP2 reduction was observed after PSMD14 knockdown ( data not shown ) , the inhibition of proteasome activity by PSMD14 knockdown and the inhibition of p27 degradation through SKP2 reduction may cause the accumulation of p27 protein in melanoma .
| PMC

reach
By contrast, the ATP independent activity of Poh1 described here could allow the proteasome to spare proteins modified with K63 linked chains from degradation.

reach
To more specifically test for any requirement of the zinc metalloproteinase motif of Poh1 to support cell viability and proteasome function, we developed a RNAi complementation strategy.
| 1 5
PSMD14 inhibits cell growth.
| 1 2
| 1 2

reach
Rpn11 is essential for viability is yeast, and depletion of its human ortholog, POH1, by RNAi inhibits cellular growth.

sparser
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel.

reach
In cancer cells, RNAi of PSMD14 decreased proteasome activity and inhibited cell growth.
PSMD14 activates cell growth.
| 3
| 3

reach
The restoration of E2F1 or Survivin expression in liver cancer cells substantially counteracted POH1 deletion induced cell growth inhibition and apoptotic response (XREF_FIG; XREF_SUPPLEMENTARY).

reach
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel.

reach
Further, knockdown of PSMD14 significantly inhibited cell growth and caused G1 arrest and cellular senescence by increasing p21 stability in LUAD cells.
PSMD14 affects MITF
| 2
PSMD14 inhibits MITF.
| 1
PSMD14 inhibits MITF. 1 / 4
| 1

reach
Finally, we show that mutations in the JAMM motif of POH1 reduced Mitf activation of promoters.
PSMD14 activates MITF.
| 1
PSMD14 activates MITF. 1 / 4
| 1

reach
Overexpression of POH1 increased Mitf 's activation of 5XGal4-TK and Acp5 promoters.
PSMD14 affects UIMC1
| 8
PSMD14 activates UIMC1.
| 4
PSMD14 activates UIMC1. 4 / 4
| 4

reach
One proposed model is that POH1 degrades RAP80 and the loss of RAP80 dependent protection of the ubiquitin chain promotes the removal of ubiquitin, leading to the removal of 53BP1 from the IRIF; however, the detailed molecular mechanism remains to be elucidated.

reach
POH1 is recruited to the IRIF core in a BRCA1 dependent manner, and promotes the clearance of RAP80, the ubiquitin chain and 53BP1 from the IRIF core in G2 phase cells in the late stages of DDR [XREF_BIBR].

reach
The detailed molecular mechanism remains to be elucidated, but one proposed model is that POH1 degrades RAP80 and the loss of RAP80 dependent protection of the ubiquitin chain promotes the removal of ubiquitin, leading to the removal of 53BP1 from the core of IRIF [XREF_BIBR].

reach
(ii) POH1 promotes RAP80 clearance from the IRIF core but is not essential for the clearance of the ubiquitin chains, as a bipolar distribution of ubiquitin chains is regained following combined depletion of POH1 and RAP80.
PSMD14 inhibits UIMC1.
| 3
PSMD14 inhibits UIMC1. 3 / 3
| 3

reach
One proposed model is that POH1 degrades RAP80 and the loss of RAP80 dependent protection of the ubiquitin chain promotes the removal of ubiquitin, leading to the removal of 53BP1 from the IRIF; however, the detailed molecular mechanism remains to be elucidated.

reach
POH1, as a component of the proteasome, may directly degrade RAP80, which allows access of ubiquitin chains to another DUB, or POH1 could remove the ubiquitin chains, which triggers loss of RAP80.

reach
The detailed molecular mechanism remains to be elucidated, but one proposed model is that POH1 degrades RAP80 and the loss of RAP80 dependent protection of the ubiquitin chain promotes the removal of ubiquitin, leading to the removal of 53BP1 from the core of IRIF [XREF_BIBR].
PSMD14 decreases the amount of UIMC1.
| 1
PSMD14 decreases the amount of UIMC1. 1 / 1
| 1

reach
POH1 removes ubiquitin chains to promote loss of RAP80 and 53BP1 from the core.

reach
Knockdown and overexpression experiments elucidated that PSMD14 stimulated OV cell proliferation, invasion and migration in vitro.

reach
The knockdown of POH1 significantly inhibited tumor cell proliferation and induced apoptosis mediated by the mitochondrial pathway in vitro.

reach
Recent studies have demonstrated that p53 is involved in PSMD14 mediated cell proliferation; p53 is upregulated in PSMD14-knockdown cells, and knockdown of PSMD14 induces cancer cell apoptosis mediated via p53 XREF_BIBR.
| PMC

reach
The colony formation assay confirmed that POH1 silencing reduced cell proliferation in HCC, EC, and CRC, as the number of colonies formed by POH1 silenced cells was much lower than that in the control groups (XREF_FIG C).

reach
MTT and colony formation assays revealed that the overexpression of POH1 failed to promote cell proliferation (XREF_FIG E-F).

reach
Ectopic expression of C120S-POH1, the enzyme dead mutant with the capacity of maintaining overall proteasomal activity, did not rescue the suppression of cell proliferation caused by endogenous POH1 deletion (XREF_SUPPLEMENTARY).

reach
POH1 Knockdown Inhibits Cancer Cell Proliferation.
PSMD14 affects TP53BP1
| 7
PSMD14 activates TP53BP1.
| 4
| 4

reach
POH1 is recruited to the IRIF core in a BRCA1 dependent manner, and promotes the clearance of RAP80, the ubiquitin chain and 53BP1 from the IRIF core in G2 phase cells in the late stages of DDR [XREF_BIBR].

reach
Co-depletion of POH1 and RAP80, BRCC36 or ABRAXAS allows establishment of the 53BP1 and ubiquitin chain-devoid core.

reach
Of note, we have previously observed that the enlargement and creation of a devoid core represent distinct steps since siRNA POH1 (a component of the proteasome) allows expansion of 53BP1 but the devoid core does not form.

reach
XREF_BIBR Importantly co-depletion of POH1 and BRCC36 did not elicit 53BP1 foci larger than POH1 depletion alone, suggesting these DUBs act in the same mechanistic pathway to restrict 53BP1 assemblies.
PSMD14 inhibits TP53BP1.
| 2
| 2

reach
Reduced DNA repair in RNF8-, RNF168- or 53BP1 depleted cells, in which no 53BP1 IRIF form, could be countered by co-depletion of POH1, which restored both repair and 53BP1 IRIF.

reach
POH1 activity associated with the proteasome results in cleavage of K63 chains at damage sites, and limits the accumulation of 53BP1 at DSBs.
PSMD14 decreases the amount of TP53BP1.
| 1
PSMD14 decreases the amount of TP53BP1. 1 / 1
| 1

reach
POH1 removes ubiquitin chains to promote loss of RAP80 and 53BP1 from the core.
PSMD14 affects IL1B
| 7
PSMD14 inhibits IL1B.
| 4
PSMD14 inhibits IL1B. 4 / 4
| 4

reach
POH1 negatively regulates IL-1beta production.

reach
As expected, ectopic POH1 expression also substantially inhibited IL-1beta secretion.

reach
Collectively, these results indicate that POH1 in macrophages inhibits IL-1beta activation upon inflammasome activation.

reach
Consistently, POH1 overexpression greatly inhibited IL-1beta secretion in LPS primed cells upon stimulation of ATP, nigericin, poly (dA : dT), flagellin, whereas no significant differences were found in the production of IL-6 or TNFalpha in these BMDMs (Figs.
PSMD14 activates IL1B.
| 2
PSMD14 activates IL1B. 2 / 2
| 2

reach
Unexpectedly, upon treatment with the inflammasome activators, POH1 deficiency did not lead to an increase in pro-caspase-1 cleavage in LPS primed BMDMs, but enhanced cleavage of pro-IL-1beta, as measured by the mature forms of pro-caspase-1 and pro-IL-1beta.

reach
POH1 deficiency in macrophages enhances mature IL-1beta production without significant alterations in inflammasome priming and ASC-caspase-1 activation.
PSMD14 increases the amount of IL1B.
| 1
PSMD14 increases the amount of IL1B. 1 / 1
| 1

reach
Consistently, Poh1 Delta and Delta mice had increased amounts of IL-1beta in cleared peritoneal lavage fluids compared with Poh1 Delta/+ mice upon alum challenge.
PSMD14 affects HDAC6
| 2 2
PSMD14 activates HDAC6. 4 / 6
| 2 2

reach
These results support the model wherein Poh1 activates HDAC6- and cortactin dependent F-actin remodeling required for aggresome clearance.

reach
We conclude that proteasome associated Poh1 activates HDAC6 dependent actinomyosin machinery to facilitate the de-aggregation and clearance of the aggresome.

sparser
Based on aggresome clearance assays and immunoprecipitation experiments in cultured HEK-293T cells, unanchored Lys63-linked Ub chains created by en bloc cleavage by the proteasomal DUB, POH1 bind to and activate HDAC6, promoting clearance of aggresomes ( xref ).

sparser
These results support the model wherein Poh1 activates HDAC6- and cortactin-dependent F-actin remodeling required for aggresome clearance.
PSMD14 affects TP53
| 6
PSMD14 activates TP53.
| 3
PSMD14 activates TP53. 3 / 3
| 3

reach
POH1 Knockdown Attenuates Degradation of p53 and Bim.

reach
Knockdown of POH1 dramatically attenuated the degradation of p53 and Bim in QGY-7701 (XREF_FIG A), EC109 (XREF_FIG B), and HCT116 (XREF_FIG C) cells.

reach
Although it may seem a bit contradictory, we demonstrate that knockdown of POH1 (a deubiquitining enzyme) could diminish the ubiquitin modification of p53 and Bim, and we speculated there were some reasons.
PSMD14 decreases the amount of TP53.
| 2
PSMD14 decreases the amount of TP53. 2 / 2
| 2

reach
Furthermore, knockdown of POH1 upregulated the protein levels of p53 and its targets such as p21, Bax, and Puma but not Noxa.

reach
We found that POH1 knockdown increased the protein level of p53 and Bim but failed to affect their mRNA levels.
PSMD14 inhibits TP53.
| 1
PSMD14 inhibits TP53. 1 / 1
| 1

reach
Furthermore, POH1 silencing resulted in the activation of PARP1, caspase-9, caspase-3, and cytochrome c and upregulation of p53, p21, Bax, Puma, Noxa, and Bim.
PSMD14 affects CDKN1A
| 2 4
PSMD14 inhibits CDKN1A.
| 1 2
| 1 2

reach
Although PSMD14 knockdown induced p21 mRNA, its induction was significantly suppressed by SMAD3 knockdown, but not by SMAD2 knockdown through the specific knockdown of either SMAD2 mRNA or SMAD3 mRNA.
| PMC

eidos
Similar to a previous report , PSMD14 knockdown strongly induced p21 expression and inhibited RB phosphorylation in melanoma .
| PMC

reach
Furthermore, POH1 silencing resulted in the activation of PARP1, caspase-9, caspase-3, and cytochrome c and upregulation of p53, p21, Bax, Puma, Noxa, and Bim.
PSMD14 activates CDKN1A.
| 1 1
PSMD14 activates CDKN1A. 2 / 2
| 1 1

reach
Although main focus of this study was p21 induction by PSMD14, p27 protein was also significantly increased after PSMD14 knockdown.
| PMC

eidos
Although main focus of this study was p21 induction by PSMD14 , p27 protein was also significantly increased after PSMD14 knockdown ( Fig. 1D ) .
| PMC
PSMD14 decreases the amount of CDKN1A.
| 1
PSMD14 decreases the amount of CDKN1A. 1 / 1
| 1

reach
XREF_FIG E, PSMD14 knockdown significantly induced the expression of p21 mRNA in melanoma cells, but not the expression of p27 mRNA, whose gene name is CDKN1B.
| PMC
PSMD14 affects BCL2L11
| 6
PSMD14 activates BCL2L11.
| 4
| 4

reach
POH1 Knockdown Attenuates Degradation of p53 and Bim.

reach
POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim 1 2 3 4 5.

reach
Knockdown of POH1 dramatically attenuated the degradation of p53 and Bim in QGY-7701 (XREF_FIG A), EC109 (XREF_FIG B), and HCT116 (XREF_FIG C) cells.

reach
Although it may seem a bit contradictory, we demonstrate that knockdown of POH1 (a deubiquitining enzyme) could diminish the ubiquitin modification of p53 and Bim, and we speculated there were some reasons.
PSMD14 inhibits BCL2L11.
| 1
| 1

reach
Furthermore, POH1 silencing resulted in the activation of PARP1, caspase-9, caspase-3, and cytochrome c and upregulation of p53, p21, Bax, Puma, Noxa, and Bim.
PSMD14 decreases the amount of BCL2L11.
| 1
PSMD14 decreases the amount of BCL2L11. 1 / 1
| 1

reach
We found that POH1 knockdown increased the protein level of p53 and Bim but failed to affect their mRNA levels.
5 |
Pirinixic acid increases the amount of PSMD14. 5 / 5
5 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Bortezomib affects PSMD14
3 1 | 1
Bortezomib inhibits PSMD14.
3 1 |
3 1 |

tas
No evidence text available

dgi
No evidence text available

tas
No evidence text available
| DOI

tas
No evidence text available
Bortezomib increases the amount of PSMD14.
| 1
Bortezomib increases the amount of PSMD14. 1 / 1
| 1

reach
In addition, the results presented in this current study report for the first time that proteasomal subunit Psmd14, anti-apoptotic GRP78, anti apoptotic protein Card10, Dffb, Traf3 and Trp53bp2 are regulated and overexpressed in response to proteasome inhibitor bortezomib in p53 deficient 4T1 cells.
| 1 4
| 1 3

reach
Further, knockdown of PSMD14 significantly inhibited cell growth and caused G1 arrest and cellular senescence by increasing p21 stability in LUAD cells.

reach
Therefore, there could be an alternative pathway that involves in pRb, cyclin-CDK, CKIs and cyclin-CDK activators in cell cycle arrest and senescence induced by PSMD14 knockdown.

eidos
PSMD14 knockdown induces cell cycle arrest , senescence and apoptosis by regulating cell cycle proteins in H1299 cells 30 .
| PMC

reach
PSMD14 knockdown induces cell cycle arrest, senescence and apoptosis by regulating cell cycle proteins in H1299 cells XREF_BIBR.
| PMC
| 1

reach
Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence.
PSMD14 affects cell cycle
| 2 3
PSMD14 activates cell cycle.
| 2 2
| 2 2

eidos
PSMD14 knockdown induces cell cycle arrest , senescence and apoptosis by regulating cell cycle proteins in H1299 cells 30 .
| PMC

reach
Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence.

eidos
The knockdown of PSMD14 via RNAi has been reported to induce cell cycle arrest , ultimately leading to senescence in carcinoma cell lines [ 76 ] .

reach
Overall, these data suggest that the PSMD14 knockdown arrests the cell cycle at the G0-G 1 and subsequently affects cellular DNA synthesis and mitosis.To determine if the deubiquitinase function of PS[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
PSMD14 inhibits cell cycle.
| 1
| 1

reach
PSMD14 knockdown induces cell cycle arrest, senescence and apoptosis by regulating cell cycle proteins in H1299 cells XREF_BIBR.
| PMC
PSMD14 affects IRF3
| 1 4
PSMD14 activates IRF3.
| 3
PSMD14 activates IRF3. 3 / 3
| 3

reach
In contrast, the deubiquitinase PSMD14/POH1 prevents autophagic degradation of IRF3 by cleaving the K27-linked poly-ubiquitin chains on IRF3 to maintain IRF3-mediated type I IFN activation .

reach
The autophagic degradation of IRF3 mediated by PSMD14 or CALCOCO2 ensures the precise control of IRF3 activity and fine-tunes the immune response against viral infection.

reach
In contrast, the deubiquitinase PSMD14/POH1 prevents autophagic degradation of IRF3 by cleaving the K27-linked poly-ubiquitin chains on IRF3 to maintain IRF3-mediated type I IFN activation (Wu et al., 2021).
PSMD14 inhibits IRF3.
| 1 1
PSMD14 inhibits IRF3. 2 / 2
| 1 1

eidos
Deubiquitinase PSMD14 / POH1 prevents IRF3 from autophagic degradation by cleaving the K27-linked poly-ubiquitin chains at lysine 313 on IRF3 to maintain its basal level and IRF3-mediated type I IFN activation .

reach
Deubiquitinase PSMD14 and POH1 prevents IRF3 from autophagic degradation by cleaving the K27 linked poly-ubiquitin chains at lysine 313 on IRF3 to maintain its basal level and IRF3 mediated type I IFN activation.
| 1 3

reach
Deubiquitinase PSMD14 Enhances Hepatocellular Carcinoma Growth and Metastasis by Stabilizing GRB2.

reach
This suggests that PSMD14 inhibition can suppress both growth and metastasis through SMAD3 induction and SLUG reduction.
| PMC

reach
Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.

eidos
This suggests that PSMD14 inhibition can suppress both growth and metastasis through SMAD3 induction and SLUG reduction .
| PMC
| 4

reach
To more specifically test for any requirement of the zinc metalloproteinase motif of Poh1 to support cell viability and proteasome function, we developed a RNAi complementation strategy.

reach
We studied the oncogenic function of POH1 in solid tumors; knockdown of POH1 expression in QGY-7701, EC109, and HCT116 cells decreased cell viability and induced apoptosis.

reach
PSMD14 siRNA knockdown in another human cell line, hTERT immortalized human mammary epithelial cell line hTERT-HMEC1, caused a dramatic reduction of cell viability (36% viability).

reach
Conversely, ectopic POH1 expression substantially potentiated tumour cell survival in detached culture conditions (XREF_FIG).
Chelator affects PSMD14
| 3 1
| 1 1

reach
Ovaa et al. reported a mono-Ub probe (Fig. 13e) with a zinc chelator 8-mercaptoquinoline (8-MQ) linked to the C terminus of Ub.129 Inhibition assays showed that the probe can inhibit Rpn11/Rpn8 with an IC50 value about 2 μM.

sparser
Thiolutin ( 42 ), a disulfide-containing antibiotic and anti-angiogenic compound produced by Streptomyces, was reported to function as a zinc chelator that inhibits RPN11 and other JAMM metalloproteases [ xref ].
| 2

sparser
Thiolutin is a zinc chelator that inhibits the Rpn11 and other JAMM metalloproteases.

sparser
We show that reduced thiolutin is a zinc chelator that inhibits the JAB1/MPN/Mov34 (JAMM) domain-containing metalloprotease Rpn11, a deubiquitinating enzyme of the 19S proteasome.
PSMD14 affects SNAIL
| 4
PSMD14 activates SNAIL.
| 2
PSMD14 activates SNAIL. 2 / 2
| 2

reach
In conclusion, this study reveals that THL, as a small-molecule inhibitor against PSMD14, attenuates migration and invasion and improves chemosensitivity of ESCC cells by suppressing PSMD14 induced SNAIL accumulation and EMT process.

reach
Subsequently, the deubiquitinating enzyme PSMD14 was identified to target SNAIL for deubiquitination and stabilization.
PSMD14 inhibits SNAIL.
| 1
PSMD14 inhibits SNAIL. 1 / 1
| 1

reach
These findings validate that restriction of PSMD14 induced SNAIL accumulation is one of the major underlying mechanisms by which THL suppresses ESCC malignancy.
PSMD14 decreases the amount of SNAIL.
| 1
PSMD14 decreases the amount of SNAIL. 1 / 1
| 1

reach
Compared with wild-type PSMD14, restoration of PSMD14 expression with the enzyme deficient mutants (C120S-, H113Q- and DeltaJAMM-PSMD14) did not rescue the expression of SNAIL caused by the deletion of endogenous PSMD14 in KYSE 150 cells.
3 |
Cyclosporin A increases the amount of PSMD14. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

tas
No evidence text available

tas
No evidence text available

tas
No evidence text available
| DOI

reach
POH1 relieves the barriers imposed by 53BP1 and RAP80 in the late stages of DDR and induces the switch from NHEJ to HR.

reach
In addition, these authors found that POH1 also enhances RAD51 loading at DNA damage sites, thereby facilitating HR repair.

reach
POH1 also appears to promote HR by a mechanism independent of 53BP1.
PSMD14 affects SNAI2
| 3
PSMD14 increases the amount of SNAI2. 3 / 3
| 3

reach
Although TGF-beta signaling is also related to the invasive phenotype of melanoma, PSMD14 knockdown suppressed melanoma migration and reduced SLUG expression, suggesting that targeting PSMD14 suppresses both growth and migration.

reach
Although TGF-beta signaling is also related to the invasive phenotype of melanoma, PSMD14 knockdown suppressed melanoma migration and reduced SLUG expression, suggesting that targeting PSMD14 suppresses both growth and migration.
| PMC

reach
Targeting PSMD14 inhibits melanoma migration and SLUG expression.
| PMC
PSMD14 affects RAD51
| 2
PSMD14 activates RAD51. 2 / 3
| 2

reach
Additionally, POH1 acts independently of 53BP1 in homologous recombination repair to promote RAD51 loading.

reach
In addition, these authors found that POH1 also enhances RAD51 loading at DNA damage sites, thereby facilitating HR repair.
PSMD14 affects Neoplasms
| 1 1
| 1 1

reach
Furthermore, the knockdown of POH1 inhibited tumor progression and induced apoptosis in mitochondria in vitro and RNAi of POH1 achieved similar results in vivo [173].

eidos
Furthermore , the knockdown of POH1 inhibited tumor progression and induced apoptosis in mitochondria in vitro and RNAi of POH1 achieved similar results in vivo [ 173 ] .
3 |
Bisphenol A increases the amount of PSMD14.
2 |
Bisphenol A increases the amount of PSMD14. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Bisphenol A decreases the amount of PSMD14.
1 |
Bisphenol A decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
| 3
PSMD14 activates proteolysis.
| 2
| 2

reach
Koulich et al. recently demonstrated that siRNA interference of PSMD14 remarkably decreased cellular proteasome activity via disrupted 26S proteasome assembly and inhibited cellular protein degradatio[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
RPN11 inhibition prevents the proteolysis of a subset of polyubiquitinated protein substrates and is emerging as a new proteosome-targeting therapy against breast cancer by perturbing protein homeostasis 34, 35 .
| DOI
PSMD14 inhibits proteolysis.
| 1
| 1

reach
POH1 knockdown could dramatically inhibit GFPu protein degradation in HEK-293 cells and induce ubiquitinated protein accumulation in HepG2 cancer cells, and this disassembly of 26S proteasome could mostly blocked the effects of CuPT on protein degradation and ubiquitinated protein accumulation, indicating that CuPT mediated proteasome malfunction did rely on the existence of intact 26S proteasome.
PSMD14 affects RNF8
| 2
PSMD14 inhibits RNF8.
| 1
PSMD14 inhibits RNF8. 1 / 2
| 1

reach
BRCC36 and POH1 antagonize the actions of RNF8 and RNF168, hydrolyzing the K63 linkages that promote 53BP1 recruitment.
PSMD14 activates RNF8.
| 1
PSMD14 activates RNF8. 1 / 1
| 1

reach
The lack of BRCA1 spreading despite the increase in local K63-Ub, and, further, the inability to restore BRCA1 IRIF in RNF8 depleted cells by reduction of POH1, suggests that Ub binding by RAP80 is insufficient for BRCA1 recruitment.
PSMD14 affects MCL1
| 3
PSMD14 decreases the amount of MCL1.
| 2
PSMD14 decreases the amount of MCL1. 2 / 2
| 2

reach
In addition, knockdown of POH1 upregulated the protein levels of Mcl-1, but the overexpression of POH1 failed to affect the expression of MCl-1.

reach
Taken together, we hypothesize that silence of POH1 causes dysfunction of proteasome and increases the expression of MCl-1.
PSMD14 activates MCL1.
| 1
PSMD14 activates MCL1. 1 / 1
| 1

reach
Unexpectedly, we validated that the proteosomal lid component, PSMD14, and multiple components of the splicosome (PRPF8, UBL5, and SART1) promote Mcl1 pro survival activity.
PSMD14 affects BIRC5
| 2
PSMD14 activates BIRC5.
| 1
PSMD14 activates BIRC5. 1 / 2
| 1

reach
Furthermore, E2F1 inhibition by siRNAs almost entirely abolished POH1 mediated upregulation of Survivin and FOXM1 in liver cancer cells (XREF_FIG).
PSMD14 increases the amount of BIRC5.
| 1
PSMD14 increases the amount of BIRC5. 1 / 1
| 1

reach
Accordingly, POH1 deletion substantially inhibited the expression of Survivin and FOXM1 proteins in human liver cancer cell lines (XREF_FIG; XREF_SUPPLEMENTARY).
PSMD14 affects FOXM1
| 3
PSMD14 increases the amount of FOXM1.
| 2
Modified PSMD14 increases the amount of FOXM1. 1 / 1
| 1

reach
Conversely, the forced expression of exogenous POH1 significantly elevated Survivin and FOXM1 levels (XREF_FIG; XREF_SUPPLEMENTARY), whereas the overrexpression of an enzymatic dead mutant of POH1 failed to up-regulate Survivin and FOXM1 (XREF_SUPPLEMENTARY).
PSMD14 increases the amount of FOXM1. 1 / 1
| 1

reach
POH1 activates Survivin and FOXM1 expression through E2F1.
PSMD14 activates FOXM1.
| 1
PSMD14 activates FOXM1. 1 / 1
| 1

reach
Furthermore, E2F1 inhibition by siRNAs almost entirely abolished POH1 mediated upregulation of Survivin and FOXM1 in liver cancer cells (XREF_FIG).
Tetrachloromethane increases the amount of PSMD14. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Gliotoxin affects PSMD14
| 2
| 2

reach
However, recent studies using the polyubiquitinated protein substrate Ub GST-Wbp2 (WW domain-binding protein 2, n > 30) to measure 26S proteasome-mediated protein degradation have revealed that gliotoxin and other ETPs inhibit proteasome activity in vitro and in cells by targeting the essential deubiquitinase Rpn11 [30,31] in the 19S regulatory complex of the 26S proteasome [111].
| PMC

reach
This assay has demonstrated that gliotoxin and other ETPs inhibit proteasome activity by targeting the essential deubiquitinase Rpn11 in the 19S regulatory complex of the 26S proteasome [111].
| PMC
Cobalt dichloride increases the amount of PSMD14. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
1 1 |
1 1 |

dgi
No evidence text available

tas
No evidence text available
Cadmium dichloride increases the amount of PSMD14. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
PSMD14 affects cisplatin
| 2
| 2

reach
PSMD14 increases cell resistance to cisplatin in HNSCC by enforcing E2F1/Akt/SOX2 axis mediated stemness.

reach
Then, we found that PSMD14 overexpression elevated the level of E2F1 and decreased CDDP induced apoptosis in vitro, while E2F1 silencing circumvented the resistance to CDDP mediated by PSMD14.

reach
To further support this hypothesis we were able to show that Psmd14 overexpression could inhibit differentiation as illustrated in XREF_FIG and XREF_SUPPLEMENTARY.

reach
In addition, the overexpression of Psmd14 and Rpn11 in mESCs antagonized the differentiation and supported the pluripotent state [XREF_BIBR].
PSMD14 affects autophagy
| 2
| 2

reach
We propose that proteasomal Poh1 serves to stimulate compensatory autophagy activity via HDAC6 when the proteasome activity is no longer adequate and challenged by protein aggregates.

reach
When localized to the aggregates, the deubiquitinase activity of RPN-11 and Poh1 releases ubiquitin chains from the aggregated protein, and these ubiquitin chains then serve to activate autophagy via the HDAC6 protein [XREF_BIBR, XREF_BIBR].
PSMD14 affects SOX2
| 2
PSMD14 activates SOX2. 2 / 2
| 2

reach
Therefore, our data indicate that PSMD14 mediated increase of E2F1 directly promotes the transcription activation of SOX2.

reach
Further, the ChIP assay showed that E2F1 bound to the promoter of SOX2, which could be attenuated by PSMD14 silencing.

eidos
Knockdown and overexpression experiments elucidated that PSMD14 stimulated OV cell proliferation , invasion and migration in vitro .

reach
Knockdown and overexpression experiments elucidated that PSMD14 stimulated OV cell proliferation, invasion and migration in vitro.
PSMD14 affects ERBB2
| 2
PSMD14 increases the amount of ERBB2. 2 / 2
| 2

reach
POH1 has also been shown to modulate the expression of ErbB2, a receptor tyrosine kinase whose over-expression is correlated with poor prognosis in breast cancer (Liu et al., 2009).

reach
POH1 can elevate ErbB2 levels by counteracting receptor ubiquitination that occurs following activating signals from growth factors.
PSMD14 affects CTTN
| 1
PSMD14 activates CTTN. 1 / 2
| 1

reach
These results support the model wherein Poh1 activates HDAC6- and cortactin dependent F-actin remodeling required for aggresome clearance.
BRCA1 affects PSMD14
| 2
BRCA1 activates PSMD14. 2 / 2
| 2

reach
We propose a model whereby BRCA1 impacts on 53BP1 to allow access of POH1 to the ubiquitin chains, which in turn facilitates the removal of 53BP1, relieving the barrier to resection.

reach
We propose a model whereby BRCA1 impacts on 53BP1 to allow access of POH1 to RAP80.
Ethanol affects PSMD14
2 |
Ethanol increases the amount of PSMD14.
1 |
Ethanol increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Ethanol decreases the amount of PSMD14.
1 |
Ethanol decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
TLR affects PSMD14
| 2
TLR increases the amount of PSMD14.
| 1
TLR increases the amount of PSMD14. 1 / 1
| 1

reach
POH1 expression is upregulated by the TLR activators.
TLR activates PSMD14.
| 1
TLR activates PSMD14. 1 / 1
| 1

reach
POH1 upregulation induced by TLR stimulation reflects POH1 being a feedback checkpoint for maintaining immune homeostasis.

sparser
Thus, the data indicate that the Rpn11 inhibitors do not inhibit Pol II transcription in mammalian cells.

reach
Therefore, our data indicate that PSMD14 mediated increase of E2F1 directly promotes the transcription activation of SOX2.
PSMD14 affects SKP2
| 1 1
PSMD14 decreases the amount of SKP2.
| 1
PSMD14 decreases the amount of SKP2. 1 / 1
| 1

reach
As p27 degradation is regulated through SKP2 31, PSMD14 knockdown may suppress SKP2 expression or impair the proteasomal degradation of p27 protein.
| PMC
PSMD14 activates SKP2.
| 1
PSMD14 activates SKP2. 1 / 1
| 1

eidos
As p27 degradation is regulated through SKP231 , PSMD14 knockdown may suppress SKP2 expression or impair the proteasomal degradation of p27 protein .
| PMC
PSMD14 affects IL6
| 2
PSMD14 inhibits IL6.
| 1
PSMD14 inhibits IL6. 1 / 1
| 1

reach
In line with our observation, POH1 depleted murine embryonic fibroblasts (MEFs) are competent in the transcriptional activation of IL-6 and TNFalpha upon poly (I : C) stimulation 25.
PSMD14 increases the amount of IL6.
| 1
PSMD14 increases the amount of IL6. 1 / 1
| 1

reach
A recent study reported that POH1 intensifies TRIM21 induced activation of NF-kappaB signalling and subsequently promotes IL-6 and tumour necrosis factoralpha (TNFalpha) expression at their transcriptional levels in murine embryonic fibroblast cells upon AdV and IgG stimulation 25.
PSMD14 affects F_actin
| 2
PSMD14 inhibits F_actin.
| 1
| 1

reach
Importantly, Poh1 KD also suppressed these F-actin structures, phenocopying HDAC6 inactivation (XREF_FIG).
PSMD14 activates F_actin.
| 1
| 1

reach
These results support the model wherein Poh1 activates HDAC6- and cortactin dependent F-actin remodeling required for aggresome clearance.
PSMD14 affects CASP3
| 2
PSMD14 inhibits CASP3.
| 1
PSMD14 inhibits CASP3. 1 / 1
| 1

reach
Furthermore, POH1 silencing resulted in the activation of PARP1, caspase-9, caspase-3, and cytochrome c and upregulation of p53, p21, Bax, Puma, Noxa, and Bim.
PSMD14 activates CASP3.
| 1
PSMD14 activates CASP3. 1 / 1
| 1

reach
Cells treated with POH1 siRNA and p53 or Bim siRNA for 48 hours showed attenuation in the cleaved form of caspase-9 and caspase-3 as compared with those treated with only POH1 siRNA (XREF_FIG A).
1 |
Zinc dichloride increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Valproic acid increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Valdecoxib affects PSMD14
1 |
Valdecoxib increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Trimellitic anhydride increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Topotecan affects PSMD14
1 |
Topotecan decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available

reach
Furthermore, POH1 upregulation by toll like receptor (TLR) stimulation suggests a POH1 mediated negative feedback control for inflammasome dependent inflammation.
Sunitinib affects PSMD14
1 |
Sunitinib decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Sodium arsenite increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available

sparser
POH1 inhibition by siRNAs markedly suppressed the colony-forming ability of three human liver cancer cell lines and the oncogenes-transformed mouse LPCs and the control cells ( xref ; xref ).
1 |
Schizandrin B increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Resveratrol increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Reagent affects PSMD14
| 1
| 1

sparser
Hence, Rpn11 is not generally inhibited by chelating reagents.
Raloxifene hydrochloride decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Protein affects PSMD14
1 |
1 |

bel
Thus, the binding of substrate to the 26S and its concomitant translocation into the 20S results in the activation of Rpn11 through a conformational change.
1 |
Propiconazole increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available

reach
The inducible Poh1 knockout mice (Mx-Cre +, Poh1 f/f), generated by crossing Poh1 f/f mice with Mx-Cre mice, were treated with three rounds of polyinosinic : polycytidylic acid (polyI : C) injection.
1 |

ctd
No evidence text available
Phlorizin affects PSMD14
1 |
Phlorizin decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Perfluorooctanoic acid increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
1 |
Oxaliplatin decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Nitric oxide increases the amount of PSMD14. 1 / 1
1 |

bel
Nitric oxide (NO*) can stabilize mRNA by activating p38 mitogen-activated protein kinase (MAPK). Here, transcript stabilization by NO* was investigated in human THP-1 cells using microarrays. After LPS pre-stimulation, cells were treated with actinomycin D and then exposed to NO* without or with the p38 MAPK inhibitor SB202190 (SB). The decay of 220 mRNAs was affected; most were stabilized by NO*. Unexpectedly, SB often enhanced rather than antagonized transcript stability. NO* activated p38 MAPK and Erk1/2; SB blocked p38 MAPK, but further activated Erk1/2. RT-PCR confirmed that NO* and SB could additively stabilize certain mRNA transcripts, an effect abolished by Erk1/2 inhibition. In affected genes, these responses were associated with CU-rich elements (CURE) in 3'-untranslated regions (3'-UTR). NO* stabilized the mRNA of a CURE-containing reporter gene, while repressing translation. Dominant-negative Mek1, an Erk1/2 inhibitor, abolished this effect. NO* similarly stabilized, but blocked translation of MAP3K7IP2, a natural CURE-containing gene. NO* increased hnRNP translocation to the cytoplasm and binding to CURE. Over-expression of hnRNP K, like NO*, repressed translation of CURE-containing mRNA. These findings define a sequence-specific mechanism of NO*-triggered gene regulation that stabilizes mRNA, but represses translation.
Nimesulide affects PSMD14
1 |
Nimesulide increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Nickel atom decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Nefazodone affects PSMD14
1 |
Nefazodone increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Monosodium L-glutamate increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available

reach
The rapid induction of POH1 in macrophages suggests that a post-transcriptional mechanism is involved in the upregulation of POH1 by LPS or poly (I : C).
1 |
Leflunomide increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |

dgi
No evidence text available
Ionomycin affects PSMD14
1 |
Ionomycin increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
| 1

sparser
It was previously shown that the structurally similar compound 8-quinolinethiol hydrochloride (8TQ) inhibits the essential proteasome deubiquitinase Rpn11, instead of the catalytic subunit of the proteasome, suggesting that QCBT7 may also affect proteasome function ( xref ) [ xref ].
1 |
Hsa-miR-23b-3p decreases the amount of PSMD14. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Gold atom affects PSMD14
1 |
Gold atom decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Glafenine affects PSMD14
1 |
Glafenine increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Fulvestrant decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Flutamide affects PSMD14
1 |
Flutamide increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Finasteride increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
| 1
| 1

sparser
ETPs inhibit Rpn11 and other JAMM proteases.
DsbA affects PSMD14
| 1
DsbA inhibits PSMD14. 1 / 1
| 1

sparser
It is also speculated that DSF inhibits POH1, a protein which plays an important role in deubiquitinating function of the proteasome lid rather than the actual core proteasome ( xref ; xref ; xref ; xref ; xref ; xref ).
| PMC
Dimethyl-4-toluidine increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Dicrotophos decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Dibenzo[a,l]pyrene decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Copper(II) sulfate increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Copper(II) chloride increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Clofibrate affects PSMD14
1 |
Clofibrate increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Cisplatin affects PSMD14
1 |
Cisplatin increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Chloropicrin increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Carbon nanotube increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Cadmium atom decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Bis(2-ethylhexyl) phthalate increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Benzo[a]pyrene increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
Afimoxifene decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Acrylamide affects PSMD14
1 |
Acrylamide increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
ZFAND2A affects PSMD14
| 1
| 1

reach
The proteasomal adaptor AIRAP is able to directly relieve PSMD14/Rpn11 inhibition.
Trans Fatty Acids increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
Tobacco Smoke Pollution increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
TP53BP1 affects PSMD14
| 1
| 1

reach
The fact that RAP80 redistribution is also regained raises the possibility that 53BP1 prevents access of POH1 to ubiquitin chains and/or RAP80 and that BRCA1 overcomes this block.
TLR9 affects PSMD14
| 1
TLR9 increases the amount of PSMD14. 1 / 1
| 1

reach
The TLR9 ligand CpG or IL-1beta, however, failed to induce POH1 expression in BMDMs.
Shock affects PSMD14
| 1
Shock activates PSMD14. 1 / 1
| 1

reach
Heat shock protein 90 (Hsp90) is a binding partner of HDAC6 [77] and contributes to aggresome clearance by stimulating Poh1 to produce unanchored ubiquitin chains [76].
SOX2 affects PSMD14
| 1
SOX2 inhibits PSMD14. 1 / 1
| 1

reach
Immunofluorescence studies showed in response to siRNA mediated knockdown of Psmd14, Ddb1, and Ubr5, ES cells had significant loss of Oct4 protein expression coupled to morphology changes, similar to ES cells lacking Sox2 (XREF_FIG).
| 1

eidos
Rpn11 is essential for viability is yeast , and depletion of its human ortholog , POH1 , by RNAi inhibits cellular growth ( 59 ) .
Proteasome affects PSMD14
| 1
| 1

reach
Interestingly, MPN- subunits of the 26S proteasome lid and of BRCC36 containing complexes are able to activate their otherwise inactive catalytic subunits, Rpn11 and POH1 and BRCC36, respectively XREF_BIBR.
PSMD14 affects substrate
| 1
| 1

eidos
It is thought that the 26S proteasome regulatory subunit RPN11 promotes substrate degradation , while other DUBs delay degradation .
PSMD14 affects protein
1 |
Active PSMD14 increases the amount of protein. 1 / 1
1 |

bel
This activity promotes both the recycling of chains back into the free cellular pool of ubiquitin and creates space for the protein substrate to enter the 20S core.
| 1

reach
Here we show that the deubiquitinase POH1 negatively regulates the immune response triggered by inflammasome activation.
| 1
| 1

reach
POH1 over-expression promoted resistance to doxorubicin, paclitaxel and 7-hydroxysporine (UCN-01), presumably through modulation of AP-1-mediated stress pathways (Spataro et al., 1997).

reach
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel.

reach
The knockdown of PSMD14 via RNAi has been reported to induce cell cycle arrest, ultimately leading to senescence in carcinoma cell lines [76].
PSMD14 affects USP8
| 1
PSMD14 activates USP8. 1 / 1
| 1

reach
Therefore, a second process involving DUBs is the recycling of ubiquitin by preventing its degradation, which is mediated by proteasome associated DUBs USP14, UCH-L5 and UCH37, and POH1, or receptor mediated endocytosis and lysosomal degradation associated DUBs USP8 and AMSH.
PSMD14 affects TNF
| 1
PSMD14 inhibits TNF. 1 / 1
| 1

reach
In line with our observation, POH1 depleted murine embryonic fibroblasts (MEFs) are competent in the transcriptional activation of IL-6 and TNFalpha upon poly (I : C) stimulation 25.

eidos
These data suggest that PSMD14 acts as an oncogene to promote HNSCC progression , and is implicated in the tumorigenesis of HNSCC , which should be further determined using knockout mice with 4-NQO administration .
PSMD14 affects STAMBP
| 1
PSMD14 activates STAMBP. 1 / 1
| 1

reach
Therefore, a second process involving DUBs is the recycling of ubiquitin by preventing its degradation, which is mediated by proteasome associated DUBs USP14, UCH-L5 and UCH37, and POH1, or receptor mediated endocytosis and lysosomal degradation associated DUBs USP8 and AMSH.
PSMD14 affects RNF168
| 1
| 1

reach
BRCC36 and POH1 antagonize the actions of RNF8 and RNF168, hydrolyzing the K63 linkages that promote 53BP1 recruitment.
PSMD14 affects RB1
| 1
PSMD14 activates RB1. 1 / 1
| 1

reach
Strikingly, PSMD14 knockdown did not attenuate the pRb depletion at all, which suggested again that 19S and 20S of proteasome have distinct biological function, although both subunits are required for[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
| 1

reach
Furthermore, the downregulation of PSMD14 and UQCRC2 expression may induce increased oxidative stress in PE, whereas the upregulation of PTGES3 expression may lead to disordered steroid synthesis and metabolism, which could participate in the development of PE.
PSMD14 affects POU5F1
| 1
PSMD14 decreases the amount of POU5F1. 1 / 1
| 1

reach
XREF_BIBR Oct4 protein expression is decreased by depletion of Psmd14, a deubiquitylating enzyme that resides in the 19S ' lid ' of the proteasome.
PSMD14 affects PMAIP1
| 1
| 1

reach
Furthermore, POH1 silencing resulted in the activation of PARP1, caspase-9, caspase-3, and cytochrome c and upregulation of p53, p21, Bax, Puma, Noxa, and Bim.
PSMD14 affects PKM
| 1
PSMD14 inhibits PKM. 1 / 1
| 1

reach
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.

reach
In line with this notion, another deubiquitinase, POH1, was also reported to restrict NLRP3 inflammasome activation by removing the K63-linked ubiquitination of pro-IL-1β.
| PMC
PSMD14 affects NFkappaB
| 1
| 1

reach
Simultaneous with this degradation process, K63 ubiquitin chains released from TRIM21 by the 19S associated deubiquitinase Poh1 stimulate NFkappaB, AP-1 and IRF3 immune transcription pathways, leading to potent activation of pro inflammatory immunity XREF_BIBR XREF_BIBR.
PSMD14 affects NANOG
| 1
PSMD14 increases the amount of NANOG. 1 / 1
| 1

reach
Silencing of the Psmd14 interacting components Psmd13 and Psmd11 induced a significant loss of Nanog-GFP expression, and both are down-regulated during ES differentiation (XREF_SUPPLEMENTARY), suggesting a more global proteasome lid response during differentiation.

reach
Importantly, the inactivation of Poh1 by four different sets of siRNA all dramatically inhibited de-aggregation and clearance of MG132 induced aggresomes (XREF_FIG and XREF_SUPPLEMENTARY).
| 1

eidos
POH1 deubiquitinates pro-IL-1beta and inhibits mature IL-1beta production , thus restricting inflammasome activity and LPS-induced inflammation [ 93 ] .
PSMD14 affects IL2RA
| 1
PSMD14 inhibits IL2RA. 1 / 1
| 1

reach
Moreover, POH1 deficiency significantly attenuated the transition of CD25 + Treg cell precursors into Foxp3 + Treg cells accompanied by downregulation of interleukin 2 (IL-2)-STAT5 signaling.
| 1
| 1

reach
(5) Liberation of K63-linked ubiquitin chains by Poh1 activates IKKα-IKKβ-NEMO and TAK-TAB1-TAB2 which in turn induces NF-κB, AP-1 and IRFs resulting in the production of pro-inflammatory cytokines and an anti-viral state.
| 1
| 1

eidos
Furthermore , stable reduction in PSMD14 ( Figure S1C ) resulted in a considerable decrease of size and weight of xenografts ( Figure 3C ) .
PSMD14 affects Half-Life
| 1
| 1

eidos
Additionally , the results of CHX pulse-chase assay showed that PSMD14 knockdown shortened the half-life of E2F1 and accelerated its degradation ( Figure 5D ) .
PSMD14 affects GRB2
| 1
PSMD14 activates GRB2. 1 / 1
| 1

reach
Deubiquitinase PSMD14 Enhances Hepatocellular Carcinoma Growth and Metastasis by Stabilizing GRB2.
PSMD14 affects EGFR
| 1
PSMD14 activates EGFR. 1 / 1
| 1

reach
Knockdown of POH1 gave a modest increase in ErbB2 turnover, but significantly enhanced the down-regulation of EGFR (XREF_FIG).
PSMD14 affects DNA Damage
| 1
| 1

reach
Attenuation of the ubiquitin conjugate DNA damage signal by the proteasomal DUB POH1.
PSMD14 affects DDB2
| 1
PSMD14 inhibits DDB2. 1 / 1
| 1

reach
In our attempts to understand the underlying mechanism, we found that depletion of the proteasome subunit PSMD14 unequivocally suppressed DDB2 accumulation.
| PMC

reach
In addition, nuclear PSMD14 is elevated in hepatocellular carcinomas and correlates with E2F1 overexpression and tumour growth 41 .
PSMD14 affects CYCS
| 1
PSMD14 inhibits CYCS. 1 / 1
| 1

reach
Furthermore, POH1 silencing resulted in the activation of PARP1, caspase-9, caspase-3, and cytochrome c and upregulation of p53, p21, Bax, Puma, Noxa, and Bim.
PSMD14 affects CDKN1B
| 1
PSMD14 decreases the amount of CDKN1B. 1 / 1
| 1

reach
XREF_FIG E, PSMD14 knockdown significantly induced the expression of p21 mRNA in melanoma cells, but not the expression of p27 mRNA, whose gene name is CDKN1B.
| PMC
PSMD14 affects CASP9
| 1
PSMD14 activates CASP9. 1 / 1
| 1

reach
Cells treated with POH1 siRNA and p53 or Bim siRNA for 48 hours showed attenuation in the cleaved form of caspase-9 and caspase-3 as compared with those treated with only POH1 siRNA (XREF_FIG A).
PSMD14 affects BBC3
| 1
PSMD14 inhibits BBC3. 1 / 1
| 1

reach
Furthermore, POH1 silencing resulted in the activation of PARP1, caspase-9, caspase-3, and cytochrome c and upregulation of p53, p21, Bax, Puma, Noxa, and Bim.
PSMD14 affects BAX
| 1
PSMD14 inhibits BAX. 1 / 1
| 1

reach
Furthermore, POH1 silencing resulted in the activation of PARP1, caspase-9, caspase-3, and cytochrome c and upregulation of p53, p21, Bax, Puma, Noxa, and Bim.
PSMD14 affects ACP5
| 1
PSMD14 activates ACP5. 1 / 1
| 1

reach
Overexpression of POH1 increased Mitf 's activation of 5XGal4-TK and Acp5 promoters.
Oprozomib affects PSMD14
1 |
1 |

dgi
No evidence text available

reach
Besides, MG132 nearly abrogated the inhibition of THL and si-PSMD14 on SNAIL in both KYSE 30 and KYSE 150 cells, suggesting THL regulated proteasome mediated degradation of SNAIL by targeting PSMD14.
IL1B affects PSMD14
| 1
IL1B increases the amount of PSMD14. 1 / 1
| 1

reach
The TLR9 ligand CpG or IL-1beta, however, failed to induce POH1 expression in BMDMs.
Hydrolysis affects PSMD14
| 1
| 1

eidos
Rpn11 is activated by proteasome association as well as by ATP hydrolysis [ 165 ] .
Heat affects PSMD14
| 1
Heat activates PSMD14. 1 / 1
| 1

reach
Heat shock protein 90 (Hsp90) is a binding partner of HDAC6 [77] and contributes to aggresome clearance by stimulating Poh1 to produce unanchored ubiquitin chains [76].
HSP90 affects PSMD14
| 1
HSP90 activates PSMD14. 1 / 1
| 1

reach
Heat shock protein 90 (Hsp90) is a binding partner of HDAC6 [77] and contributes to aggresome clearance by stimulating Poh1 to produce unanchored ubiquitin chains [76].
HDAC6 affects PSMD14
| 1
HDAC6 activates PSMD14. 1 / 1
| 1

reach
As HDAC6 binds unanchored ubiquitin chains in vitro (XREF_FIG), we investigated if HDAC6 is a regulatory target of Poh1.
E2F1 affects PSMD14
| 1
E2F1 activates PSMD14. 1 / 1
| 1

reach
Furthermore, E2F1 inhibition by siRNAs almost entirely abolished POH1 mediated upregulation of Survivin and FOXM1 in liver cancer cells (XREF_FIG).
1 |
1 |

tas
No evidence text available
BRCC3 affects PSMD14
| 1
BRCC3 activates PSMD14. 1 / 1
| 1

reach
Interestingly, MPN- subunits of the 26S proteasome lid and of BRCC36 containing complexes are able to activate their otherwise inactive catalytic subunits, Rpn11 and POH1 and BRCC36, respectively XREF_BIBR.
1 |
Aroclor 1254 decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
2-hydroxypropanoic acid decreases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
1 |
1H-pyrazole increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1 |
17beta-estradiol increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
17alpha-ethynylestradiol increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available
1,2-dithiol-3-thione increases the amount of PSMD14. 1 / 1
1 |

ctd
No evidence text available